{"PubmedArticle":[{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"32430766","DateCompleted":{"Year":"2020","Month":"07","Day":"01"},"DateRevised":{"Year":"2020","Month":"07","Day":"01"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1435-1269","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"53","Issue":"4","PubDate":{"Year":"2020","Month":"Jul"}},"Title":"Zeitschrift fur Gerontologie und Geriatrie","ISOAbbreviation":"Z Gerontol Geriatr"},"ArticleTitle":"Neurogeriatrics-a\u00a0vision for improved care and research for geriatric patients with predominating neurological disabilities.","Pagination":{"MedlinePgn":"340-346"},"ELocationID":"10.1007\/s00391-020-01734-1","Abstract":{"AbstractText":"Geriatric medicine is a\u00a0rapidly evolving field that addresses diagnostic, therapeutic and care aspects of older adults. Some disabilities and disorders affecting cognition (e.g. dementia), motor function (e.g. stroke, Parkinson's disease, neuropathies), mood (e.g. depression), behavior (e.g. delirium) and chronic pain disorders are particularly frequent in old subjects. As knowledge about these age-associated conditions and disabilities is steadily increasing, the integral implementation of neurogeriatric knowledge in geriatric medicine and specific neurogeriatric research is essential to develop the field. This article discusses how neurological know-how could be integrated in academic geriatric medicine to improve care of neurogeriatric patients, to foster neurogeriatric research and training concepts and to provide innovative care concepts for geriatric patients with predominant neurological conditions and disabilities."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Jacobs","ForeName":"Andreas H","Initials":"AH","AffiliationInfo":{"Affiliation":"Department for Geriatric Medicine and Neurology, Johanniter Hospital, Bonn and European Institute for Molecular Imaging (EIMI), University of M\u00fcnster, M\u00fcnster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Emmert","ForeName":"Kirsten","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Baron","ForeName":"Ralf","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartsch","ForeName":"Thorsten","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bauer","ForeName":"Juergen","Initials":"J","AffiliationInfo":{"Affiliation":"Center for Geriatric Medicine, University of Heidelberg and Agaplesion Bethanien Hospital, Heidelberg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Becker","ForeName":"Clemens","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Clinical Gerontology, Robert Bosch Hospital, Stuttgart, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bergmann","ForeName":"Philipp","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Internal Medicine I, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Boetzel","ForeName":"Kai","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital LMU Munich, Munich, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bollheimer","ForeName":"Cornelius","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschl","ForeName":"Guenther","Initials":"G","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Djukic","ForeName":"Marija","Initials":"M","AffiliationInfo":[{"Affiliation":"Department of Neuropathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."},{"Affiliation":"Department of Geriatrics, Protestant Hospital G\u00f6ttingen-Weende, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Drey","ForeName":"Michael","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Medicine IV, University Hospital LMU Munich, Munich, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Durwen","ForeName":"Herbert","Initials":"H","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, St. Martinus Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ebersbach","ForeName":"Georg","Initials":"G","AffiliationInfo":{"Affiliation":"Hospital for Movement Disorders\/Parkinson's Disease, Beelitz-Heilst\u00e4tten, Beelitz, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Elshehabi","ForeName":"Morad","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geritz","ForeName":"Johanna","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gisinger","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Center for Geriatric Medicine and Geriatric Nursing, Danube University Krems, Krems an der Donau, Austria."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Guennewig","ForeName":"Thomas","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Geriatrics and Neurology, Elisabeth Hospital Recklinghausen, Recklinghausen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauptmann","ForeName":"Bjoern","Initials":"B","AffiliationInfo":[{"Affiliation":"Department of Neurology, Segeberger Kliniken, Bad Segeberg, Germany."},{"Affiliation":"Department of Therapeutic Sciences, MSH Medical School Hamburg, Hamburg, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Heppner","ForeName":"Hans-Juergen","Initials":"HJ","AffiliationInfo":[{"Affiliation":"Department of Geriatrics, University Witten\/Herdecke, Schwelm, Germany."},{"Affiliation":"Helios Clinic Schwelm, Schwelm, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hobert","ForeName":"Markus A","Initials":"MA","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hofmann","ForeName":"Werner","Initials":"W","AffiliationInfo":{"Affiliation":"Geriatric Center Neum\u00fcnster and Bad Bramstedt, Friedrich-Ebert-Hospital Neum\u00fcnster, Neum\u00fcnster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Huellemann","ForeName":"Philipp","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jahn","ForeName":"Klaus","Initials":"K","AffiliationInfo":[{"Affiliation":"Sch\u00f6n Klinik Bad Aibling, Bad Aibling, Germany."},{"Affiliation":"German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians-University of Munich, Munich, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Klucken","ForeName":"Jochen","Initials":"J","AffiliationInfo":[{"Affiliation":"Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg, Erlangen, Germany."},{"Affiliation":"Research Group Digital Health Pathways, Fraunhofer IIS, Erlangen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurth","ForeName":"Roland","Initials":"R","AffiliationInfo":{"Affiliation":"Neurological Practice Roland Kurth, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lindner","ForeName":"Reinhard","Initials":"R","AffiliationInfo":{"Affiliation":"Institute for Social Work, University of Kassel, Kassel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lingor","ForeName":"Paul","Initials":"P","AffiliationInfo":[{"Affiliation":"Department of Neurology, Technical University of Munich, Munich, Germany."},{"Affiliation":"Department of Neurology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Lukas","ForeName":"Albert","Initials":"A","AffiliationInfo":[{"Affiliation":"Agaplesion Bethesda Clinic, Competence Centre of Geriatrics and Aging Research, University of Ulm, Ulm, Germany."},{"Affiliation":"Malteser Hospital Bonn, Geriatric Centre, Academic Teaching Hospital, University of Bonn, Bonn, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzold","ForeName":"Sara","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mokrusch","ForeName":"Thomas","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Neurology and Early Neurological Rehabilitation, MediClin Hedon Klinik Lingen, Lingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mollenhauer","ForeName":"Brit","Initials":"B","AffiliationInfo":[{"Affiliation":"Paracelsus-Elena-Klinik Kassel, Kassel, Germany."},{"Affiliation":"Department of Neurology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Nau","ForeName":"Roland","Initials":"R","AffiliationInfo":[{"Affiliation":"Department of Neuropathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."},{"Affiliation":"Department of Geriatrics, Protestant Hospital G\u00f6ttingen-Weende, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Plate","ForeName":"Annika","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital LMU Munich, Munich, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Polidori","ForeName":"Maria Cristina","Initials":"MC","AffiliationInfo":{"Affiliation":"Ageing Clinical Research, Dpt. II Internal Medicine, University Hospital of Cologne, and Cologne Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases, Cologne, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Prell","ForeName":"Tino","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Neurology, Jena University Hospital, Jena, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schellinger","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Departments of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, Ruhr University Bochum, Minden, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Spira","ForeName":"Dominik","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Endocrinology and Metabolism, Charit\u00e9-University Medical Center, Berlin, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephani","ForeName":"Ulrich","Initials":"U","AffiliationInfo":{"Affiliation":"Department of Neuropediatrics, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Studt","ForeName":"Simone","Initials":"S","AffiliationInfo":{"Affiliation":"Gerontopsychiatry, Department of Psychiatry and Psychotherapy, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Trenkwalder","ForeName":"Claudia","Initials":"C","AffiliationInfo":[{"Affiliation":"Clinic of Neurosurgery, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."},{"Affiliation":"Paracelsus-Elena Klinik, Kassel, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Unger","ForeName":"Heinz L","Initials":"HL","AffiliationInfo":{"Affiliation":"Department of Geriatrics and Early Rehabilitation, Evangelical Hospital Kalk Cologne, Cologne, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Urban","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurology, Asklepios Klinik Barmbek, Hamburg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"von Arnim","ForeName":"Christine A F","Initials":"CAF","AffiliationInfo":{"Affiliation":"Department of Geriatrics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Warnecke","ForeName":"Tobias","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Neurology, University of M\u00fcnster, M\u00fcnster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Weiss","ForeName":"Michael","Initials":"M","AffiliationInfo":{"Affiliation":"Clinic for Neurology and Clinical Neurophysiology, Sch\u00f6n Klinik Neustadt, Neustadt, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wiedemann","ForeName":"Andreas","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Urology, Evangelical Hospital Witten, Witten, Germany."},{"Affiliation":"Department of Geriatrics, Witten-Herdecke University, Witten, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wirth","ForeName":"Rainer","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, Marien Hospital Herne, University Hospital Ruhr University Bochum, Bochum, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Witt","ForeName":"Karsten","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Neurology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dodel","ForeName":"Richard","Initials":"R","AffiliationInfo":{"Affiliation":"Chair of Geriatrics, University Hospital Essen and Geriatriezentrum Haus Berge, Contilia Group, Essen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, House D, 24105, Kiel, Germany. w.maetzler@neurologie.uni-kiel.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Review"]},"VernacularTitle":"Neurogeriatrie \u2013 eine Vision f\u00fcr die verbesserte Versorgung und Forschung f\u00fcr geriatrische Patienten mit f\u00fchrend neurologischen Erkrankungen.","ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2020","Month":"05","Day":"19"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Z Gerontol Geriatr","NlmUniqueID":"9506215","ISSNLinking":"0948-6704"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Delirium"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Geriatrics"},{"DescriptorName":"Humans"},{"DescriptorName":"Nervous System Diseases","QualifierName":"therapy"},{"DescriptorName":"Parkinson Disease","QualifierName":"therapy"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Centers for Aging Medicine","Cognitive decline","Interdisciplinarity","Movement disorder","Multidisciplinary team","Neurogeriatric assessment","Neurology"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2020","Month":"03","Day":"17"},{"@attributes":{"PubStatus":"accepted"},"Year":"2020","Month":"04","Day":"20"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2020","Month":"5","Day":"21","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"7","Day":"2","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2020","Month":"5","Day":"21","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["32430766","10.1007\/s00391-020-01734-1","10.1007\/s00391-020-01734-1","PMC7311516"]},"ReferenceList":{"Reference":[{"Citation":"Lancet. 2000 Sep 9;356(9233):894-9","ArticleIdList":{"ArticleId":"11036894"}},{"Citation":"Lancet. 2015 Apr 25;385(9978):1623-33","ArticleIdList":{"ArticleId":"25662415"}},{"Citation":"Front Aging Neurosci. 2018 Mar 23;10:80","ArticleIdList":{"ArticleId":"29628887"}},{"Citation":"BMC Geriatr. 2014 Jun 12;14:73","ArticleIdList":{"ArticleId":"24924703"}},{"Citation":"BMC Neurol. 2015 Oct 09;15:192","ArticleIdList":{"ArticleId":"26452640"}},{"Citation":"BMJ. 2011 Oct 27;343:d6553","ArticleIdList":{"ArticleId":"22034146"}},{"Citation":"J Geriatr Oncol. 2020 Jan 9;:","ArticleIdList":{"ArticleId":"31928942"}},{"Citation":"CNS Spectr. 2016 Jun;21(3):223-9","ArticleIdList":{"ArticleId":"27322690"}},{"Citation":"JAMA. 2007 Jan 3;297(1):77-86","ArticleIdList":{"ArticleId":"17200478"}},{"Citation":"Dtsch Arztebl Int. 2020 Jan 24;117(4):53-59","ArticleIdList":{"ArticleId":"32036854"}},{"Citation":"Lancet Neurol. 2019 Feb;18(2):177-184","ArticleIdList":{"ArticleId":"30663607"}},{"Citation":"Z Gerontol Geriatr. 2019 Jul;52(4):324-329","ArticleIdList":{"ArticleId":"31139963"}},{"Citation":"Gerontology. 2014;60(6):483-92","ArticleIdList":{"ArticleId":"25171300"}},{"Citation":"Lancet Neurol. 2016 Mar;15(3):249-58","ArticleIdList":{"ArticleId":"26795874"}},{"Citation":"J Am Geriatr Soc. 1984 Apr;32(4):253-8","ArticleIdList":{"ArticleId":"6368651"}},{"Citation":"N Engl J Med. 2009 Jul 9;361(2):109-12","ArticleIdList":{"ArticleId":"19494209"}},{"Citation":"Neurorehabil Neural Repair. 2015 Feb;29(2):103-11","ArticleIdList":{"ArticleId":"24961993"}},{"Citation":"J Am Med Dir Assoc. 2017 Feb 1;18(2):192.e1-192.e11","ArticleIdList":{"ArticleId":"28049616"}},{"Citation":"J Am Geriatr Soc. 2016 Jul;64(7):1400-4","ArticleIdList":{"ArticleId":"27351753"}},{"Citation":"J Am Geriatr Soc. 2012 Jan;60(1):8-15","ArticleIdList":{"ArticleId":"22211512"}},{"Citation":"J Acad Nutr Diet. 2013 Sep;113(9):1219-37","ArticleIdList":{"ArticleId":"23871528"}},{"Citation":"Z Gerontol Geriatr. 2019 Jul;52(4):309-315","ArticleIdList":{"ArticleId":"31161337"}},{"Citation":"Z Gerontol Geriatr. 2019 Jul;52(4):316-323","ArticleIdList":{"ArticleId":"31161336"}},{"Citation":"Nutrients. 2016 Jan 27;8(2):69","ArticleIdList":{"ArticleId":"26828516"}},{"Citation":"Parkinsonism Relat Disord. 2016 May;26:73-7","ArticleIdList":{"ArticleId":"26997654"}},{"Citation":"Ageing Res Rev. 2013 Mar;12(2):561-6","ArticleIdList":{"ArticleId":"23228882"}},{"Citation":"Z Gerontol Geriatr. 2019 Jul;52(4):330-335","ArticleIdList":{"ArticleId":"31139962"}},{"Citation":"Swiss Med Wkly. 2014 Dec 04;144:w14040","ArticleIdList":{"ArticleId":"25474710"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"31809862","DateCompleted":{"Year":"2020","Month":"03","Day":"04"},"DateRevised":{"Year":"2020","Month":"03","Day":"09"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"2210-3244","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"17","Issue":"4","PubDate":{"Year":"2019","Month":"08"}},"Title":"Genomics, proteomics & bioinformatics","ISOAbbreviation":"Genomics Proteomics Bioinformatics"},"ArticleTitle":"Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs.","Pagination":{"MedlinePgn":"430-440"},"ELocationID":["S1672-0229(19)30157-3","10.1016\/j.gpb.2019.09.004"],"Abstract":{"AbstractText":"Blood-borne small non-coding (sncRNAs) are among the prominent candidates for blood-based diagnostic tests. Often, high-throughput approaches are applied to discover biomarker signatures. These have to be validated in larger cohorts and evaluated by adequate statistical learning approaches. Previously, we published high-throughput sequencing based microRNA (miRNA) signatures in Alzheimer's disease (AD) patients in the United States (US) and Germany. Here, we determined abundance levels of 21 known circulating miRNAs in 465 individuals encompassing AD patients and controls by RT-qPCR. We computed models to assess the relation between miRNA expression and phenotypes, gender, age, or disease severity (Mini-Mental State Examination; MMSE). Of the 21 miRNAs, expression levels of 20 miRNAs were consistently de-regulated in the US and German cohorts. 18 miRNAs were significantly correlated with neurodegeneration (Benjamini-Hochberg adjusted P\u202f<\u202f0.05) with highest significance for miR-532-5p (Benjamini-Hochberg adjusted P\u202f=\u202f4.8\u202f\u00d7\u202f10). Machine learning models reached an area under the curve (AUC) value of 87.6% in differentiating AD patients from controls. Further, ten miRNAs were significantly correlated with MMSE, in particular miR-26a\/26b-5p (adjusted P\u202f=\u202f0.0002). Interestingly, the miRNAs with lower abundance in AD were enriched in monocytes and T-helper cells, while those up-regulated in AD were enriched in serum, exosomes, cytotoxic t-cells, and B-cells. Our study represents the next important step in translational research for a miRNA-based AD test.","CopyrightInformation":"Copyright \u00a9 2019 The Authors. Published by Elsevier B.V. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Ludwig","ForeName":"Nicole","Initials":"N","AffiliationInfo":{"Affiliation":"Department of Human Genetics, Saarland University, 66421 Homburg\/Saar, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fehlmann","ForeName":"Tobias","Initials":"T","AffiliationInfo":{"Affiliation":"Chair for Clinical Bioinformatics, Saarland University, 66123 Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kern","ForeName":"Fabian","Initials":"F","AffiliationInfo":{"Affiliation":"Chair for Clinical Bioinformatics, Saarland University, 66123 Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gogol","ForeName":"Manfred","Initials":"M","AffiliationInfo":{"Affiliation":"Institut f\u00fcr Gerontologie, Universit\u00e4t Heidelberg, 69047 Heidelberg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany; Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deutscher","ForeName":"Stephanie","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Human Genetics, Saarland University, 66421 Homburg\/Saar, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gurlit","ForeName":"Simone","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Anesthesiology and Intensive Care, St. Franziskus Hospital Muenster, 48145 Muenster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C","AffiliationInfo":{"Affiliation":"Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"von Thaler","ForeName":"Anna-Katharina","Initials":"AK","AffiliationInfo":{"Affiliation":"Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":{"Affiliation":"Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian","Initials":"F","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University Hospital Tuebingen, 72016 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurology, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany; Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Suenkel","ForeName":"Ulrike","Initials":"U","AffiliationInfo":{"Affiliation":"Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Verena","Initials":"V","AffiliationInfo":{"Affiliation":"Department of Medicine II, Saarland University Medical Center, 66421 Homburg\/Saar, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Backes","ForeName":"Christina","Initials":"C","AffiliationInfo":{"Affiliation":"Chair for Clinical Bioinformatics, Saarland University, 66123 Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lenhof","ForeName":"Hans-Peter","Initials":"HP","AffiliationInfo":{"Affiliation":"Center for Bioinformatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meese","ForeName":"Eckart","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Human Genetics, Saarland University, 66421 Homburg\/Saar, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Andreas","Initials":"A","AffiliationInfo":{"Affiliation":"Chair for Clinical Bioinformatics, Saarland University, 66123 Saarbr\u00fccken, Germany; Center for Bioinformatics, Saarland Informatics Campus, 66123 Saarbr\u00fccken, Germany. Electronic address: andreas.keller@ccb.uni-saarland.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"12","Day":"04"}},"MedlineJournalInfo":{"Country":"China","MedlineTA":"Genomics Proteomics Bioinformatics","NlmUniqueID":"101197608","ISSNLinking":"1672-0229"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"MicroRNAs"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","genetics"]},{"DescriptorName":"Area Under Curve"},{"DescriptorName":"Biomarkers","QualifierName":"blood"},{"DescriptorName":"Exosomes"},{"DescriptorName":"Female"},{"DescriptorName":"Germany"},{"DescriptorName":"High-Throughput Nucleotide Sequencing"},{"DescriptorName":"Humans"},{"DescriptorName":"Machine Learning"},{"DescriptorName":"Male"},{"DescriptorName":"MicroRNAs","QualifierName":["blood","genetics"]},{"DescriptorName":"Monocytes","QualifierName":"cytology"},{"DescriptorName":"Real-Time Polymerase Chain Reaction"},{"DescriptorName":"T-Lymphocytes, Helper-Inducer","QualifierName":"cytology"},{"DescriptorName":"Up-Regulation"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer\u2019s disease","Biomarker","Gene regulation","Neurodegeneration","Non-coding RNAs","miRNAs"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"05","Day":"14"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"08","Day":"26"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"10","Day":"07"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"12","Day":"7","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"3","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"12","Day":"7","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31809862","S1672-0229(19)30157-3","10.1016\/j.gpb.2019.09.004","PMC6943763"]},"ReferenceList":{"Reference":[{"Citation":"Nat Med. 2014 Apr;20(4):415-8","ArticleIdList":{"ArticleId":"24608097"}},{"Citation":"Genome Biol. 2013 Jul 29;14(7):R78","ArticleIdList":{"ArticleId":"23895045"}},{"Citation":"Front Mol Neurosci. 2018 Aug 28;11:288","ArticleIdList":{"ArticleId":"30210287"}},{"Citation":"N Engl J Med. 2010 Jan 28;362(4):329-44","ArticleIdList":{"ArticleId":"20107219"}},{"Citation":"Nucleic Acids Res. 2017 Jan 4;45(D1):D90-D96","ArticleIdList":{"ArticleId":"27742822"}},{"Citation":"PLoS One. 2018 May 10;13(5):e0197329","ArticleIdList":{"ArticleId":"29746584"}},{"Citation":"Nucleic Acids Res. 2016 Jul 8;44(W1):W110-6","ArticleIdList":{"ArticleId":"27131362"}},{"Citation":"Methods. 2010 Apr;50(4):237-43","ArticleIdList":{"ArticleId":"20079844"}},{"Citation":"J Frailty Aging. 2018;7(2):100-103","ArticleIdList":{"ArticleId":"29741193"}},{"Citation":"Alzheimers Dement. 2014 Mar;10(2):e40-6","ArticleIdList":{"ArticleId":"24698031"}},{"Citation":"Anal Chem. 2016 Feb 16;88(4):2088-95","ArticleIdList":{"ArticleId":"26760198"}},{"Citation":"Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30","ArticleIdList":{"ArticleId":"30906802"}},{"Citation":"Biomed Environ Sci. 2018 Feb;31(2):87-96","ArticleIdList":{"ArticleId":"29606187"}},{"Citation":"Alzheimers Dement. 2018 Jan;14(1):81-103","ArticleIdList":{"ArticleId":"29127806"}},{"Citation":"Clin Chem. 2014 Sep;60(9):1200-8","ArticleIdList":{"ArticleId":"24987111"}},{"Citation":"Alzheimers Dement. 2016 May;12(5):565-76","ArticleIdList":{"ArticleId":"26806387"}},{"Citation":"Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5842-5850","ArticleIdList":{"ArticleId":"30280764"}},{"Citation":"Clin Chem. 2010 Jun;56(6):998-1006","ArticleIdList":{"ArticleId":"20378769"}},{"Citation":"Nucleic Acids Res. 2017 Sep 19;45(16):9290-9301","ArticleIdList":{"ArticleId":"28934507"}},{"Citation":"Front Aging Neurosci. 2016 Feb 09;8:13","ArticleIdList":{"ArticleId":"26903857"}},{"Citation":"Ann Neurol. 2017 May;81(5):703-717","ArticleIdList":{"ArticleId":"28411393"}},{"Citation":"Anal Chem. 2015 Sep 1;87(17):8910-6","ArticleIdList":{"ArticleId":"26207298"}},{"Citation":"Nucleic Acids Res. 2016 May 5;44(8):3865-77","ArticleIdList":{"ArticleId":"26921406"}},{"Citation":"Chem Biol Interact. 2019 Feb 25;300:73-81","ArticleIdList":{"ArticleId":"30639441"}},{"Citation":"J Immunother Cancer. 2019 Jul 16;7(1):187","ArticleIdList":{"ArticleId":"31311583"}},{"Citation":"Mol Neurobiol. 2019 Sep;56(9):6156-6167","ArticleIdList":{"ArticleId":"30734227"}},{"Citation":"Mol Neurobiol. 2016 Oct;53(8):5772-81","ArticleIdList":{"ArticleId":"26497032"}},{"Citation":"Alzheimers Dement. 2016 Jul;12(7):815-22","ArticleIdList":{"ArticleId":"26806385"}},{"Citation":"Cell Death Dis. 2019 Jan 18;10(2):46","ArticleIdList":{"ArticleId":"30718475"}},{"Citation":"N Engl J Med. 2018 Jan 25;378(4):391-392","ArticleIdList":{"ArticleId":"29365295"}},{"Citation":"Nat Methods. 2011 Sep 04;8(10):841-3","ArticleIdList":{"ArticleId":"21892151"}},{"Citation":"J Alzheimers Dis. 2013;33(3):737-53","ArticleIdList":{"ArticleId":"23042217"}},{"Citation":"Int J Mol Sci. 2016 Apr 14;17(4):564","ArticleIdList":{"ArticleId":"27089332"}},{"Citation":"Mol Neurobiol. 2017 Sep;54(7):5550-5562","ArticleIdList":{"ArticleId":"27631879"}},{"Citation":"NPJ Digit Med. 2019 Feb 4;2:4","ArticleIdList":{"ArticleId":"31304354"}},{"Citation":"Sci Rep. 2017 Jul 12;7(1):5162","ArticleIdList":{"ArticleId":"28701729"}},{"Citation":"Nature. 2018 Feb 8;554(7691):249-254","ArticleIdList":{"ArticleId":"29420472"}},{"Citation":"Oncotarget. 2016 Jan 26;7(4):4611-23","ArticleIdList":{"ArticleId":"26672767"}},{"Citation":"Ageing Res Rev. 2019 Jan;49:125-143","ArticleIdList":{"ArticleId":"30391753"}},{"Citation":"Neurobiol Aging. 2017 Feb;50:167.e1-167.e10","ArticleIdList":{"ArticleId":"27816213"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"31591382","DateCompleted":{"Year":"2020","Month":"07","Day":"16"},"DateRevised":{"Year":"2020","Month":"10","Day":"06"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"2158-3188","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"9","Issue":"1","PubDate":{"Year":"2019","Month":"10","Day":"07"}},"Title":"Translational psychiatry","ISOAbbreviation":"Transl Psychiatry"},"ArticleTitle":"A combined miRNA-piRNA signature to detect Alzheimer's disease.","Pagination":{"MedlinePgn":"250"},"ELocationID":"10.1038\/s41398-019-0579-2","Abstract":{"AbstractText":"Alzheimer's disease (AD) is the most common neurodegenerative disorder causing huge emotional and economic burden to our societies. An effective therapy has not been implicated yet, which is in part also due to the fact that pathological changes occur years before clinical symptoms manifest. Thus, there is a great need for the development of a translatable biomarker. Recent evidence highlights microRNAs as candidate biomarkers. In this study, we use next-generation sequencing to study the small noncoding RNAome (sncRNAome) in exosomes derived from human cerebrospinal fluid (CSF). We show that the sncRNAome from CSF-derived exosomes is dominated not only by microRNAs (miRNAs) but also by PIWI-interacting RNAs (piRNAs). We define a combined signature consisting of three miRNAs and three piRNAs that are suitable to detect AD with an AUC of 0.83 in a replication cohort and furthermore predict the conversion of mild-cognitive impaired (MCI) patients to AD dementia with an AUC of 0.86 for the piRNA signature. When combining the smallRNA signature with pTau and A\u03b2 42\/40 ratio the AUC reaches 0.98. Our study reports a novel exosomal small noncoding RNA signature to detect AD pathology and provides the first evidence that in addition to miRNAs, piRNAs should also be considered as a candidate biomarker for AD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Jain","ForeName":"Gaurav","Initials":"G","AffiliationInfo":{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stuendl","ForeName":"Anne","Initials":"A","AffiliationInfo":{"Affiliation":"Translational Dementia Research, German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rao","ForeName":"Pooja","Initials":"P","AffiliationInfo":{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berulava","ForeName":"Tea","Initials":"T","AffiliationInfo":{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pena Centeno","ForeName":"Tonatiuh","Initials":"T","Identifier":"http:\/\/orcid.org\/0000-0002-9329-8912","AffiliationInfo":[{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."},{"Affiliation":"Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, Goettingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaurani","ForeName":"Lalit","Initials":"L","AffiliationInfo":{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Burkhardt","ForeName":"Susanne","Initials":"S","AffiliationInfo":{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Delalle","ForeName":"Ivana","Initials":"I","AffiliationInfo":{"Affiliation":"Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kornhuber","ForeName":"Johannes","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, 91054, Erlangen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"H\u00fcll","ForeName":"Michael","Initials":"M","AffiliationInfo":[{"Affiliation":"Center for Geriatric Medicine and Gerontology, University Medical Center Freiburg, 79106, Freiburg, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University Medical Centre Freiburg, 79106, Freiburg, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maier","ForeName":"Wolfgang","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, 53127, Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Peters","ForeName":"Oliver","Initials":"O","AffiliationInfo":[{"Affiliation":"Department of Psychiatry, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 12200, Berlin, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), 12203, Berlin, Germany."},{"Affiliation":"Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), 13125, Berlin, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Esselmann","ForeName":"Hermann","Initials":"H","Identifier":"http:\/\/orcid.org\/0000-0001-5484-9710","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen (UMG), 37075, G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, 72076, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), 72076, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, 72076, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), 72076, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Mathis","Initials":"M","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, 72076, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), 72076, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wiltfang","ForeName":"Jens","Initials":"J","Identifier":"http:\/\/orcid.org\/0000-0003-1492-5330","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen (UMG), 37075, G\u00f6ttingen, Germany."},{"Affiliation":"iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Mollenhauer","ForeName":"Brit","Initials":"B","AffiliationInfo":[{"Affiliation":"Department of Neurology, University Medical Center G\u00f6ttingen (UMG), 37075, G\u00f6ttingen, Germany."},{"Affiliation":"Paracelsus-Elena-Klinik, 34128, Kassel, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, 72076, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), 72076, Tuebingen, Germany."},{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein, 24105, Kiel, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Schneider","ForeName":"Anja","Initials":"A","AffiliationInfo":[{"Affiliation":"Translational Dementia Research, German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany. anja.scheider@dzne.de."},{"Affiliation":"Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, 53127, Bonn, Germany. anja.scheider@dzne.de."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Fischer","ForeName":"Andre","Initials":"A","AffiliationInfo":[{"Affiliation":"Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, G\u00f6ttingen, Germany. andre.fischer@dzne.de."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen (UMG), 37075, G\u00f6ttingen, Germany. andre.fischer@dzne.de."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"10","Day":"07"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Transl Psychiatry","NlmUniqueID":"101562664","ISSNLinking":"2158-3188"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"MicroRNAs"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"RNA, Small Interfering"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (40-42)"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","diagnosis","genetics"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Area Under Curve"},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":["cerebrospinal fluid","diagnosis","genetics"]},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Germany"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"MicroRNAs","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"RNA, Small Interfering","QualifierName":["cerebrospinal fluid","genetics"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"02","Day":"15"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"08","Day":"18"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"06","Day":"05"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"10","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"10","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"7","Day":"17","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["31591382","10.1038\/s41398-019-0579-2","10.1038\/s41398-019-0579-2","PMC6779890"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"31189032","DateCompleted":{"Year":"2020","Month":"03","Day":"27"},"DateRevised":{"Year":"2020","Month":"03","Day":"27"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1531-8257","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"7","PubDate":{"Year":"2019","Month":"07"}},"Title":"Movement disorders : official journal of the Movement Disorder Society","ISOAbbreviation":"Mov Disord"},"ArticleTitle":"Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.","Pagination":{"MedlinePgn":"1069-1073"},"ELocationID":"10.1002\/mds.27731","Abstract":{"AbstractText":["Patients with dementia with Lewy bodies reveal a variable pathology including alpha-synuclein, amyloid-beta, and Tau. Mutations in GBA1 are specifically associated with synucleinopathies. PD patients with GBA1 mutations show reduced CSF levels of total alpha-synuclein.","Whether GBA1 mutations are associated with a CSF alpha-synuclein profile in dementia with Lewy bodies.","Screening of the GBA1 gene and single-nucleotide polymorphisms in SNCA rs356220, APOE rs429358, and MAPT rs1052587 as well as CSF levels of total alpha-synuclein, amyloid-beta , total-Tau, phospho-Tau, and neurofilament light chain were assessed in 100 dementia with Lewy bodies and 39 controls cross-sectionally.","Severity of GBA1 mutations was associated with a younger age at onset and higher prevalence of rapid eye movement sleep behavior disorder. CSF levels of total alpha-synuclein were lowest in DLB compared to DLB and DLB .","Similar to PD, pathogenic GBA1 mutations seem to be associated with CSF alpha-synuclein profiles in dementia with Lewy bodies. That might be useful for patient stratification for specific alpha-synuclein-lowering compounds. \u00a9 2019 International Parkinson and Movement Disorder Society."],"CopyrightInformation":"\u00a9 2019 International Parkinson and Movement Disorder Society."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Lerche","ForeName":"Stefanie","Initials":"S","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Machetanz","ForeName":"Gerrit","Initials":"G","Identifier":"0000-0002-8955-5306","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wurster","ForeName":"Isabel","Initials":"I","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Roeben","ForeName":"Benjamin","Initials":"B","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Zimmermann","ForeName":"Milan","Initials":"M","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Pilotto","ForeName":"Andrea","Initials":"A","AffiliationInfo":[{"Affiliation":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy."},{"Affiliation":"Parkinson's Disease Rehabilitation Centre, FERB ONLUS-S. Isidoro Hospital, Trescore Balneario (BG), Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Preische","ForeName":"Oliver","Initials":"O","AffiliationInfo":[{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauser","ForeName":"Ann-Kathrin","Initials":"AK","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C","Identifier":"0000-0003-4006-1265","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Lachmann","ForeName":"Ingolf","Initials":"I","AffiliationInfo":{"Affiliation":"AJ Roboscreen GmbH, Leipzig, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Waniek","ForeName":"Katharina","Initials":"K","AffiliationInfo":{"Affiliation":"AJ Roboscreen GmbH, Leipzig, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurology, Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology, Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K","AffiliationInfo":[{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"06","Day":"12"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Mov Disord","NlmUniqueID":"8610688","ISSNLinking":"0885-3185"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"EC 3.2.1.45","NameOfSubstance":"GBA protein, human"},{"RegistryNumber":"EC 3.2.1.45","NameOfSubstance":"Glucosylceramidase"}]},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"Mov Disord. 2019 Oct;34(10):1581-1582","PMID":"31769092"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Expression","QualifierName":"genetics"},{"DescriptorName":"Glucosylceramidase","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Bodies","QualifierName":"metabolism"},{"DescriptorName":"Lewy Body Disease","QualifierName":["diagnosis","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation","QualifierName":"genetics"},{"DescriptorName":"alpha-Synuclein","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["CSF","DLB","GBA","alpha-synuclein"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"02","Day":"01"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"04","Day":"02"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"05","Day":"13"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"6","Day":"13","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"3","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"6","Day":"13","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31189032","10.1002\/mds.27731"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"31139963","DateCompleted":{"Year":"2019","Month":"09","Day":"27"},"DateRevised":{"Year":"2020","Month":"02","Day":"25"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1435-1269","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"52","Issue":"4","PubDate":{"Year":"2019","Month":"Jul"}},"Title":"Zeitschrift fur Gerontologie und Geriatrie","ISOAbbreviation":"Z Gerontol Geriatr"},"ArticleTitle":"Functional movement disorders in neurogeriatric inpatients : Underdiagnosed, often comorbid to neurodegenerative disorders and treatable.","Pagination":{"MedlinePgn":"324-329"},"ELocationID":"10.1007\/s00391-019-01562-y","Abstract":{"AbstractText":["The proportion of patients with functional movement disorders (FMD) is particularly high in neurology clinics. Treatment options have not been consistently developed, not well evaluated and not validated. This article presents the preliminary data on the prevalence and treatment response of patients with FMD who were treated within the framework of an early rehabilitative geriatric complex treatment at a\u00a0university hospital for neurology.","From July 2017 to November 2018 the prevalence, demographic and clinical parameters, and response to treatment of FMD patients were documented and compared to non-FMD patients treated at the neurogeriatric ward of the University Hospital Schleswig-Holstein, in Kiel. Clinical endpoints were the Short Physical Performance Battery (SPPB) for mobility and the Barthel index for instrumented activity of daily life (iADL).","The prevalence of FMD was 11% (19\/175) and predominantly observed in women (74%). Of the FMD patients nine also had a\u00a0diagnosis of either idiopathic Parkinson's disease (N\u202f=\u20097), dementia with Lewy bodies (N\u202f=\u20091) or progressive supranuclear palsy (N\u202f=\u20091). At admission, neither the SPPB nor the iADL differed significantly between FMD and non-FMD patients. The treatment response was comparable between the groups: SPPB change was +0.3\u00b11.8 (mean, standard deviation) in FMD and +0.4\u00b11.9 in non-FMD patients (p\u202f=\u20090.83). The iADL change was +19\u00b115 in FMD and +18\u00b117 in non-FMD (p\u202f=\u20090.83).","The prevalence of FMD was unexpectedly high in the neurogeriatric ward of a\u00a0German university hospital. There were comparable impairments and responses to multidisciplinary treatment in mobility and iADL between FMD and non-FMD geriatric patients, suggesting that specific and informed treatment provided by a\u00a0multidisciplinary geriatric team is effective in geriatric FMD patients. Further studies of this underdiagnosed disorder in older age are warranted."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00e4tzold","ForeName":"Sara","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geritz","ForeName":"Johanna","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zeuner","ForeName":"Kirsten E","Initials":"KE","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Paschen","ForeName":"Steffen","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hieke","ForeName":"Johanne","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sablowsky","ForeName":"Simone","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ortlieb","ForeName":"Christian","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bergmann","ForeName":"Philipp","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Internal Medicine I, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hofmann","ForeName":"Werner","Initials":"W","AffiliationInfo":{"Affiliation":"Institute of Family Medicine, Center of Geriatrics, University Hospital Schleswig-Holstein, Campus L\u00fcbeck, Neum\u00fcnster and Bad Bramstedt, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Espay","ForeName":"Alberto J","Initials":"AJ","AffiliationInfo":{"Affiliation":"James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, OH, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Schleswig Holstein, Campus Kiel, Christian-Albrechts-University, Arnold-Heller-Str. 3, Haus\u00a041, 24105, Kiel, Germany. w.maetzler@neurologie.uni-kiel.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Review"]},"VernacularTitle":"Funktionelle Bewegungsst\u00f6rungen in der Geriatrie : Unterdiagnostiziert, oft mit neurodegenerativen Erkrankungen assoziiert und behandelbar.","ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"05","Day":"28"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Z Gerontol Geriatr","NlmUniqueID":"9506215","ISSNLinking":"0948-6704"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Activities of Daily Living"},{"DescriptorName":"Age Distribution"},{"DescriptorName":"Aged"},{"DescriptorName":"Dementia","QualifierName":"epidemiology"},{"DescriptorName":"Female"},{"DescriptorName":"Geriatric Assessment","QualifierName":"methods"},{"DescriptorName":"Germany","QualifierName":"epidemiology"},{"DescriptorName":"Hospitals, University"},{"DescriptorName":"Humans"},{"DescriptorName":"Inpatients"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":"epidemiology"},{"DescriptorName":"Parkinson Disease","QualifierName":"epidemiology"},{"DescriptorName":"Physical Functional Performance"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Activities of daily living","Dementia","Mobility","Movement disorder","Parkinson\u2019s disease"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"03","Day":"23"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"05","Day":"08"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"5","Day":"30","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"9","Day":"29","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"5","Day":"30","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31139963","10.1007\/s00391-019-01562-y","10.1007\/s00391-019-01562-y"]},"ReferenceList":{"Reference":[{"Citation":"Z Gerontol Geriatr. 2004 Aug;37(4):316-26","ArticleIdList":{"ArticleId":"15338161"}},{"Citation":"Fortschr Neurol Psychiatr. 2005 Feb;73(2):74-82","ArticleIdList":{"ArticleId":"15685491"}},{"Citation":"Internist (Berl). 2007 Nov;48(11):1190, 1192-4","ArticleIdList":{"ArticleId":"17934704"}},{"Citation":"Curr Opin Neurol. 2009 Aug;22(4):430-6","ArticleIdList":{"ArticleId":"19542886"}},{"Citation":"Z Gerontol Geriatr. 2010 Jun;43(3):170-6","ArticleIdList":{"ArticleId":"19760357"}},{"Citation":"Parkinsonism Relat Disord. 2012 Mar;18(3):247-51","ArticleIdList":{"ArticleId":"22113131"}},{"Citation":"Lancet Neurol. 2012 Mar;11(3):250-60","ArticleIdList":{"ArticleId":"22341033"}},{"Citation":"J Aging Health. 2012 Aug;24(5):863-78","ArticleIdList":{"ArticleId":"22422762"}},{"Citation":"Neurology. 2012 Jul 17;79(3):282-4","ArticleIdList":{"ArticleId":"22764261"}},{"Citation":"Mov Disord. 2013 Apr;28(4):540-3","ArticleIdList":{"ArticleId":"23418043"}},{"Citation":"Mov Disord. 2013 Oct;28(12):1622-7","ArticleIdList":{"ArticleId":"23737007"}},{"Citation":"Mov Disord. 2014 Jun;29(7):849-52","ArticleIdList":{"ArticleId":"23843209"}},{"Citation":"Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1383-96","ArticleIdList":{"ArticleId":"24092294"}},{"Citation":"J Rehabil Med. 2014 Feb;46(2):181-7","ArticleIdList":{"ArticleId":"24248149"}},{"Citation":"Neurotherapeutics. 2014 Jan;11(1):201-7","ArticleIdList":{"ArticleId":"24356785"}},{"Citation":"Neurol Clin. 2015 Feb;33(1):205-24","ArticleIdList":{"ArticleId":"25432730"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1113-9","ArticleIdList":{"ArticleId":"25433033"}},{"Citation":"Curr Neurol Neurosci Rep. 2015 Jun;15(6):32","ArticleIdList":{"ArticleId":"25900093"}},{"Citation":"Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S149-52","ArticleIdList":{"ArticleId":"26365778"}},{"Citation":"Mov Disord. 2015 Oct;30(12):1591-601","ArticleIdList":{"ArticleId":"26474316"}},{"Citation":"J Mov Disord. 2017 Jan;10(1):40-44","ArticleIdList":{"ArticleId":"28122424"}},{"Citation":"Mov Disord. 2017 Jun;32(6):853-864","ArticleIdList":{"ArticleId":"28467028"}},{"Citation":"Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:18-26","ArticleIdList":{"ArticleId":"28522290"}},{"Citation":"Neurology. 2017 Jul 4;89(1):88-100","ArticleIdList":{"ArticleId":"28592453"}},{"Citation":"J Physiother. 2018 Jan;64(1):61","ArticleIdList":{"ArticleId":"28645532"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):566-571","ArticleIdList":{"ArticleId":"29549192"}},{"Citation":"JAMA Neurol. 2018 Sep 1;75(9):1132-1141","ArticleIdList":{"ArticleId":"29868890"}},{"Citation":"Eur J Public Health. 2019 Feb 1;29(1):182-189","ArticleIdList":{"ArticleId":"29878097"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"29727890","DateCompleted":{"Year":"2018","Month":"06","Day":"15"},"DateRevised":{"Year":"2018","Month":"06","Day":"15"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1439-4413","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"143","Issue":"10","PubDate":{"Year":"2018","Month":"May"}},"Title":"Deutsche medizinische Wochenschrift (1946)","ISOAbbreviation":"Dtsch Med Wochenschr"},"ArticleTitle":"[Therapy of Dementia: State of the Art].","Pagination":{"MedlinePgn":"741-747"},"ELocationID":"10.1055\/s-0043-113619","Abstract":{"AbstractText":"Due to the aging population, dementias represent a growing challenge for the health systems and for the society. This overview summarizes the current state of already practice-relevant therapies and management of dementias. Non-pharmacological approaches have a greater impact than pharmacological treatment. Increasing evidence underlines that consistent management of cardiovascular risk factors has beneficial effects on the progression of at least some, possibly almost all types of dementias. The main pharmacological agents for symptomatic treatment of cognitive deficits in Alzheimer's and Parkinson's disease-associated dementias are cholinesterase inhibitors and memantine. In most other dementias, no specific pharmacological treatment is currently available. There is an urgent need for further research on the effective management of dementias.","CopyrightInformation":"\u00a9\u00a0Georg Thieme Verlag KG Stuttgart \u00b7 New York."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y","EqualContrib":"N"},"LastName":"Roeben","ForeName":"Benjamin","Initials":"B"},{"@attributes":{"ValidYN":"Y","EqualContrib":"N"},"LastName":"Zieschang","ForeName":"Tania","Initials":"T"},{"@attributes":{"ValidYN":"Y","EqualContrib":"N"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"}]},"Language":"ger","PublicationTypeList":{"PublicationType":"Journal Article"},"VernacularTitle":"Fortschritte in der Demenztherapie \u2013 Was ist bereits praxisrelevant?","ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2018","Month":"05","Day":"04"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Dtsch Med Wochenschr","NlmUniqueID":"0006723","ISSNLinking":"0012-0472"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"},{"RegistryNumber":"W8O17SJF3T","NameOfSubstance":"Memantine"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":"complications"},{"DescriptorName":"Cholinesterase Inhibitors"},{"DescriptorName":"Dementia","QualifierName":["epidemiology","prevention & control","therapy"]},{"DescriptorName":"Humans"},{"DescriptorName":"Memantine"},{"DescriptorName":"Parkinson Disease","QualifierName":"complications"},{"DescriptorName":"Risk Factors"}]},"CoiStatement":"Disclosure The authors report no conflicts of interest in this work."},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"5","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"5","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"6","Day":"16","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["29727890","10.1055\/s-0043-113619"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"29117956","DateCompleted":{"Year":"2017","Month":"12","Day":"12"},"DateRevised":{"Year":"2017","Month":"12","Day":"12"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1526-632X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"89","Issue":"23","PubDate":{"Year":"2017","Month":"Dec","Day":"05"}},"Title":"Neurology","ISOAbbreviation":"Neurology"},"ArticleTitle":"SNPs in A\u03b2 clearance proteins: Lower CSF A\u03b2 levels and earlier onset of dementia in PD.","Pagination":{"MedlinePgn":"2335-2340"},"ELocationID":"10.1212\/WNL.0000000000004705","Abstract":{"AbstractText":["To evaluate whether genetic variants in \u03b2-amyloid (A\u03b2) clearance proteins are associated with CSF levels of A\u03b2 on a biological level and the onset of dementia on a clinical level in Parkinson disease (PD).","We analyzed genetic variants known to be involved in A\u03b2 clearance in a PD group comprising 456 patients, 103 of them with dementia. Single nucleotide polymorphisms in the genes , cystatin C (), and membrane metalloendopeptidase () were evaluated in relation to demographic variables, clinical phenotypes, and CSF A\u03b2 levels using a cross-sectional approach.","Risk variants in the genes  and  were associated with lower CSF A\u03b2 levels. Clinically, patients with 2 risk alleles in  tended to show a shorter interval from age at onset of PD to age at onset of dementia.","This study suggests that genetic variants associated with A\u03b2 clearance are involved in the pathogenesis of dementia in PD and possibly influence the onset of dementia."],"CopyrightInformation":"\u00a9 2017 American Academy of Neurology."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lerche","ForeName":"Stefanie","Initials":"S","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dilger","ForeName":"Sarah Selina","Initials":"SS","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stirnkorb","ForeName":"Johannes Georg","Initials":"JG","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Apel","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauser","ForeName":"Ann-Kathrin","Initials":"AK","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt-Scarfone","ForeName":"Inga","Initials":"I","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of T\u00fcbingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany. w.maetzler@neurologie.uni-kiel.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"11","Day":"08"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurology","NlmUniqueID":"0401060","ISSNLinking":"0028-3878"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"CST3 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Cystatin C"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"EC 3.4.24.-","NameOfSubstance":"Metalloendopeptidases"}]},"CitationSubset":["AIM","IM"],"CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"Neurology. 2017 Dec 5;89(23):2339","PMID":"29117960"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alleles"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Cystatin C","QualifierName":"genetics"},{"DescriptorName":"Dementia","QualifierName":["etiology","genetics"]},{"DescriptorName":"Female"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Metalloendopeptidases","QualifierName":"genetics"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parkinson Disease","QualifierName":["complications","genetics"]},{"DescriptorName":"Peptide Fragments","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Polymorphism, Single Nucleotide","QualifierName":"genetics"},{"DescriptorName":"Risk Assessment"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"11","Day":"23"},{"@attributes":{"PubStatus":"accepted"},"Year":"2017","Month":"08","Day":"30"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"11","Day":"10","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"12","Day":"13","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"11","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["29117956","WNL.0000000000004705","10.1212\/WNL.0000000000004705"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28953602","DateCompleted":{"Year":"2018","Month":"06","Day":"04"},"DateRevised":{"Year":"2018","Month":"06","Day":"04"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1473-558X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"28","Issue":"16","PubDate":{"Year":"2017","Month":"Nov","Day":"08"}},"Title":"Neuroreport","ISOAbbreviation":"Neuroreport"},"ArticleTitle":"Dementia with Lewy bodies: cerebrospinal fluid suppresses neuronal network activity.","Pagination":{"MedlinePgn":"1061-1065"},"ELocationID":"10.1097\/WNR.0000000000000890","Abstract":{"AbstractText":"One of the core clinical criteria of Dementia with Lewy bodies (DLB) are fluctuations of cognition. Underlying processes may be rather functional than neurodegenerative, reflected by, for example, factors present in cerebrospinal fluid (CSF). The aim of this study was to identify in-vitro neuronal network activity (ivNNA) changes of CSF from DLB patients compared with patients with Parkinson's disease (PD) and controls. Primary neuronal mouse cultures were grown on microelectrode arrays to record ivNNA when exposed to respective CSF samples. If exposed to CSF of DLB patients, ivNNA showed a reduced spike rate and burst rate compared with CSF of PD patients and controls. Our data are suggestive of the presence of functional factors in the CSF of DLB patients that differentiate network activity from PD patients and controls. Future studies should evaluate whether this pilot observation might be related to fluctuations of cognition in DLB."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Theiss","ForeName":"Stephan","Initials":"S","AffiliationInfo":{"Affiliation":"aInstitute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University bResult Medical GmbH, D\u00fcsseldorf cDepartment of Neurodegeneration, Center for Neurology and Hertie Institute for Clinical Brain Research, University of T\u00fcbingen dDZNE, German Center for Neurodegenerative Diseases eDepartment of Epileptology, Center for Neurology and Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen fDepartment of Neurology, Kiel University, Keil, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lerche","ForeName":"Holger","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Koch","ForeName":"Henner","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dihn\u00e9","ForeName":"Marcel","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Neuroreport","NlmUniqueID":"9100935","ISSNLinking":"0959-4965"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Animals"},{"DescriptorName":"Cells, Cultured"},{"DescriptorName":"Cerebrospinal Fluid"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Mice"},{"DescriptorName":"Nerve Net","QualifierName":"physiopathology"},{"DescriptorName":"Parkinson Disease","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Pilot Projects"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"9","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"9","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"6","Day":"5","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["28953602","10.1097\/WNR.0000000000000890","00001756-201712010-00006"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28749476","DateCompleted":{"Year":"2018","Month":"09","Day":"26"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1530-0366","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"20","Issue":"2","PubDate":{"Year":"2018","Month":"02"}},"Title":"Genetics in medicine : official journal of the American College of Medical Genetics","ISOAbbreviation":"Genet Med"},"ArticleTitle":"The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects.","Pagination":{"MedlinePgn":"240-249"},"ELocationID":"10.1038\/gim.2017.102","Abstract":{"AbstractText":"PurposeTo define the genetic spectrum and relative gene frequencies underlying clinical frontotemporal dementia (FTD).MethodsWe investigated the frequencies and mutations in neurodegenerative disease genes in 121 consecutive FTD subjects using an unbiased, combined sequencing approach, complemented by cerebrospinal fluid A\u03b2 and serum progranulin measurements. Subjects were screened for C9orf72 repeat expansions, GRN and MAPT mutations, and, if negative, mutations in other neurodegenerative disease genes, by whole-exome sequencing (WES) (n\u2009=\u2009108), including WES-based copy-number variant (CNV) analysis.ResultsPathogenic and likely pathogenic mutations were identified in 19% of the subjects, including mutations in C9orf72 (n\u2009=\u20098), GRN (n\u2009=\u20097, one 11-exon macro-deletion) and, more rarely, CHCHD10, TARDBP, SQSTM1 and UBQLN2 (each n\u2009=\u20091), but not in MAPT or TBK1. WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD. It unravels several mutations and CNVs in genes and pathways hitherto not linked to FTD. This suggests that clinical FTD might be the converging downstream result of a delicate susceptibility of frontotemporal brain networks to insults in various pathways."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Blauwendraat","ForeName":"Cornelis","Initials":"C","AffiliationInfo":{"Affiliation":"Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wilke","ForeName":"Carlo","Initials":"C","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen Germany."},{"Affiliation":"Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sim\u00f3n-S\u00e1nchez","ForeName":"Javier","Initials":"J","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen Germany."},{"Affiliation":"Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Jansen","ForeName":"Iris E","Initials":"IE","AffiliationInfo":{"Affiliation":"Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Reifschneider","ForeName":"Anika","Initials":"A","AffiliationInfo":{"Affiliation":"Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Capell","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Haass","ForeName":"Christian","Initials":"C","AffiliationInfo":[{"Affiliation":"Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"Affiliation":"Munich Cluster for Systems Neurology (SyNergy), Munich, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Castillo-Lizardo","ForeName":"Melissa","Initials":"M","AffiliationInfo":{"Affiliation":"Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Biskup","ForeName":"Saskia","Initials":"S","AffiliationInfo":{"Affiliation":"Center for Genomics and Transcriptomics, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen Germany."},{"Affiliation":"Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Rizzu","ForeName":"Patrizia","Initials":"P","AffiliationInfo":{"Affiliation":"Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Heutink","ForeName":"Peter","Initials":"P","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen Germany."},{"Affiliation":"Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen Germany."},{"Affiliation":"Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"07","Day":"27"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Genet Med","NlmUniqueID":"9815831","ISSNLinking":"1098-3600"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alleles"},{"DescriptorName":"Biomarkers"},{"DescriptorName":"C9orf72 Protein","QualifierName":"genetics"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["diagnosis","epidemiology","genetics","metabolism"]},{"DescriptorName":"Gene Frequency"},{"DescriptorName":"Genetic Association Studies","QualifierName":"methods"},{"DescriptorName":"Genetic Predisposition to Disease"},{"DescriptorName":"Genetic Testing"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":"genetics"},{"DescriptorName":"Pedigree"},{"DescriptorName":"Phenotype"},{"DescriptorName":"Sequence Analysis, DNA"},{"DescriptorName":"Whole Exome Sequencing"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2017","Month":"02","Day":"08"},{"@attributes":{"PubStatus":"accepted"},"Year":"2017","Month":"05","Day":"23"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"7","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"9","Day":"27","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"7","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["28749476","gim2017102","10.1038\/gim.2017.102","PMC5846812"]},"ReferenceList":{"Reference":[{"Citation":"Biochemistry. 1998 Oct 27;37(43):15050-6","ArticleIdList":{"ArticleId":"9790667"}},{"Citation":"J Hum Genet. 2015 Apr;60(4):175-82","ArticleIdList":{"ArticleId":"25608832"}},{"Citation":"BMC Neurol. 2008 Dec 17;8:48","ArticleIdList":{"ArticleId":"19091059"}},{"Citation":"Brain. 2015 Sep;138(Pt 9):2732-49","ArticleIdList":{"ArticleId":"26141491"}},{"Citation":"Mol Neurodegener. 2016 Feb 24;11:21","ArticleIdList":{"ArticleId":"26912063"}},{"Citation":"Eur J Hum Genet. 2014 Apr;22(4):492-6","ArticleIdList":{"ArticleId":"23942205"}},{"Citation":"JAMA Neurol. 2013 Nov;70(11):1403-10","ArticleIdList":{"ArticleId":"24042580"}},{"Citation":"Neurobiol Dis. 2015 Mar;75:64-77","ArticleIdList":{"ArticleId":"25526708"}},{"Citation":"Ann Neurol. 2006 Jun;59(6):952-62","ArticleIdList":{"ArticleId":"16718704"}},{"Citation":"Am J Hum Genet. 2002 Jun;70(6):1582-8","ArticleIdList":{"ArticleId":"11992264"}},{"Citation":"Neurology. 2014 Nov 4;83(19):1769-70","ArticleIdList":{"ArticleId":"25274848"}},{"Citation":"Neurology. 2011 Mar 15;76(11):1006-14","ArticleIdList":{"ArticleId":"21325651"}},{"Citation":"J Inherit Metab Dis. 2001 Jun;24(3):379-92","ArticleIdList":{"ArticleId":"11486904"}},{"Citation":"Acta Neuropathol. 2015 Jul;130(1):77-92","ArticleIdList":{"ArticleId":"25943890"}},{"Citation":"Am J Hum Genet. 1999 Feb;64(2):414-21","ArticleIdList":{"ArticleId":"9973279"}},{"Citation":"Neurology. 2015 Dec 15;85(24):2116-25","ArticleIdList":{"ArticleId":"26581300"}},{"Citation":"Hum Mutat. 2017 Mar;38(3):297-309","ArticleIdList":{"ArticleId":"28008748"}},{"Citation":"Neurology. 2008 Oct 14;71(16):1235-9","ArticleIdList":{"ArticleId":"18768919"}},{"Citation":"Ann Neurol. 2001 Jul;50(1):108-12","ArticleIdList":{"ArticleId":"11456299"}},{"Citation":"Lancet Neurol. 2012 Apr;11(4):323-30","ArticleIdList":{"ArticleId":"22406228"}},{"Citation":"Neurobiol Aging. 2015 Mar;36(3):1605.e7-12","ArticleIdList":{"ArticleId":"25444595"}},{"Citation":"Neurobiol Aging. 2016 Jan;37:208.e11-208.e17","ArticleIdList":{"ArticleId":"26522186"}},{"Citation":"Acta Neuropathol. 2014;127(6):845-60","ArticleIdList":{"ArticleId":"24619111"}},{"Citation":"Am J Med Genet A. 2005 Dec 1;139A(2):114-7","ArticleIdList":{"ArticleId":"16278884"}},{"Citation":"Neurobiol Aging. 2012 Dec;33(12):2949.e13-7","ArticleIdList":{"ArticleId":"22892309"}},{"Citation":"Neurodegener Dis. 2017;17 (2-3):83-88","ArticleIdList":{"ArticleId":"27760429"}},{"Citation":"Neurology. 2009 Nov 3;73(18):1451-6","ArticleIdList":{"ArticleId":"19884572"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Neurobiol Aging. 2014 May;35(5):1212.e1-5","ArticleIdList":{"ArticleId":"24300238"}},{"Citation":"Orphanet J Rare Dis. 2014 Nov 26;9:179","ArticleIdList":{"ArticleId":"25424010"}},{"Citation":"Hum Mol Genet. 2016 Oct 15;25(20):4473-4483","ArticleIdList":{"ArticleId":"28172957"}},{"Citation":"Brain. 2014 Aug;137(Pt 8):2329-45","ArticleIdList":{"ArticleId":"24934289"}},{"Citation":"Neurobiol Aging. 2016 Oct;46:236.e1-6","ArticleIdList":{"ArticleId":"27524508"}},{"Citation":"Brain. 2009 Mar;132(Pt 3):583-91","ArticleIdList":{"ArticleId":"19158106"}},{"Citation":"Neuropathol Appl Neurobiol. 2015 Dec;41(7):858-81","ArticleIdList":{"ArticleId":"26041104"}},{"Citation":"Brain. 2011 Sep;134(Pt 9):2456-77","ArticleIdList":{"ArticleId":"21810890"}},{"Citation":"Neurobiol Aging. 2013 Oct;34(10):2443.e1-2","ArticleIdList":{"ArticleId":"23759145"}},{"Citation":"J Alzheimers Dis. 2010;20(1):253-60","ArticleIdList":{"ArticleId":"20164582"}},{"Citation":"Hum Mol Genet. 2013 Apr 1;22(7):1417-23","ArticleIdList":{"ArticleId":"23297359"}},{"Citation":"Neurology. 2000 Nov 28;55(10):1577-8","ArticleIdList":{"ArticleId":"11094121"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28086931","DateCompleted":{"Year":"2017","Month":"11","Day":"09"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"1750-1326","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"12","Issue":"1","PubDate":{"Year":"2017","Month":"01","Day":"13"}},"Title":"Molecular neurodegeneration","ISOAbbreviation":"Mol Neurodegener"},"ArticleTitle":"The release and trans-synaptic transmission of Tau via exosomes.","Pagination":{"MedlinePgn":"5"},"ELocationID":"10.1186\/s13024-016-0143-y","Abstract":{"AbstractText":["Tau pathology in AD spreads in a hierarchical pattern, whereby it first appears in the entorhinal cortex, then spreads to the hippocampus and later to the surrounding areas. Based on this sequential appearance, AD can be classified into six stages (\"Braak stages\"). The mechanisms and agents underlying the progression of Tau pathology are a matter of debate. Emerging evidence indicates that the propagation of Tau pathology may be due to the transmission of Tau protein, but the underlying pathways and Tau species are not well understood. In this study we investigated the question of Tau spreading via small extracellular vesicles called exosomes.","Exosomes from different sources were analyzed by biochemical methods and electron microscopy (EM) and cryo-EM. Microfluidic devices that allow the culture of cell populations in different compartments were used to investigate the spreading of Tau.","We show that Tau protein is released by cultured primary neurons or by N2a cells overexpressing different Tau constructs via exosomes. Neuron-derived exosomal Tau is hypo-phosphorylated, compared with cytosolic Tau. Depolarization of neurons promotes release of Tau-containing exosomes, highlighting the importance of neuronal activity. Using microfluidic devices we show that exosomes mediate trans-neuronal transfer of Tau depending on synaptic connectivity. Tau spreading is achieved by direct transmission of exosomes between neurons. In organotypic hippocampal slices, Tau-containing exosomes in conditioned medium are taken up by neurons and microglia, not astrocytes. In N2a cells, Tau assemblies are released via exosomes. They can induce inclusions of other Tau molecules in N2a cells expressing mutant human Tau. We also studied exosomes from cerebrospinal fluid in AD and control subjects containing monomeric and oligomeric Tau. Split-luciferase complementation reveals that exosomes from CSF can promote Tau aggregation in cultured cells.","Our study demonstrates that exosomes contribute to trans-synaptic Tau transmission, and thus offer new approches to control the spreading of pathology in AD and other tauopathies."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Wang","ForeName":"Yipeng","Initials":"Y","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Yipeng.wang@dzne.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Balaji","ForeName":"Varun","Initials":"V","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaniyappan","ForeName":"Senthilvelrajan","Initials":"S","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kr\u00fcger","ForeName":"Lars","Initials":"L","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irsen","ForeName":"Stephan","Initials":"S","AffiliationInfo":{"Affiliation":"CAESAR Research Center, Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tepper","ForeName":"Katharina","Initials":"K","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Chandupatla","ForeName":"RamReddy","Initials":"R","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology, University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schneider","ForeName":"Anja","Initials":"A","AffiliationInfo":[{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."},{"Affiliation":"Department for Psychiatry and Psychotherapy, University Medical Center, Goettingen, Germany."},{"Affiliation":"MPI for Experimental Medicine, G\u00f6ttingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Mandelkow","ForeName":"Eckhard","Initials":"E","AffiliationInfo":[{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."},{"Affiliation":"CAESAR Research Center, Bonn, Germany."},{"Affiliation":"MPI for Metabolism Research, Hamburg Outstation, c\/o DESY, Hamburg, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Mandelkow","ForeName":"Eva-Maria","Initials":"EM","AffiliationInfo":[{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. mandelkow@mpasmb.desy.de."},{"Affiliation":"CAESAR Research Center, Bonn, Germany. mandelkow@mpasmb.desy.de."},{"Affiliation":"MPI for Metabolism Research, Hamburg Outstation, c\/o DESY, Hamburg, Germany. mandelkow@mpasmb.desy.de."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"01","Day":"13"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Mol Neurodegener","NlmUniqueID":"101266600","ISSNLinking":"1750-1326"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":"pathology"},{"DescriptorName":"Animals"},{"DescriptorName":"Cryoelectron Microscopy"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay"},{"DescriptorName":"Exosomes","QualifierName":"metabolism"},{"DescriptorName":"Female"},{"DescriptorName":"Flow Cytometry"},{"DescriptorName":"Fluorescent Antibody Technique"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Mice"},{"DescriptorName":"Microfluidic Analytical Techniques"},{"DescriptorName":"Microscopy, Atomic Force"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neurons","QualifierName":"metabolism"},{"DescriptorName":"Protein Transport"},{"DescriptorName":"Rats"},{"DescriptorName":"Tauopathies","QualifierName":["metabolism","pathology"]},{"DescriptorName":"tau Proteins","QualifierName":"metabolism"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer disease","Exosomes","Spreading","Tau"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"09","Day":"01"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"12","Day":"16"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"1","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"1","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"11","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["28086931","10.1186\/s13024-016-0143-y","10.1186\/s13024-016-0143-y","PMC5237256"]},"ReferenceList":{"Reference":[{"Citation":"Cell Rep. 2015 May 26;11(8):1176-83","ArticleIdList":{"ArticleId":"25981034"}},{"Citation":"Acta Neuropathol. 1996 Aug;92(2):197-201","ArticleIdList":{"ArticleId":"8841666"}},{"Citation":"Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10252-7","ArticleIdList":{"ArticleId":"17535890"}},{"Citation":"Nat Neurosci. 2015 Nov;18(11):1584-93","ArticleIdList":{"ArticleId":"26436904"}},{"Citation":"J Biol Chem. 2013 Jan 18;288(3):1856-70","ArticleIdList":{"ArticleId":"23188818"}},{"Citation":"Brain. 2016 Feb;139(Pt 2):481-94","ArticleIdList":{"ArticleId":"26647156"}},{"Citation":"Acta Neuropathol. 2015 May;129(5):695-713","ArticleIdList":{"ArticleId":"25778619"}},{"Citation":"J Biol Chem. 2012 Dec 14;287(51):42751-62","ArticleIdList":{"ArticleId":"23105105"}},{"Citation":"PLoS One. 2012;7(2):e31302","ArticleIdList":{"ArticleId":"22312444"}},{"Citation":"J Cell Sci. 2011 Feb 1;124(Pt 3):447-58","ArticleIdList":{"ArticleId":"21242314"}},{"Citation":"Mol Cell Neurosci. 2006 Apr;31(4):642-8","ArticleIdList":{"ArticleId":"16446100"}},{"Citation":"Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77","ArticleIdList":{"ArticleId":"26858453"}},{"Citation":"J Neurosci. 2011 Sep 14;31(37):13110-7","ArticleIdList":{"ArticleId":"21917794"}},{"Citation":"Nat Cell Biol. 2009 Jul;11(7):909-13","ArticleIdList":{"ArticleId":"19503072"}},{"Citation":"J Extracell Vesicles. 2014 Aug 04;3:null","ArticleIdList":{"ArticleId":"25143819"}},{"Citation":"Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8","ArticleIdList":{"ArticleId":"15210972"}},{"Citation":"Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22","ArticleIdList":{"ArticleId":"18228490"}},{"Citation":"Neuron. 2013 Oct 16;80(2):402-14","ArticleIdList":{"ArticleId":"24075978"}},{"Citation":"Hum Mol Genet. 2009 Nov 1;18(21):4153-70","ArticleIdList":{"ArticleId":"19654187"}},{"Citation":"J Biol Chem. 2012 Feb 3;287(6):3842-9","ArticleIdList":{"ArticleId":"22057275"}},{"Citation":"Mol Cell Neurosci. 2011 Feb;46(2):409-18","ArticleIdList":{"ArticleId":"21111824"}},{"Citation":"J Biol Chem. 2012 Jun 8;287(24):20522-33","ArticleIdList":{"ArticleId":"22496370"}},{"Citation":"J Struct Biol. 2005 Oct;152(1):36-51","ArticleIdList":{"ArticleId":"16182563"}},{"Citation":"EMBO Rep. 2013 Apr;14(4):389-94","ArticleIdList":{"ArticleId":"23412472"}},{"Citation":"Biochem Soc Trans. 2013 Feb 1;41(1):241-4","ArticleIdList":{"ArticleId":"23356290"}},{"Citation":"J Exp Med. 2014 Mar 10;211(3):387-93","ArticleIdList":{"ArticleId":"24534188"}},{"Citation":"J Neurosci. 2014 Mar 19;34(12):4260-72","ArticleIdList":{"ArticleId":"24647946"}},{"Citation":"Neurodegener Dis. 2012;10(1-4):73-5","ArticleIdList":{"ArticleId":"22269430"}},{"Citation":"Acta Neuropathol. 1991;82(4):239-59","ArticleIdList":{"ArticleId":"1759558"}},{"Citation":"Hum Mol Genet. 2012 Oct 15;21(R1):R125-34","ArticleIdList":{"ArticleId":"22872698"}},{"Citation":"J Alzheimers Dis. 2010;19(2):647-64","ArticleIdList":{"ArticleId":"20110609"}},{"Citation":"Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10032-7","ArticleIdList":{"ArticleId":"12888622"}},{"Citation":"J Neurosci. 2015 Jul 29;35(30):10851-65","ArticleIdList":{"ArticleId":"26224867"}},{"Citation":"Structure. 2015 Apr 7;23 (4):628-38","ArticleIdList":{"ArticleId":"25728926"}},{"Citation":"Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11172-7","ArticleIdList":{"ArticleId":"16837572"}},{"Citation":"PLoS One. 2014 Jun 27;9(6):e100760","ArticleIdList":{"ArticleId":"24971751"}},{"Citation":"Nat Rev Mol Cell Biol. 2009 Feb;10(2):148-55","ArticleIdList":{"ArticleId":"19122676"}},{"Citation":"J Biol Chem. 2011 Apr 29;286(17):15317-31","ArticleIdList":{"ArticleId":"21372138"}},{"Citation":"Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247","ArticleIdList":{"ArticleId":"22762014"}},{"Citation":"Mol Neurodegener. 2012 Aug 24;7:42","ArticleIdList":{"ArticleId":"22920859"}},{"Citation":"Free Radic Biol Med. 2013 Sep;62:90-101","ArticleIdList":{"ArticleId":"23200807"}},{"Citation":"Acta Neuropathol Commun. 2014 Jan 30;2:14","ArticleIdList":{"ArticleId":"24479894"}},{"Citation":"Science. 1984 Sep 14;225(4667):1168-70","ArticleIdList":{"ArticleId":"6474172"}},{"Citation":"PLoS One. 2015 Oct 01;10(10):e0139233","ArticleIdList":{"ArticleId":"26426747"}},{"Citation":"J Struct Biol. 1997 Dec;120(3):343-52","ArticleIdList":{"ArticleId":"9441937"}},{"Citation":"PLoS Biol. 2013 Jul;11(7):e1001604","ArticleIdList":{"ArticleId":"23874151"}},{"Citation":"PLoS One. 2010 Jan 05;5(1):e8577","ArticleIdList":{"ArticleId":"20052414"}},{"Citation":"FEBS Lett. 2012 Jan 2;586(1):47-54","ArticleIdList":{"ArticleId":"22138183"}},{"Citation":"Neuron. 2013 Mar 20;77(6):1039-46","ArticleIdList":{"ArticleId":"23522040"}},{"Citation":"Acta Neuropathol. 2011 Feb;121(2):171-81","ArticleIdList":{"ArticleId":"21170538"}},{"Citation":"Cell. 2006 Nov 17;127(4):831-46","ArticleIdList":{"ArticleId":"17110340"}},{"Citation":"PLoS One. 2013 Apr 29;8(4):e62402","ArticleIdList":{"ArticleId":"23638068"}},{"Citation":"Curr Opin Cell Biol. 2004 Aug;16(4):415-21","ArticleIdList":{"ArticleId":"15261674"}},{"Citation":"J Biol Chem. 2006 Jan 13;281(2):1205-14","ArticleIdList":{"ArticleId":"16246844"}},{"Citation":"Neuron. 2012 Feb 23;73(4):685-97","ArticleIdList":{"ArticleId":"22365544"}},{"Citation":"Eur J Neurosci. 2013 Jun;37(12):1939-48","ArticleIdList":{"ArticleId":"23773063"}},{"Citation":"J Biol Chem. 2009 May 8;284(19):12845-52","ArticleIdList":{"ArticleId":"19282288"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Alzheimers Dement. 2015 Jun;11(6):600-7.e1","ArticleIdList":{"ArticleId":"25130657"}},{"Citation":"Nat Commun. 2015 Oct 13;6:8490","ArticleIdList":{"ArticleId":"26458742"}},{"Citation":"J Cell Biol. 2016 Apr 25;213(2):173-84","ArticleIdList":{"ArticleId":"27114500"}},{"Citation":"Neurobiol Aging. 2013 May;34(5):1343-54","ArticleIdList":{"ArticleId":"23158765"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28008748","DateCompleted":{"Year":"2017","Month":"12","Day":"22"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1098-1004","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"38","Issue":"3","PubDate":{"Year":"2017","Month":"03"}},"Title":"Human mutation","ISOAbbreviation":"Hum Mutat"},"ArticleTitle":"TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.","Pagination":{"MedlinePgn":"297-309"},"ELocationID":"10.1002\/humu.23161","Abstract":{"AbstractText":"We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. We assessed pathogenicity of predicted protein-truncating mutations by measuring loss of RNA expression. Functional effect of in-frame amino acid deletions and missense mutations was further explored in vivo on protein level and in vitro by an NF\u03baB-induced luciferase reporter assay and measuring phosphorylated TBK1. The protein-truncating mutations led to the loss of transcript through nonsense-mediated mRNA decay. For the in-frame amino acid deletions, we demonstrated loss of TBK1 or phosphorylated TBK1 protein. An important fraction of the missense mutations compromised NF\u03baB activation indicating that at least some functions of TBK1 are lost. Although missense mutations were also present in controls, over three times more mutations affecting TBK1 functioning were found in the mutation fraction observed in patients only, suggesting high-risk alleles (P = 0.03). Total mutation frequency for confirmed TBK1 LoF mutations in the European cohort was 0.7%, with frequencies in the clinical subgroups of 0.4% in FTD, 1.3% in ALS, and 3.6% in FTD-ALS.","CopyrightInformation":"\u00a9 2016 The Authors. **Human Mutation published by Wiley Periodicals, Inc."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Mossevelde","ForeName":"Sara","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology, Antwerp University Hospital, Edegem, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Perrone","ForeName":"Federica","Initials":"F","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Heeman","ForeName":"Bavo","Initials":"B","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S","AffiliationInfo":[{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"De Bleecker","ForeName":"Jan","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurology, University Hospital Ghent and University of Ghent, Ghent, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Baets","ForeName":"Jonathan","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology, Antwerp University Hospital, Edegem, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E","AffiliationInfo":{"Affiliation":"Neurological Tissue Bank of the Biobanc - Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rojas-Garc\u00eda","ForeName":"Ricardo","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clarim\u00f3n","ForeName":"Jordi","Initials":"J","AffiliationInfo":[{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain."},{"Affiliation":"Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Lle\u00f3","ForeName":"Alberto","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain."},{"Affiliation":"Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Alexopoulos","ForeName":"Panagiotis","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Psychotherapy, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany."},{"Affiliation":"Neuroepidemiology and Ageing Research Unit, School of Public Health, The Imperial College of Science, Technology and Medicine, London, UK."},{"Affiliation":"West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, TW8 8DS, UK."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and Centre of Neurology, T\u00fcbingen, Germany."},{"Affiliation":"German Research Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Just","ForeName":"Jennifer","Initials":"J","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and Centre of Neurology, T\u00fcbingen, Germany."},{"Affiliation":"German Research Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and Centre of Neurology, T\u00fcbingen, Germany."},{"Affiliation":"German Research Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C","AffiliationInfo":[{"Affiliation":"Department of Neurobiology, Care Sciences and Society (NVS), KI-Alzheimer Disease Research Center, Karolinska Institutet, Stockholm, Sweden."},{"Affiliation":"Department of Geriatric Medicine, Genetics unit, Karolinska University Hospital, Stockholm, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Thonberg","ForeName":"H\u00e5kan","Initials":"H","AffiliationInfo":[{"Affiliation":"Department of Neurobiology, Care Sciences and Society (NVS), KI-Alzheimer Disease Research Center, Karolinska Institutet, Stockholm, Sweden."},{"Affiliation":"Department of Geriatric Medicine, Genetics unit, Karolinska University Hospital, Stockholm, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurology, Medical University-Sofia, Sofia, Bulgaria."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I","AffiliationInfo":{"Affiliation":"Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A","AffiliationInfo":[{"Affiliation":"Hospital Santa Maria, Lisbon, Portugal."},{"Affiliation":"Faculty of Medicine and Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Milt\u00e9nyi","ForeName":"Gabriel","Initials":"G","AffiliationInfo":[{"Affiliation":"Hospital Santa Maria, Lisbon, Portugal."},{"Affiliation":"Faculty of Medicine and Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sim\u00f5es do Couto","ForeName":"Frederico","Initials":"F","AffiliationInfo":[{"Affiliation":"Hospital Santa Maria, Lisbon, Portugal."},{"Affiliation":"Faculty of Medicine and Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany."},{"Affiliation":"Institute of Human Genetics, University of Bonn, Bonn, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT","AffiliationInfo":[{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany."},{"Affiliation":"Clinical Neuroscience Unit, Department of Neurology, University of Bonn, Bonn, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"G\u00f3mez-Tortosa","ForeName":"Estrella","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Neurology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Danek","ForeName":"Adrian","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurology, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Munich, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P","AffiliationInfo":[{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology, Antwerp University Hospital, Edegem, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenberghe","ForeName":"Rik","Initials":"R","AffiliationInfo":[{"Affiliation":"Department of Neurosciences, Faculty of Medicine, KU Leuven, Leuven, Belgium."},{"Affiliation":"Department of Neurology, University Hospitals Leuven, Leuven, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"De Jonghe","ForeName":"Peter","Initials":"P","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology, Antwerp University Hospital, Edegem, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter P","Initials":"PP","AffiliationInfo":[{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."},{"Affiliation":"Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Institute Born-Bunge, University of Antwerp, Antwerp, Belgium."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Goeman","ForeName":"Johan","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Hospital Network Antwerp, Antwerp."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Nuytten","ForeName":"Dirk","Initials":"D","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Hospital Network Antwerp, Antwerp."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Smets","ForeName":"Katrien","Initials":"K","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Antwerp University Hospital, Edegem."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Robberecht","ForeName":"Wim","Initials":"W","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospitals Leuven Gasthuisberg, Leuven."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Damme","ForeName":"Philip Van","Initials":"PV","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospitals Leuven Gasthuisberg, Leuven."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bleecker","ForeName":"Jan De","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital Ghent, Ghent."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital Ghent, Ghent."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Dermaut","ForeName":"Bart","Initials":"B","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital Ghent, Ghent."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Versijpt","ForeName":"Jan","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital Brussels, Brussels."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Michotte","ForeName":"Alex","Initials":"A","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital Brussels, Brussels."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ivanoiu","ForeName":"Adrian","Initials":"A","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Saint-Luc University Hospital, Brussels."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Deryck","ForeName":"Olivier","Initials":"O","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"General Hospital Sint-Jan Brugge, Bruges."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bergmans","ForeName":"Bruno","Initials":"B","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"General Hospital Sint-Jan Brugge, Bruges."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Delbeck","ForeName":"Jean","Initials":"J","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"General Hospital Sint-Maria, Halle."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bruyland","ForeName":"Marc","Initials":"M","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"General Hospital Glorieux Ronse."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Willems","ForeName":"Christiana","Initials":"C","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Jessa Hospital, Hasselt."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University of Li\u00e8ge and Memory Clinic, CHU Li\u00e8ge, Li\u00e8ge."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Pastor","ForeName":"Pau","Initials":"P","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University Hospital M\u00fatua de Terrassa and Fundaci\u00f3 Doc\u00e8ncia i Recerca M\u00fatua Terrassa, University of Barcelona School of Medicine, Terrassa, Barcelona, Spain."},{"Affiliation":"CIBERNED Instituto de Salud Carlos III, Madrid, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ortega-Cubero","ForeName":"Sara","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"CIBERNED Instituto de Salud Carlos III, Madrid, Spain."},{"Affiliation":"Deparment of Neurology, Complejo Asistencial Universitario de Palencia, Palencia, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"MAC Memory Center and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hern\u00e1ndez","ForeName":"Isabel","Initials":"I","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8ncies Aplicades, Barcelona, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Boada","ForeName":"Merc\u00e8","Initials":"M","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8ncies Aplicades, Barcelona, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruiz","ForeName":"Agust\u00edn","Initials":"A","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8ncies Aplicades, Barcelona, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"IRCCS Don Carlo Gnocchi Scandicci, Florence, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Hospital Cl\u00ednic, IDIBAPS, Barcelona, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Hospital Cl\u00ednic, IDIBAPS, Barcelona, Spain."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University of Coimbra, Coimbra, Portugal."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ros\u00e1rio Almeida","ForeName":"Maria","Initials":"M","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University of Coimbra, Coimbra, Portugal."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"H\u00f4pitaux Universitaires de Gen\u00e8ve et Universit\u00e9 de Gen\u00e8ve, Gen\u00e8ve, Switzerland and IRCCS Fatebenefratelli, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Hertie Institute for Clinical Brain Research, T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Matej","ForeName":"Radoslav","Initials":"R","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Thomayer Hospital, Prague and Charles University, Prague, Czech Republic."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Fraidakis","ForeName":"Matthew J","Initials":"MJ","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"NeuroRARE Centre for Rare and Genetic Neurological & Neuromuscular Diseases & Neurogenetics Athens, Greece."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"Medical University of Vienna, Vienna, Austria."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Fabrizi","ForeName":"Gian Maria","Initials":"GM","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University of Verona, Verona, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S","AffiliationInfo":[{"Affiliation":"Center for Molecular Neurology, VIB, Antwerp, Belgium."},{"Affiliation":"University of Verona, Verona, Italy."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"01","Day":"19"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Hum Mutat","NlmUniqueID":"9215429","ISSNLinking":"1059-7794"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"NF-kappa B"},{"RegistryNumber":"EC 2.7.11.1","NameOfSubstance":"Protein-Serine-Threonine Kinases"},{"RegistryNumber":"EC 2.7.11.1","NameOfSubstance":"TBK1 protein, human"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alleles"},{"DescriptorName":"Amino Acid Substitution"},{"DescriptorName":"Amyotrophic Lateral Sclerosis","QualifierName":["diagnosis","epidemiology","genetics"]},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Enzyme Activation"},{"DescriptorName":"European Continental Ancestry Group","QualifierName":"genetics"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["diagnosis","epidemiology","genetics"]},{"DescriptorName":"Genetic Association Studies"},{"DescriptorName":"Heterozygote"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"NF-kappa B","QualifierName":"metabolism"},{"DescriptorName":"Phenotype"},{"DescriptorName":"Protein-Serine-Threonine Kinases","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Sequence Deletion"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["ALS","FTD","NF\u03baB luciferase reporter assay","TANK-Binding Kinase 1","TBK1","amyotrophic lateral sclerosis","frontotemporal dementia","mutations"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"10","Day":"10"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"12","Day":"15"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"12","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"12","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"12","Day":"24","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["28008748","10.1002\/humu.23161","PMC5324646"]},"ReferenceList":{"Reference":[{"Citation":"Acta Neuropathol. 2009 Feb;117(2):151-8","ArticleIdList":{"ArticleId":"19039597"}},{"Citation":"Neurology. 2002 Oct 8;59(7):1077-9","ArticleIdList":{"ArticleId":"12370467"}},{"Citation":"Cell Rep. 2013 Mar 28;3(3):734-46","ArticleIdList":{"ArticleId":"23453971"}},{"Citation":"Neurobiol Aging. 2015 Nov;36(11):3116.e5-8","ArticleIdList":{"ArticleId":"26476236"}},{"Citation":"Immunity. 2012 Aug 24;37(2):223-34","ArticleIdList":{"ArticleId":"22921120"}},{"Citation":"Neurobiol Aging. 2011 Jul;32(7):1296-303","ArticleIdList":{"ArticleId":"19695742"}},{"Citation":"J Neuropathol Exp Neurol. 2004 Sep;63(9):911-8","ArticleIdList":{"ArticleId":"15453090"}},{"Citation":"Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9","ArticleIdList":{"ArticleId":"11464847"}},{"Citation":"Neuropathol Appl Neurobiol. 2014 Feb;40(2):225-30","ArticleIdList":{"ArticleId":"23692129"}},{"Citation":"Neurology. 2011 Mar 15;76(11):1006-14","ArticleIdList":{"ArticleId":"21325651"}},{"Citation":"Acta Neuropathol. 2015 Jul;130(1):77-92","ArticleIdList":{"ArticleId":"25943890"}},{"Citation":"Nat Genet. 2004 Apr;36(4):377-81","ArticleIdList":{"ArticleId":"15034582"}},{"Citation":"Neuron. 2011 Oct 20;72(2):245-56","ArticleIdList":{"ArticleId":"21944778"}},{"Citation":"Science. 2008 Mar 21;319(5870):1668-72","ArticleIdList":{"ArticleId":"18309045"}},{"Citation":"Neurology. 2010 Feb 2;74(5):366-71","ArticleIdList":{"ArticleId":"20124201"}},{"Citation":"Hum Mutat. 2012 Sep;33(9):1340-4","ArticleIdList":{"ArticleId":"22581678"}},{"Citation":"Acta Neuropathol. 2013 Jul;126(1):51-7","ArticleIdList":{"ArticleId":"23604587"}},{"Citation":"Neurology. 2015 Dec 15;85(24):2116-25","ArticleIdList":{"ArticleId":"26581300"}},{"Citation":"Hum Mutat. 2013 Feb;34(2):363-73","ArticleIdList":{"ArticleId":"23111906"}},{"Citation":"Brain. 2016 Feb;139(Pt 2):452-67","ArticleIdList":{"ArticleId":"26674655"}},{"Citation":"Amyotroph Lateral Scler Frontotemporal Degener. 2013 Jan;14(1):70-2","ArticleIdList":{"ArticleId":"22742426"}},{"Citation":"Nat Neurosci. 2015 May;18(5):631-6","ArticleIdList":{"ArticleId":"25803835"}},{"Citation":"Acta Neuropathol. 2014 Sep;128(3):397-410","ArticleIdList":{"ArticleId":"24899140"}},{"Citation":"Neurobiol Aging. 2015 Dec;36(12):3334.e1-5","ArticleIdList":{"ArticleId":"26350399"}},{"Citation":"Neuron. 2011 Oct 20;72(2):257-68","ArticleIdList":{"ArticleId":"21944779"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Cell Res. 2008 Sep;18(9):889-99","ArticleIdList":{"ArticleId":"19160540"}},{"Citation":"Trends Neurosci. 2013 Aug;36(8):450-9","ArticleIdList":{"ArticleId":"23746459"}},{"Citation":"Neuron. 2010 Dec 9;68(5):857-64","ArticleIdList":{"ArticleId":"21145000"}},{"Citation":"Lancet Neurol. 2012 Jan;11(1):54-65","ArticleIdList":{"ArticleId":"22154785"}},{"Citation":"Hum Mutat. 2009 Nov;30(11):E974-83","ArticleIdList":{"ArticleId":"19655382"}},{"Citation":"Brain. 2011 Sep;134(Pt 9):2456-77","ArticleIdList":{"ArticleId":"21810890"}},{"Citation":"Science. 2009 Feb 27;323(5918):1205-8","ArticleIdList":{"ArticleId":"19251627"}},{"Citation":"Science. 2015 Mar 27;347(6229):1436-41","ArticleIdList":{"ArticleId":"25700176"}},{"Citation":"Nat Genet. 2008 May;40(5):572-4","ArticleIdList":{"ArticleId":"18372902"}},{"Citation":"Acta Neuropathol. 2011 Jul;122(1):111-3","ArticleIdList":{"ArticleId":"21644037"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27760429","DateCompleted":{"Year":"2017","Month":"09","Day":"13"},"DateRevised":{"Year":"2018","Month":"12","Day":"02"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1660-2862","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"17","Issue":"2-3","PubDate":{"Year":"2017"}},"Title":"Neuro-degenerative diseases","ISOAbbreviation":"Neurodegener Dis"},"ArticleTitle":"Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.","Pagination":{"MedlinePgn":"83-88"},"ELocationID":"10.1159\/000448896","Abstract":{"AbstractText":["Reduced progranulin levels are a hallmark of frontotemporal dementia (FTD) caused by loss-of-function (LoF) mutations in the progranulin gene (GRN). However, alterations of central nervous progranulin expression also occur in neurodegenerative disorders unrelated to GRN mutations, such as Alzheimer's disease. We hypothesised that central nervous progranulin levels are also reduced in GRN-negative FTD.","Progranulin levels were determined in both cerebrospinal fluid (CSF) and serum in 75 subjects (37 FTD patients and 38 controls). All FTD patients were assessed by whole-exome sequencing for GRN mutations, yielding a target cohort of 34 patients without pathogenic mutations in GRN (GRN-negative cohort) and 3 GRN mutation carriers (2 LoF variants and 1 novel missense variant).","Not only the GRN mutation carriers but also the GRN-negative patients showed decreased CSF levels of progranulin (serum levels in GRN-negative patients were normal). The decreased CSF progranulin levels were unrelated to patients' increased CSF levels of total tau, possibly indicating different destructive neuronal processes within FTD neurodegeneration. The patient with the novel GRN missense variant (c.1117C>T, p.P373S) showed substantially decreased CSF levels of progranulin, comparable to the 2 patients with GRN LoF mutations, suggesting a pathogenic effect of this missense variant.","Our results indicate that central nervous progranulin reduction is not restricted to the relatively rare cases of FTD caused by GRN LoF mutations, but also contributes to the more common GRN-negative forms of FTD. Central nervous progranulin reduction might reflect a partially distinct pathogenic mechanism underlying FTD neurodegeneration and is not directly linked to tau alterations."],"CopyrightInformation":"\u00a9 2016 S. Karger AG, Basel."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Wilke","ForeName":"Carlo","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research (HIH), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gillardon","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hobert","ForeName":"Markus A","Initials":"MA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jansen","ForeName":"Iris E","Initials":"IE"},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian G","Initials":"FG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heutink","ForeName":"Peter","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Blauwendraat","ForeName":"Cornelis","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"10","Day":"20"}},"MedlineJournalInfo":{"Country":"Switzerland","MedlineTA":"Neurodegener Dis","NlmUniqueID":"101189034","ISSNLinking":"1660-2854"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"GRN protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Intercellular Signaling Peptides and Proteins"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Progranulins"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["blood","cerebrospinal fluid","genetics"]},{"DescriptorName":"Humans"},{"DescriptorName":"Intercellular Signaling Peptides and Proteins","QualifierName":["blood","cerebrospinal fluid","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Mutation, Missense"},{"DescriptorName":"Phosphorylation"},{"DescriptorName":"Polymorphism, Single Nucleotide"},{"DescriptorName":"Progranulins"},{"DescriptorName":"tau Proteins","QualifierName":["cerebrospinal fluid","metabolism"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"03","Day":"17"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"08","Day":"03"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"10","Day":"21","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"9","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"10","Day":"21","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27760429","000448896","10.1159\/000448896"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27666590","DateCompleted":{"Year":"2017","Month":"11","Day":"16"},"DateRevised":{"Year":"2020","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1558-1497","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"49","PubDate":{"Year":"2017","Month":"01"}},"Title":"Neurobiology of aging","ISOAbbreviation":"Neurobiol Aging"},"ArticleTitle":"Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.","Pagination":{"MedlinePgn":"214.e13-214.e15"},"ELocationID":["S0197-4580(16)30201-9","10.1016\/j.neurobiolaging.2016.08.023"],"Abstract":{"AbstractText":"C9orf72 repeat expansions are a common cause of amyotrophic lateral sclerosis and frontotemporal dementia. To date, no large-scale study of dementia with Lewy bodies (DLB) has been undertaken to assess the role of C9orf72 repeat expansions in the disease. Here, we investigated the prevalence of C9orf72 repeat expansions in a large cohort of DLB cases and identified no pathogenic repeat expansions in neuropathologically or clinically defined cases, showing that C9orf72 repeat expansions are not causally associated with DLB.","CopyrightInformation":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Kun-Rodrigues","ForeName":"Celia","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ross","ForeName":"Owen A","Initials":"OA","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orme","ForeName":"Tatiana","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Shepherd","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Parkkinen","ForeName":"Laura","Initials":"L","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Darwent","ForeName":"Lee","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hernandez","ForeName":"Dena","Initials":"D","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ansorge","ForeName":"Olaf","Initials":"O","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Lorraine N","Initials":"LN","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Honig","ForeName":"Lawrence S","Initials":"LS","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marder","ForeName":"Karen","Initials":"K","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lemstra","ForeName":"Afina","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scheltens","ForeName":"Philippe","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Flier","ForeName":"Wiesje","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Louwersheimer","ForeName":"Eva","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Holstege","ForeName":"Henne","Initials":"H","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rogaeva","ForeName":"Ekaterina","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"St George-Hyslop","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Londos","ForeName":"Elisabet","Initials":"E","AffiliationInfo":{"Affiliation":"Clinical Memory Research Unit, Institution of Clinical Sciences Malm\u00f6, Lund University, Lund, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zetterberg","ForeName":"Henrik","Initials":"H","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Barber","ForeName":"Imelda","Initials":"I","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Braae","ForeName":"Anne","Initials":"A","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brown","ForeName":"Kristelle","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morgan","ForeName":"Kevin","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; Department of Neurology, Christian-Albrechts University of Kiel, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; Department of Neurology, Christian-Albrechts University of Kiel, Kiel, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Troakes","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Basic and Clinical Neuroscience and Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Al-Sarraj","ForeName":"Safa","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Basic and Clinical Neuroscience and Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lashley","ForeName":"Tammaryn","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Holton","ForeName":"Janice","Initials":"J","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Compta","ForeName":"Yaroslau","Initials":"Y","AffiliationInfo":{"Affiliation":"Movement Disorders Unit, Neurology Service, Clinical Neuroscience Institute (ICN), Hospital Cl\u00ednic, University of Barcelona, IDIBAPS, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Deerlin","ForeName":"Vivianna","Initials":"V","AffiliationInfo":{"Affiliation":"Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Trojanowski","ForeName":"John Q","Initials":"JQ","AffiliationInfo":{"Affiliation":"Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Serrano","ForeName":"Geidy E","Initials":"GE","AffiliationInfo":{"Affiliation":"Banner Sun Health Research Institute, Sun City, AZ, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Beach","ForeName":"Thomas G","Initials":"TG","AffiliationInfo":{"Affiliation":"Banner Sun Health Research Institute, Sun City, AZ, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clarimon","ForeName":"Jordi","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universidad Aut\u00f2noma de Barcelona, Barcelona, Catalonia, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lle\u00f3","ForeName":"Alberto","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universidad Aut\u00f2noma de Barcelona, Barcelona, Catalonia, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morenas-Rodr\u00edguez","ForeName":"Estrella","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universidad Aut\u00f2noma de Barcelona, Barcelona, Catalonia, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lesage","ForeName":"Suzanne","Initials":"S","AffiliationInfo":{"Affiliation":"Sorbonne Universit\u00e9, Universit\u00e9 Pierre et Marie Curie-Paris 06, Inserm, Centre National de la Reserche Scientifique, Institute du Cerveau et de la Moelle \u00e9pini\u00e8re, Paris, France; Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital de la Salp\u00eatri\u00e8re, D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galasko","ForeName":"Douglas","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Masliah","ForeName":"Eliezer","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I","AffiliationInfo":{"Affiliation":"Centro Hospitalar e Universit\u00e1rio de Coimbra, Coimbra, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Diez","ForeName":"Monica","Initials":"M","AffiliationInfo":{"Affiliation":"Memory Unit, Department of Neurology, University Hospital M\u00fatua de Terrassa, and Foundation M\u00fatua de Terrassa, Barcelona, Spain; Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pastor","ForeName":"Pau","Initials":"P","AffiliationInfo":{"Affiliation":"Memory Unit, Department of Neurology, University Hospital M\u00fatua de Terrassa, and Foundation M\u00fatua de Terrassa, Barcelona, Spain; Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tienari","ForeName":"Pentti J","Initials":"PJ","AffiliationInfo":{"Affiliation":"Molecular Neurology, Research Programs Unit, University of Helsinki, Department of Neurology, Helsinki University Hospital, Helsinki, Finland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Myllykangas","ForeName":"Liisa","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Pathology, University of Helsinki, Helsinki, Finland and HUSLAB."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Oinas","ForeName":"Minna","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neuropathology and Neurosurgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Revesz","ForeName":"Tamas","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lees","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Boeve","ForeName":"Brad F","Initials":"BF","AffiliationInfo":{"Affiliation":"Neurology Department, Mayo Clinic, Rochester, MN, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Petersen","ForeName":"Ronald C","Initials":"RC","AffiliationInfo":{"Affiliation":"Neurology Department, Mayo Clinic, Rochester, MN, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferman","ForeName":"Tanis J","Initials":"TJ","AffiliationInfo":{"Affiliation":"Department of Psychiatry, Mayo Clinic, Jacksonville, FL, USA; Department of Psychology, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Escott-Price","ForeName":"Valentina","Initials":"V","AffiliationInfo":{"Affiliation":"MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff-Radford","ForeName":"Neill","Initials":"N","AffiliationInfo":{"Affiliation":"Department of Neurology, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cairns","ForeName":"Nigel J","Initials":"NJ","AffiliationInfo":{"Affiliation":"Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morris","ForeName":"John C","Initials":"JC","AffiliationInfo":{"Affiliation":"Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stone","ForeName":"David J","Initials":"DJ","AffiliationInfo":{"Affiliation":"Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pickering-Brown","ForeName":"Stuart","Initials":"S","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mann","ForeName":"David","Initials":"D","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dickson","ForeName":"Dennis W","Initials":"DW","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Halliday","ForeName":"Glenda M","Initials":"GM","AffiliationInfo":{"Affiliation":"Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Singleton","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Guerreiro","ForeName":"Rita","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Department of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, Aveiro, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bras","ForeName":"Jose","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Department of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, Aveiro, Portugal. Electronic address: j.bras@ucl.ac.uk."}}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"P30 AG010124","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"G1100540","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P50 AG005131","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50 AG008702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50 NS053488","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"G0900652","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/P005748\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"R01 NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"U01 AG006786","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P30 ES009089","Acronym":"ES","Agency":"NIEHS NIH HHS","Country":"United States"},{"GrantID":"Z01 AG000951","Acronym":"ImNIH","Agency":"Intramural NIH HHS","Country":"United States"},{"GrantID":"R01 NS078086","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P50 NS038370","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P50 AG016574","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01 AG003991","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50 AG005681","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"G0502157","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"Agency":"CIHR","Country":"Canada"},{"GrantID":"G0400074","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P50 NS072187","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"UL1 TR000040","Acronym":"TR","Agency":"NCATS NIH HHS","Country":"United States"},{"Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Research Support, N.I.H., Intramural"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"09","Day":"02"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Aging","NlmUniqueID":"8100437","ISSNLinking":"0197-4580"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 protein, human"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"C9orf72 Protein","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"DNA Repeat Expansion","QualifierName":"genetics"},{"DescriptorName":"Genetic Association Studies"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"genetics"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["C9orf72","Dementia with Lewy bodies (DLB)","Genetic screen"]},"CoiStatement":"statement Ronald C. Petersen reports consultancies with Roche, Inc, Merck, Inc, Genentech, Inc, Biogen, Inc, and Eli Lilly. Brad F. Boeve reports GE Healthcare, FORUM Pharmaceuticals, and C2N Diagnostics as research support and advisory board member of the Tau Consortium. The remaining authors report no competing interests."},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"07","Day":"13"},{"@attributes":{"PubStatus":"revised"},"Year":"2016","Month":"08","Day":"22"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"08","Day":"25"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"9","Day":"27","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"11","Day":"29","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"9","Day":"27","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27666590","S0197-4580(16)30201-9","10.1016\/j.neurobiolaging.2016.08.023","PMC5154872","NIHMS826260"]},"ReferenceList":{"Reference":[{"Citation":"Neurodegener Dis. 2016;16(5-6):370-2","ArticleIdList":{"ArticleId":"27241037"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):765-83","ArticleIdList":{"ArticleId":"22366793"}},{"Citation":"Semin Neurol. 2007 Feb;27(1):42-7","ArticleIdList":{"ArticleId":"17226740"}},{"Citation":"N Engl J Med. 2012 Jan 19;366(3):283-4","ArticleIdList":{"ArticleId":"22216764"}},{"Citation":"Hum Mol Genet. 2014 Dec 1;23(23):6139-46","ArticleIdList":{"ArticleId":"24973356"}},{"Citation":"Acta Neuropathol. 2015 May;129(5):715-27","ArticleIdList":{"ArticleId":"25716178"}},{"Citation":"Neurology. 2014 Jan 28;82(4):292-9","ArticleIdList":{"ArticleId":"24363131"}},{"Citation":"J Geriatr Psychiatry Neurol. 2002 Winter;15(4):182-7","ArticleIdList":{"ArticleId":"12489913"}},{"Citation":"Brain. 2013 Feb;136(Pt 2):385-91","ArticleIdList":{"ArticleId":"23413259"}},{"Citation":"Neuron. 2011 Oct 20;72(2):245-56","ArticleIdList":{"ArticleId":"21944778"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1435-6","ArticleIdList":{"ArticleId":"24648039"}},{"Citation":"Neurobiol Aging. 2016 Feb;38:214.e7-10","ArticleIdList":{"ArticleId":"26643944"}},{"Citation":"Cogn Behav Neurol. 2008 Sep;21(3):157-63","ArticleIdList":{"ArticleId":"18797258"}},{"Citation":"Hum Mutat. 2013 Feb;34(2):363-73","ArticleIdList":{"ArticleId":"23111906"}},{"Citation":"Lancet Neurol. 2012 Apr;11(4):323-30","ArticleIdList":{"ArticleId":"22406228"}},{"Citation":"Transl Psychiatry. 2016 Feb 02;6:e728","ArticleIdList":{"ArticleId":"26836416"}},{"Citation":"Neurobiol Aging. 2012 Aug;33(8):1846.e5-6","ArticleIdList":{"ArticleId":"22410647"}},{"Citation":"Neurobiol Aging. 2012 Mar;33(3):629.e5-629.e18","ArticleIdList":{"ArticleId":"22118943"}},{"Citation":"Neurobiol Aging. 2013 Apr;34(4):1311.e3-4","ArticleIdList":{"ArticleId":"23063644"}},{"Citation":"Arch Neurol. 2012 Dec;69(12):1583-90","ArticleIdList":{"ArticleId":"22964832"}},{"Citation":"Neuron. 2011 Oct 20;72(2):257-68","ArticleIdList":{"ArticleId":"21944779"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1031-2","ArticleIdList":{"ArticleId":"22832738"}},{"Citation":"Am J Hum Genet. 2013 Mar 7;92 (3):345-53","ArticleIdList":{"ArticleId":"23434116"}},{"Citation":"Neurobiol Aging. 2012 Oct;33(10):2527.e1-2","ArticleIdList":{"ArticleId":"22721568"}},{"Citation":"JAMA Neurol. 2013 Jun;70(6):736-41","ArticleIdList":{"ArticleId":"23588422"}},{"Citation":"Neurobiol Aging. 2013 May;34(5):1519.e5-12","ArticleIdList":{"ArticleId":"23107433"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):723-35","ArticleIdList":{"ArticleId":"22300876"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27273178","DateCompleted":{"Year":"2018","Month":"07","Day":"13"},"DateRevised":{"Year":"2018","Month":"07","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1438-8782","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"38","Issue":"3","PubDate":{"Year":"2017","Month":"Jun"}},"Title":"Ultraschall in der Medizin (Stuttgart, Germany : 1980)","ISOAbbreviation":"Ultraschall Med"},"ArticleTitle":"Structural Ultrasound of the Medial Temporal Lobe in\u00a0Alzheimer's Disease.","Pagination":{"MedlinePgn":"294-300"},"ELocationID":"10.1055\/s-0042-107150","Abstract":{"AbstractText":{"b":["Purpose","Materials and Methods","Results","Conclusion"]},"CopyrightInformation":"\u00a9\u00a0Georg Thieme Verlag KG Stuttgart \u00b7 New York."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Yilmaz","ForeName":"Rezzak","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pilotto","ForeName":"Andrea","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Roeben","ForeName":"Benjamin","Initials":"B","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Preische","ForeName":"Oliver","Initials":"O","AffiliationInfo":[{"Affiliation":"Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Suenkel","ForeName":"Ulrike","Initials":"U","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Heinzel","ForeName":"Sebastian","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian G","Initials":"FG","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Geriatric Center at the University Hospital, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C","AffiliationInfo":[{"Affiliation":"Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."},{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Geriatric Center at the University Hospital, University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Section for Dementia Research, University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."},{"Affiliation":"Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."},{"Affiliation":"Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"VernacularTitle":"Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz.","ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"06","Day":"07"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Ultraschall Med","NlmUniqueID":"8303585","ISSNLinking":"0172-4614"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"ErratumIn"},"RefSource":"Ultraschall Med. 2017 Jun;38(3):e16","PMID":"27459251"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnostic imaging","economics"]},{"DescriptorName":"Atrophy"},{"DescriptorName":"Cerebral Ventricles","QualifierName":"diagnostic imaging"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Cost-Benefit Analysis"},{"DescriptorName":"Echoencephalography","QualifierName":["economics","methods"]},{"DescriptorName":"Female"},{"DescriptorName":"Hippocampus","QualifierName":"diagnostic imaging"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Mass Screening","QualifierName":"economics"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Organ Size","QualifierName":"physiology"},{"DescriptorName":"Reference Values"},{"DescriptorName":"Sensitivity and Specificity"},{"DescriptorName":"Statistics as Topic"},{"DescriptorName":"Temporal Lobe","QualifierName":["diagnostic imaging","pathology"]}]},"OtherAbstract":{"@attributes":{"Type":"Publisher","Language":"ger"},"AbstractText":{"b":["Ziel","Material und Methoden","Ergebnisse","Schlussfolgerung"]}},"CoiStatement":"Disclosure The authors report no conflicts of interest in this work."},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"6","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"7","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"6","Day":"9","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27273178","10.1055\/s-0042-107150"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27188986","DateCompleted":{"Year":"2018","Month":"03","Day":"12"},"DateRevised":{"Year":"2018","Month":"03","Day":"12"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1468-330X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"87","Issue":"11","PubDate":{"Year":"2016","Month":"11"}},"Title":"Journal of neurology, neurosurgery, and psychiatry","ISOAbbreviation":"J Neurol Neurosurg Psychiatry"},"ArticleTitle":"Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.","Pagination":{"MedlinePgn":"1270-1272"},"ELocationID":"10.1136\/jnnp-2015-312972","AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Wilke","ForeName":"Carlo","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Preische","ForeName":"Oliver","Initials":"O","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany Department of Psychiatry, University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Roeben","ForeName":"Benjamin","Initials":"B","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Apel","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Barro","ForeName":"Christian","Initials":"C","AffiliationInfo":{"Affiliation":"Neurology, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, Basel, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maia","ForeName":"Luis","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany Department of Neurology, Hospital de Santo Ant\u00f3nio-CHP, Porto, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kuhle","ForeName":"Jens","Initials":"J","AffiliationInfo":{"Affiliation":"Neurology, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, Basel, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany German Center for Neurodegenerative Diseases (DZNE), University of T\u00fcbingen, T\u00fcbingen, Germany."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Letter"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"05","Day":"17"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"J Neurol Neurosurg Psychiatry","NlmUniqueID":"2985191R","ISSNLinking":"0022-3050"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Neurofilament Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Amyotrophic Lateral Sclerosis","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Biomarkers","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["blood","cerebrospinal fluid","pathology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Neurofilament Proteins","QualifierName":["blood","cerebrospinal fluid"]}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["ALS","CSF","DEMENTIA","FRONTAL LOBE"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"12","Day":"22"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"04","Day":"18"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"5","Day":"18","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"3","Day":"13","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"5","Day":"19","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27188986","jnnp-2015-312972","10.1136\/jnnp-2015-312972"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26971930","DateCompleted":{"Year":"2017","Month":"01","Day":"03"},"DateRevised":{"Year":"2019","Month":"10","Day":"27"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-5828","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"13","Issue":"6","PubDate":{"Year":"2016"}},"Title":"Current Alzheimer research","ISOAbbreviation":"Curr Alzheimer Res"},"ArticleTitle":"Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.","Pagination":{"MedlinePgn":"654-62"},"Abstract":{"AbstractText":"Altered progranulin levels play a major role in neurodegenerative diseases, like Alzheimer's dementia (AD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), even in the absence of GRN mutations. Increasing progranulin levels could hereby provide a novel treatment strategy. However, knowledge on progranulin regulation in neurodegenerative diseases remains limited. We here demonstrate that cerebrospinal fluid progranulin levels do not correlate with its serum levels in AD, FTD and ALS, indicating a differential regulation of its central and peripheral levels in neurodegeneration. Blood progranulin levels thus do not reliably predict central nervous progranulin levels and their response to future progranulin-increasing therapeutics. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Wilke","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gillardon","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dubois","ForeName":"Evelyn","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hobert","ForeName":"Markus A","Initials":"MA"},{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00fcller vom Hagen","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kr\u00fcger","ForeName":"Stefanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Biskup","ForeName":"Saskia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Blauwendraat","ForeName":"Cornelis","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hruscha","ForeName":"Michael","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaeser","ForeName":"Stephan A","Initials":"SA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heutink","ForeName":"Peter","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, University of T\u00fcbingen, Hoppe-Seyler-Str. 3, 72076 T\u00fcbingen, Germany. matthis.synofzik@uni-tuebingen.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United Arab Emirates","MedlineTA":"Curr Alzheimer Res","NlmUniqueID":"101208441","ISSNLinking":"1567-2050"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"GRN protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Intercellular Signaling Peptides and Proteins"},{"RegistryNumber":"0","NameOfSubstance":"Progranulins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Amyotrophic Lateral Sclerosis","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Biomarkers","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Humans"},{"DescriptorName":"Intercellular Signaling Peptides and Proteins","QualifierName":["blood","cerebrospinal fluid","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Progranulins"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"10","Day":"13"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"03","Day":"07"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"3","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"3","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"1","Day":"4","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26971930","CAR-EPUB-74362","10.2174\/1567205013666160314151247"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26938614","DateCompleted":{"Year":"2016","Month":"07","Day":"25"},"DateRevised":{"Year":"2019","Month":"02","Day":"19"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"11","Issue":"3","PubDate":{"Year":"2016"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"GDF15\/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.","Pagination":{"MedlinePgn":"e0149349"},"ELocationID":"10.1371\/journal.pone.0149349","Abstract":{"AbstractText":"Based on animal and ex-vivo experiments, Growth\/Differentiation Factor-15 (GDF15, also called Macrophage Inhibitory Cytokine-1, MIC1), a member of the transforming growth factor-beta family, and Matrix Metalloproteinase-9 (MMP9), a member of the matrix metalloprotease family may be potential markers for Lewy body disorders, i.e. Parkinson's disease with (PDD) and without dementia (PDND) and Lewy body dementia (DLB). GDF15 has a prominent role in development, cell proliferation, differentiation, and repair, whereas MMP9 degrades, as a proteolytic enzyme, components of the extracellular matrix. In this study, cerebrospinal fluid GDF15 and MMP9 levels of 59 PDND, 17 PDD and 23 DLB patients, as well as of 95 controls were determined, and associated with demographic, clinical and biochemical parameters. Our analysis confirmed the already described association of GDF15 levels with age and gender. Corrected GDF15 levels were significantly higher in PDD than in PDND patients, and intermediate in DLB patients. Within Lewy body disorders, GDF15 levels correlated positively with age at onset of Parkinsonism and dementia, Hoehn & Yahr stage and cerebrospinal fluid t-Tau and p-Tau levels, and negatively with the Mini Mental State Examination. Remarkably, it does not relevantly correlate with disease duration. MMP9 was not relevantly associated with any of these parameters. Cerebrospinal GDF15, but not MMP9, may be a potential marker of and in Lewy body disorders. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Deleersnijder","ForeName":"Willy","Initials":"W","AffiliationInfo":{"Affiliation":"Fujirebio Europe NV, Technologiepark, Gent, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hanssens","ForeName":"Val\u00e9rie","Initials":"V","AffiliationInfo":{"Affiliation":"Fujirebio Europe NV, Technologiepark, Gent, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bernard","ForeName":"Alice","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Marquetand","ForeName":"Justus","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Epileptology, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wurster","ForeName":"Isabel","Initials":"I","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Rattay","ForeName":"Tim W","Initials":"TW","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Roncoroni","ForeName":"Lorenzo","Initials":"L","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Schaeffer","ForeName":"Eva","Initials":"E","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Lerche","ForeName":"Stefanie","Initials":"S","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Apel","ForeName":"Anja","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":[{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany."},{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"03","Day":"03"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"GDF15 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Growth Differentiation Factor 15"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Protein Isoforms"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"EC 3.4.24.35","NameOfSubstance":"MMP9 protein, human"},{"RegistryNumber":"EC 3.4.24.35","NameOfSubstance":"Matrix Metalloproteinase 9"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Age Factors"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Expression"},{"DescriptorName":"Growth Differentiation Factor 15","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["cerebrospinal fluid","diagnosis","genetics","pathology"]},{"DescriptorName":"Male"},{"DescriptorName":"Matrix Metalloproteinase 9","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parkinson Disease","QualifierName":["cerebrospinal fluid","diagnosis","genetics","pathology"]},{"DescriptorName":"Protein Isoforms","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Sex Factors"},{"DescriptorName":"tau Proteins","QualifierName":["cerebrospinal fluid","genetics"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"08","Day":"14"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"01","Day":"29"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"3","Day":"4","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"3","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"7","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["26938614","10.1371\/journal.pone.0149349","PONE-D-15-35768","PMC4777571"]},"ReferenceList":{"Reference":[{"Citation":"J Neural Transm (Vienna). 1999;106(2):139-44","ArticleIdList":{"ArticleId":"10226934"}},{"Citation":"Gene. 1999 Sep 3;237(1):105-11","ArticleIdList":{"ArticleId":"10524241"}},{"Citation":"J Neurosci. 2000 Dec 1;20(23):8597-603","ArticleIdList":{"ArticleId":"11102463"}},{"Citation":"Clin Neuropathol. 2001 Mar-Apr;20(2):60-3","ArticleIdList":{"ArticleId":"11327298"}},{"Citation":"J Comp Neurol. 2001 Oct 8;439(1):32-45","ArticleIdList":{"ArticleId":"11579380"}},{"Citation":"J Physiol Paris. 2002 Jan-Mar;96(1-2):25-30","ArticleIdList":{"ArticleId":"11755780"}},{"Citation":"J Biol Chem. 2003 Mar 14;278(11):8904-12","ArticleIdList":{"ArticleId":"12514175"}},{"Citation":"Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536","ArticleIdList":{"ArticleId":"12540195"}},{"Citation":"Brain Res. 2003 Apr 25;970(1-2):205-13","ArticleIdList":{"ArticleId":"12706262"}},{"Citation":"J Neural Transm Suppl. 2003;(65):197-203","ArticleIdList":{"ArticleId":"12946057"}},{"Citation":"J Neurosci. 2003 Dec 3;23(35):11127-35","ArticleIdList":{"ArticleId":"14657171"}},{"Citation":"Neurobiol Aging. 2004 May-Jun;25(5):663-74","ArticleIdList":{"ArticleId":"15172746"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4","ArticleIdList":{"ArticleId":"1564476"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"Clin Cancer Res. 2006 Jan 1;12(1):89-96","ArticleIdList":{"ArticleId":"16397029"}},{"Citation":"J Biol Chem. 2006 Aug 25;281(34):24566-74","ArticleIdList":{"ArticleId":"16787929"}},{"Citation":"Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837","ArticleIdList":{"ArticleId":"17542011"}},{"Citation":"Int Psychogeriatr. 2008 Feb;20(1):67-76","ArticleIdList":{"ArticleId":"17697439"}},{"Citation":"J Cell Mol Med. 2008 Oct;12(5B):1820-9","ArticleIdList":{"ArticleId":"18671754"}},{"Citation":"Lancet Neurol. 2009 Feb;8(2):205-16","ArticleIdList":{"ArticleId":"19161911"}},{"Citation":"Int J Cancer. 2009 Dec 1;125(11):2624-30","ArticleIdList":{"ArticleId":"19521960"}},{"Citation":"J Neurosci. 2009 Oct 28;29(43):13640-8","ArticleIdList":{"ArticleId":"19864576"}},{"Citation":"Biomark Med. 2008 Aug;2(4):363-84","ArticleIdList":{"ArticleId":"20477391"}},{"Citation":"J Neurol. 2010 Nov;257(11):1875-81","ArticleIdList":{"ArticleId":"20563821"}},{"Citation":"Mov Disord. 2011 Jan;26(1):176-81","ArticleIdList":{"ArticleId":"20842692"}},{"Citation":"Aging Cell. 2010 Dec;9(6):1057-64","ArticleIdList":{"ArticleId":"20854422"}},{"Citation":"Cell Tissue Res. 2011 Feb;343(2):399-409","ArticleIdList":{"ArticleId":"21128084"}},{"Citation":"Environ Health Perspect. 2011 Jun;119(6):807-14","ArticleIdList":{"ArticleId":"21245015"}},{"Citation":"Growth Factors. 2011 Oct;29(5):187-95","ArticleIdList":{"ArticleId":"21831009"}},{"Citation":"Cardiovasc Pathol. 2012 Nov-Dec;21(6):499-505","ArticleIdList":{"ArticleId":"22386250"}},{"Citation":"Curr Pharm Des. 2013;19(6):1085-9","ArticleIdList":{"ArticleId":"23016686"}},{"Citation":"PLoS One. 2012;7(10):e48042","ArticleIdList":{"ArticleId":"23133543"}},{"Citation":"Cell Tissue Res. 2013 Jul;353(1):1-8","ArticleIdList":{"ArticleId":"23640134"}},{"Citation":"Eur Heart J. 2013 Aug;34(32):2538-47","ArticleIdList":{"ArticleId":"23666250"}},{"Citation":"Aging Cell. 2013 Oct;12(5):882-9","ArticleIdList":{"ArticleId":"23758647"}},{"Citation":"Front Integr Neurosci. 2013 Aug 13;7:59","ArticleIdList":{"ArticleId":"23964211"}},{"Citation":"Biomark Med. 2014;8(2):225-7","ArticleIdList":{"ArticleId":"24521018"}},{"Citation":"Biochim Biophys Acta. 2014 Sep;1842(9):1379-84","ArticleIdList":{"ArticleId":"24815357"}},{"Citation":"Turk Neurosurg. 2014;24(3):363-8","ArticleIdList":{"ArticleId":"24848175"}},{"Citation":"J Biomed Sci. 2014 Aug 19;21:72","ArticleIdList":{"ArticleId":"25135219"}},{"Citation":"JAMA Neurol. 2015 Aug;72(8):863-73","ArticleIdList":{"ArticleId":"26076039"}},{"Citation":"Exp Neurobiol. 2015 Jun;24(2):133-8","ArticleIdList":{"ArticleId":"26113792"}},{"Citation":"J Neuroinflammation. 2016 May 24;13(1):122","ArticleIdList":{"ArticleId":"27220776"}},{"Citation":"Eur J Neurol. 2017 Feb;24(2):427-e6","ArticleIdList":{"ArticleId":"28102045"}},{"Citation":"J Neurosci. 1996 Dec 15;16(24):7910-9","ArticleIdList":{"ArticleId":"8987819"}},{"Citation":"Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9","ArticleIdList":{"ArticleId":"9326641"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26806387","DateCompleted":{"Year":"2017","Month":"10","Day":"23"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1552-5279","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"12","Issue":"5","PubDate":{"Year":"2016","Month":"05"}},"Title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","ISOAbbreviation":"Alzheimers Dement"},"ArticleTitle":"Validating Alzheimer's disease micro RNAs using next-generation sequencing.","Pagination":{"MedlinePgn":"565-76"},"ELocationID":["10.1016\/j.jalz.2015.12.012","S1552-5260(15)03036-8"],"Abstract":{"AbstractText":["Molecular biomarkers for Alzheimer's disease (AD) can support detection and improved care for patients, but novel candidates require verification. We previously reported a 12-micro RNA (miRNA) blood-based signature using next-generation sequencing (NGS) of 54 AD cases and 22 controls.","We performed validation of 49 AD cases and 55 controls using NGS and also included 20 mild cognitive impairment and 90 multiple sclerosis samples to identify nonspecific markers. Thus, 103 AD cases, 77 unaffected controls, and 110 diseased controls were sequenced. Although the initial cohort came predominantly from the United States, the validation samples were collected in Germany.","Five hundred eighty miRNAs were detected in the blood. In the initial cohort, we observed 203, in the validation cohort, 146 dysregulated miRNAs at a significance level of 0.05. With 68 miRNAs, the overlap was significant (P\u00a0=\u00a0.0003). Likewise, the area under the receiver operator characteristic curve values of the miRNAs correlated (correlation of 0.93; 95% confidence interval 0.89-0.96; P <10(-16)).","MiRNAs have the potential to support AD diagnosis and patient care."],"CopyrightInformation":"Copyright \u00a9 2016 Alzheimer's Association. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Andreas","Initials":"A","AffiliationInfo":{"Affiliation":"Clinical Bioinformatics, Saarland University, Saarbr\u00fccken, Germany. Electronic address: andreas.keller@ccb.uni-saarland.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Backes","ForeName":"Christina","Initials":"C","AffiliationInfo":{"Affiliation":"Clinical Bioinformatics, Saarland University, Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Haas","ForeName":"Jan","Initials":"J","AffiliationInfo":{"Affiliation":"Internal Medicine, Heidelberg University, Heidelberg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Leidinger","ForeName":"Petra","Initials":"P","AffiliationInfo":{"Affiliation":"Department for Human Genetics, Saarland University Hospital, Homburg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration and Hertie-Institute of Clinical Brain Research of the Eberhard-Karls-University, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration and Hertie-Institute of Clinical Brain Research of the Eberhard-Karls-University, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration and Hertie-Institute of Clinical Brain Research of the Eberhard-Karls-University, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruschil","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration and Hertie-Institute of Clinical Brain Research of the Eberhard-Karls-University, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galata","ForeName":"Valentina","Initials":"V","AffiliationInfo":{"Affiliation":"Clinical Bioinformatics, Saarland University, Saarbr\u00fccken, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruprecht","ForeName":"Klemens","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Neurology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"St\u00e4hler","ForeName":"Cord","Initials":"C","AffiliationInfo":{"Affiliation":"Siemens Healthcare, Erlangen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"W\u00fcrstle","ForeName":"Maximilian","Initials":"M","AffiliationInfo":{"Affiliation":"Siemens Healthcare, Erlangen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sickert","ForeName":"Daniel","Initials":"D","AffiliationInfo":{"Affiliation":"Siemens Healthcare, Erlangen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gogol","ForeName":"Manfred","Initials":"M","AffiliationInfo":{"Affiliation":"Krankenhaus Lindenbrunn, Lindenbrunn, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meder","ForeName":"Benjamin","Initials":"B","AffiliationInfo":{"Affiliation":"Internal Medicine, Heidelberg University, Heidelberg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meese","ForeName":"Eckart","Initials":"E","AffiliationInfo":{"Affiliation":"Department for Human Genetics, Saarland University Hospital, Homburg, Germany."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Validation Study"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"01","Day":"22"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimers Dement","NlmUniqueID":"101231978","ISSNLinking":"1552-5260"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"MicroRNAs"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","genetics"]},{"DescriptorName":"Biomarkers","QualifierName":"blood"},{"DescriptorName":"Cognitive Dysfunction"},{"DescriptorName":"Female"},{"DescriptorName":"Germany"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"MicroRNAs","QualifierName":["blood","genetics"]},{"DescriptorName":"Sequence Analysis","QualifierName":"methods"},{"DescriptorName":"United States"},{"DescriptorName":"Up-Regulation"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer's disease","Biomarker","Validation","miRNA"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"09","Day":"30"},{"@attributes":{"PubStatus":"revised"},"Year":"2015","Month":"11","Day":"24"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"12","Day":"04"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"1","Day":"26","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"1","Day":"26","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"10","Day":"24","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26806387","S1552-5260(15)03036-8","10.1016\/j.jalz.2015.12.012"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26643944","DateCompleted":{"Year":"2016","Month":"12","Day":"13"},"DateRevised":{"Year":"2020","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1558-1497","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"38","PubDate":{"Year":"2016","Month":"Feb"}},"Title":"Neurobiology of aging","ISOAbbreviation":"Neurobiol Aging"},"ArticleTitle":"Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.","Pagination":{"MedlinePgn":"214.e7-214.e10"},"ELocationID":["S0197-4580(15)00540-0","10.1016\/j.neurobiolaging.2015.10.028"],"Abstract":{"AbstractText":"The similarities between dementia with Lewy bodies (DLB) and both Parkinson's disease (PD) and Alzheimer's disease (AD) are many and range from clinical presentation, to neuropathological characteristics, to more recently identified, genetic determinants of risk. Because of these overlapping features, diagnosing DLB is challenging and has clinical implications since some therapeutic agents that are applicable in other diseases have adverse effects in DLB. Having shown that DLB shares some genetic risk with PD and AD, we have now quantified the amount of sharing through the application of genetic correlation estimates, and show that, from a purely genetic perspective, and excluding the strong association at the APOE locus, DLB is equally correlated to AD and PD. ","CopyrightInformation":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Guerreiro","ForeName":"Rita","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Escott-Price","ForeName":"Valentina","Initials":"V","AffiliationInfo":{"Affiliation":"MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Darwent","ForeName":"Lee","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Parkkinen","ForeName":"Laura","Initials":"L","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ansorge","ForeName":"Olaf","Initials":"O","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hernandez","ForeName":"Dena G","Initials":"DG","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA; German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nalls","ForeName":"Michael A","Initials":"MA","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Lorraine","Initials":"L","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Honig","ForeName":"Lawrence","Initials":"L","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marder","ForeName":"Karen","Initials":"K","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Columbia University, New York, NY, USA; Department of Neurology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Flier","ForeName":"Wiesje","Initials":"W","AffiliationInfo":{"Affiliation":"Department Of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Holstege","ForeName":"Henne","Initials":"H","AffiliationInfo":{"Affiliation":"Department Of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Louwersheimer","ForeName":"Eva","Initials":"E","AffiliationInfo":{"Affiliation":"Department Of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lemstra","ForeName":"Afina","Initials":"A","AffiliationInfo":{"Affiliation":"Department Of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scheltens","ForeName":"Philip","Initials":"P","AffiliationInfo":{"Affiliation":"Department Of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rogaeva","ForeName":"Ekaterina","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"St George-Hyslop","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada; Cambridge Institute for Medical Research, and Cambridge National Institute of Health Research Biomedical Research Unit in Dementia, University of Cambridge, Cambridge, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Londos","ForeName":"Elisabet","Initials":"E","AffiliationInfo":{"Affiliation":"Clinical Memory Research Unit, Institute of Clinical Sciences Malm\u00f6, Lund University, Lund, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zetterberg","ForeName":"Henrik","Initials":"H","AffiliationInfo":{"Affiliation":"Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ortega-Cubero","ForeName":"Sara","Initials":"S","AffiliationInfo":{"Affiliation":"Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, (CIMA), University of Navarra, Pamplona, Spain; CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pastor","ForeName":"Pau","Initials":"P","AffiliationInfo":{"Affiliation":"Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, (CIMA), University of Navarra, Pamplona, Spain; CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain; Memory and Movement Disorders Units, Department of Neurology, University Hospital Mutua de Terrassa, University of Barcelona School of Medicine, Terrassa, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferman","ForeName":"Tanis J","Initials":"TJ","AffiliationInfo":{"Affiliation":"Departments of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff-Radford","ForeName":"Neill R","Initials":"NR","AffiliationInfo":{"Affiliation":"Department of Neurology, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ross","ForeName":"Owen A","Initials":"OA","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Barber","ForeName":"Imelda","Initials":"I","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Braae","ForeName":"Anne","Initials":"A","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brown","ForeName":"Kristelle","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morgan","ForeName":"Kevin","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, and DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, and DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Troakes","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"MRC London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Department of Clinical Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Al-Sarraj","ForeName":"Safa","Initials":"S","AffiliationInfo":{"Affiliation":"MRC London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Department of Clinical Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lashley","ForeName":"Tammaryn","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Compta","ForeName":"Yaroslau","Initials":"Y","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Parkinson's Disease & Movement Disorders Unit, Neurology Service, Clinical Neuroscience Institute (ICN), Hospital Cl\u00ednic\/University of Barcelona\/IDIBAPS, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Revesz","ForeName":"Tamas","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lees","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cairns","ForeName":"Nigel J","Initials":"NJ","AffiliationInfo":{"Affiliation":"Department of Neurology, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, Saint Louis, MO, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Halliday","ForeName":"Glenda M","Initials":"GM","AffiliationInfo":{"Affiliation":"Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mann","ForeName":"David","Initials":"D","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pickering-Brown","ForeName":"Stuart","Initials":"S","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Powell","ForeName":"John","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lunnon","ForeName":"Katie","Initials":"K","AffiliationInfo":{"Affiliation":"Institute of Clinical and Biomedical Science, University of Exeter Medical School, University of Exeter, Exeter, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lupton","ForeName":"Michelle K","Initials":"MK","AffiliationInfo":{"Affiliation":"Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"International Parkinson's Disease Genomics Consortium (IPDGC)"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dickson","ForeName":"Dennis","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hardy","ForeName":"John","Initials":"J","AffiliationInfo":{"Affiliation":"Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Singleton","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bras","ForeName":"Jose","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK. Electronic address: j.bras@ucl.ac.uk."}}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"200","Acronym":"ALZS_","Agency":"Alzheimer's Society","Country":"United Kingdom"},{"GrantID":"NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"MR\/N012453\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P50 NS038370","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P50 AG008702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"Acronym":"CAPMC","Agency":" CIHR","Country":"Canada"},{"GrantID":"G1100695","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"AG000951-12","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"G-0909","Acronym":"PUK_","Agency":"Parkinson's UK","Country":"United Kingdom"},{"GrantID":"R01 NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P50 NS072187","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"UL1TR000040","Acronym":"TR","Agency":"NCATS NIH HHS","Country":"United States"},{"GrantID":"MR\/L016397\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"UL1 TR000040","Acronym":"TR","Agency":"NCATS NIH HHS","Country":"United States"},{"GrantID":"P50NS038370","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"Z01 AG000951","Acronym":"ImNIH","Agency":"Intramural NIH HHS","Country":"United States"},{"GrantID":"R01 NS078086","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"WT089698","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"P01 AG003991","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50 AG005681","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50AG008702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"089703","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"G9318379","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L010305\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"081864","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L022656\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"K-1204","Acronym":"PUK_","Agency":"Parkinson's UK","Country":"United Kingdom"},{"GrantID":"MC_G1000734","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P30 ES009089","Acronym":"ES","Agency":"NIEHS NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"11","Day":"02"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Aging","NlmUniqueID":"8100437","ISSNLinking":"0197-4580"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":"genetics"},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Genetic Loci","QualifierName":"genetics"},{"DescriptorName":"Genome-Wide Association Study"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"genetics"},{"DescriptorName":"Parkinson Disease","QualifierName":"genetics"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer's disease","Dementia with Lewy bodies","Genetic correlation","Parkinson's disease"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"10","Day":"13"},{"@attributes":{"PubStatus":"revised"},"Year":"2015","Month":"10","Day":"27"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"10","Day":"28"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"12","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"12","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"12","Day":"15","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26643944","S0197-4580(15)00540-0","10.1016\/j.neurobiolaging.2015.10.028","PMC4759606"]},"ReferenceList":{"Reference":[{"Citation":"Nat Genet. 2010 Jul;42(7):565-9","ArticleIdList":{"ArticleId":"20562875"}},{"Citation":"Alzheimers Res Ther. 2014 Apr 25;6(2):21","ArticleIdList":{"ArticleId":"25031635"}},{"Citation":"Hum Mol Genet. 2014 Dec 1;23(23):6139-46","ArticleIdList":{"ArticleId":"24973356"}},{"Citation":"Nat Genet. 2014 Sep;46(9):989-93","ArticleIdList":{"ArticleId":"25064009"}},{"Citation":"Brain. 2011 May;134(Pt 5):1493-505","ArticleIdList":{"ArticleId":"21596773"}},{"Citation":"JAMA Neurol. 2013 Oct;70(10):1268-76","ArticleIdList":{"ArticleId":"23921447"}},{"Citation":"Hum Mol Genet. 2012 Nov 15;21(22):4996-5009","ArticleIdList":{"ArticleId":"22892372"}},{"Citation":"Bioinformatics. 2012 Oct 1;28(19):2540-2","ArticleIdList":{"ArticleId":"22843982"}},{"Citation":"Neurobiol Aging. 2015 Mar;36(3):1605.e7-12","ArticleIdList":{"ArticleId":"25444595"}},{"Citation":"Neurology. 1991 Apr;41(4):479-86","ArticleIdList":{"ArticleId":"2011243"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26522186","DateCompleted":{"Year":"2016","Month":"09","Day":"26"},"DateRevised":{"Year":"2017","Month":"07","Day":"31"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1558-1497","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"37","PubDate":{"Year":"2016","Month":"Jan"}},"Title":"Neurobiology of aging","ISOAbbreviation":"Neurobiol Aging"},"ArticleTitle":"Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants.","Pagination":{"MedlinePgn":"208.e11-208.e17"},"ELocationID":["S0197-4580(15)00473-X","10.1016\/j.neurobiolaging.2015.09.016"],"Abstract":{"AbstractText":"Early-onset Alzheimer's disease (EOAD) accounts for 1%-2% of all Alzheimer's disease (AD) subjects, with large variation in the reported genetic contribution of known dementia genes. In this pilot study, we genetically characterized a German EOAD cohort (23 subjects) by whole-exome sequencing, capturing variants in all recognized AD and frontotemporal dementia genes. After variant filtering, we identified 7 events of altogether 6 different rare variants in 6 subjects, including 4 novel variants. Four of the 6 variants, observed in 5 different index subjects (5\/23 = 22%), were considered to be possibly pathogenic. These included 2 presenilin 2 (PSEN2) variants (p.N141I-previously denoted as a Volga German variant, observed in 2 index subjects; and p.L238P), 1 amyloid precursor protein (p.I716M), and 1 presenilin 1 (\u0394E9). Using a control exome data set of 96 ethnically matched neurodegenerative disease controls (Parkinson's disease), we identified only 1 variant (PSEN2 p.T18M) (1%), demonstrating a significantly higher mutational burden in the EOAD group (p > 0.0001). Our findings demonstrate a substantial frequency of variants in dementia genes in EOAD, including several seemingly \"sporadic\" subjects. This indicates that heritability in EOAD might be higher than assumed. The finding of 3 subjects carrying potential pathogenic PSEN2 variants suggests that, in specific populations PSEN2 variants might be as frequent as (or more frequent than) presenilin 1, for example, in German populations which are influenced by Volga German heritage. Variants in AD genes were also associated with rare phenotypes such as frontal AD or primary progressive aphasia, demonstrating the need to screen AD genes in frontotemporal dementia-like phenotypes.","CopyrightInformation":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Blauwendraat","ForeName":"Cornelis","Initials":"C","AffiliationInfo":{"Affiliation":"Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wilke","ForeName":"Carlo","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jansen","ForeName":"Iris E","Initials":"IE","AffiliationInfo":{"Affiliation":"Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sim\u00f3n-S\u00e1nchez","ForeName":"Javier","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian G","Initials":"FG","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy and Geriatric Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bender","ForeName":"Benjamin","Initials":"B","AffiliationInfo":{"Affiliation":"Magnetic Resonance Research Group, Department of Diagnostic and Interventional Neuroradiology, University, Hospital T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rizzu","ForeName":"Patrizia","Initials":"P","AffiliationInfo":{"Affiliation":"Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Heutink","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany; Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany. Electronic address: matthis.synofzik@uni-tuebingen.de."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"09","Day":"30"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Aging","NlmUniqueID":"8100437","ISSNLinking":"0197-4580"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"PSEN2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Presenilin-2"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Exome","QualifierName":"genetics"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":"genetics"},{"DescriptorName":"Genetic Association Studies"},{"DescriptorName":"Genetic Variation","QualifierName":"genetics"},{"DescriptorName":"Germany"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Pilot Projects"},{"DescriptorName":"Presenilin-2","QualifierName":"genetics"},{"DescriptorName":"Sequence Analysis, DNA","QualifierName":"methods"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer's disease","Early-onset dementia","Exome sequencing","Frontotemporal dementia","PSEN2","Volga German N141I"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"09","Day":"18"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"09","Day":"19"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"11","Day":"3","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"11","Day":"3","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"9","Day":"27","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26522186","S0197-4580(15)00473-X","10.1016\/j.neurobiolaging.2015.09.016"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26394050","DateCompleted":{"Year":"2016","Month":"06","Day":"14"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"10","Issue":"9","PubDate":{"Year":"2015"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency.","Pagination":{"MedlinePgn":"e0138863"},"ELocationID":"10.1371\/journal.pone.0138863","Abstract":{"AbstractText":["Aging processes and several vascular burden factors have been shown to increase the risk of dementia including Alzheimer's disease. While pathological alterations in dementia precede diagnosis by many years, reorganization of brain processing might temporarily delay cognitive decline. We hypothesized that in healthy elderly individuals both age-related neural and vascular factors known to be related to the development of dementia impact functional cortical hemodynamics during increased cognitive demands.","Vascular burden factors and cortical functional hemodynamics during verbal fluency were assessed in 1052 non-demented elderly individuals (51 to 83 years; cross-sectional data of the longitudinal TREND study) using functional near-infrared spectroscopy (fNIRS). The prediction of functional hemodynamic responses by age in multiple regressions and the impact of single and cumulative vascular burden factors including hypertension, diabetes, obesity, smoking and atherosclerosis were investigated.","Replicating and extending previous findings we could show that increasing age predicted functional hemodynamics to be increased in right prefrontal and bilateral parietal cortex, and decreased in bilateral inferior frontal junction during phonological fluency. Cumulative vascular burden factors, with hypertension in particular, decreased left inferior frontal junction hemodynamic responses during phonological fluency. However, age and vascular burden factors showed no statistical interaction on functional hemodynamics.","Based on these findings, one might hypothesize that increased fronto-parietal processing may represent age-related compensatory reorganization during increased cognitive demands. Vascular burden factors, such as hypertension, may contribute to regional cerebral hypoperfusion. These neural and vascular hemodynamic determinants should be investigated longitudinally and combined with other markers to advance the prediction of future cognitive decline and dementia."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Heinzel","ForeName":"Sebastian","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany; Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian G","Initials":"FG","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; Geriatric Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ehlis","ForeName":"Ann-Christine","Initials":"AC","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Korell","ForeName":"Robert","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Alboji","ForeName":"Ahmed","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Haeussinger","ForeName":"Florian B","Initials":"FB","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wurster","ForeName":"Isabel","Initials":"I","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Suenkel","ForeName":"Ulrike","Initials":"U","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Eschweiler","ForeName":"Gerhard W","Initials":"GW","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; Geriatric Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fallgatter","ForeName":"Andreas J","Initials":"AJ","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"09","Day":"22"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Aging","QualifierName":"physiology"},{"DescriptorName":"Blood Pressure","QualifierName":"physiology"},{"DescriptorName":"Brain","QualifierName":["blood supply","physiology","physiopathology"]},{"DescriptorName":"Cerebrovascular Circulation","QualifierName":"physiology"},{"DescriptorName":"Cognition Disorders","QualifierName":["diagnosis","physiopathology"]},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Dementia","QualifierName":["diagnosis","physiopathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Hemodynamics","QualifierName":"physiology"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Psychomotor Performance","QualifierName":"physiology"},{"DescriptorName":"Risk Factors"},{"DescriptorName":"Spectroscopy, Near-Infrared"},{"DescriptorName":"Verbal Behavior","QualifierName":"physiology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"05","Day":"06"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"09","Day":"04"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"9","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"9","Day":"24","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"6","Day":"15","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["26394050","10.1371\/journal.pone.0138863","PONE-D-15-19255","PMC4578891"]},"ReferenceList":{"Reference":[{"Citation":"Neurology. 2013 Nov 5;81(19):1711-8","ArticleIdList":{"ArticleId":"24132374"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):71-8","ArticleIdList":{"ArticleId":"23123510"}},{"Citation":"Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):19-27","ArticleIdList":{"ArticleId":"20220321"}},{"Citation":"Neuroimage. 2007 Apr 1;35(2):625-34","ArticleIdList":{"ArticleId":"17258472"}},{"Citation":"Cogn Affect Behav Neurosci. 2012 Jun;12(2):241-68","ArticleIdList":{"ArticleId":"22282036"}},{"Citation":"J Int Neuropsychol Soc. 2006 Nov;12(6):896-900","ArticleIdList":{"ArticleId":"17064451"}},{"Citation":"Trends Neurosci. 2005 Apr;28(4):202-8","ArticleIdList":{"ArticleId":"15808355"}},{"Citation":"Brain. 2012 Jan;135(Pt 1):201-15","ArticleIdList":{"ArticleId":"22184615"}},{"Citation":"Lancet Neurol. 2012 Nov;11(11):1006-12","ArticleIdList":{"ArticleId":"23079557"}},{"Citation":"J Alzheimers Dis. 2012;32(3):553-67","ArticleIdList":{"ArticleId":"22842871"}},{"Citation":"Biol Psychiatry. 2011 Jul 15;70(2):115-22","ArticleIdList":{"ArticleId":"21316037"}},{"Citation":"Am J Geriatr Psychiatry. 2008 Feb;16(2):125-35","ArticleIdList":{"ArticleId":"17998307"}},{"Citation":"Front Aging Neurosci. 2014 Apr 07;6:59","ArticleIdList":{"ArticleId":"24778617"}},{"Citation":"Arch Neurol. 2005 Oct;62(10):1556-60","ArticleIdList":{"ArticleId":"16216938"}},{"Citation":"Neuropsychologia. 2012 Jan;50(1):55-66","ArticleIdList":{"ArticleId":"22063904"}},{"Citation":"Neurology. 2013 Nov 12;81(20):1753-8","ArticleIdList":{"ArticleId":"24132375"}},{"Citation":"J Appl Physiol (1985). 2001 May;90(5):1657-62","ArticleIdList":{"ArticleId":"11299252"}},{"Citation":"Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):1-10","ArticleIdList":{"ArticleId":"18703981"}},{"Citation":"Lancet Neurol. 2010 Jan;9(1):119-28","ArticleIdList":{"ArticleId":"20083042"}},{"Citation":"Front Aging Neurosci. 2014 Jul 09;6:161","ArticleIdList":{"ArticleId":"25071568"}},{"Citation":"Arch Neurol. 2003 Dec;60(12):1707-12","ArticleIdList":{"ArticleId":"14676044"}},{"Citation":"Neuroimage. 2008 Oct 15;43(1):147-55","ArticleIdList":{"ArticleId":"18657624"}},{"Citation":"Neurobiol Aging. 2013 Feb;34(2):477-88","ArticleIdList":{"ArticleId":"22459599"}},{"Citation":"Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S195-8","ArticleIdList":{"ArticleId":"22166433"}},{"Citation":"Neurobiol Aging. 2000 Mar-Apr;21(2):153-60","ArticleIdList":{"ArticleId":"10867200"}},{"Citation":"J Int Neuropsychol Soc. 2009 Mar;15(2):196-204","ArticleIdList":{"ArticleId":"19203431"}},{"Citation":"J Biomed Opt. 2012 May;17(5):056002","ArticleIdList":{"ArticleId":"22612125"}},{"Citation":"Psychol Aging. 2002 Mar;17(1):85-100","ArticleIdList":{"ArticleId":"11931290"}},{"Citation":"Biomed Tech (Berl). 2013 Sep 7;:null","ArticleIdList":{"ArticleId":"24043201"}},{"Citation":"Neuroimage. 2011 Aug 1;57(3):991-1002","ArticleIdList":{"ArticleId":"21600294"}},{"Citation":"Neurobiol Aging. 2013 Feb;34(2):439-50","ArticleIdList":{"ArticleId":"22770542"}},{"Citation":"PLoS One. 2011;6(11):e27831","ArticleIdList":{"ArticleId":"22114705"}},{"Citation":"Acta Neurol Scand Suppl. 2006;185:50-7","ArticleIdList":{"ArticleId":"16866911"}},{"Citation":"Brain Res Cogn Brain Res. 1997 Jul;6(1):67-72","ArticleIdList":{"ArticleId":"9395850"}},{"Citation":"Psychiatry Clin Neurosci. 2001 Oct;55(5):459-63","ArticleIdList":{"ArticleId":"11555340"}},{"Citation":"Phys Med Biol. 2002 Apr 7;47(7):1121-41","ArticleIdList":{"ArticleId":"11996059"}},{"Citation":"Neurobiol Aging. 2012 Apr;33(4):825.e25-36","ArticleIdList":{"ArticleId":"21782287"}},{"Citation":"Psychol Aging. 1994 Sep;9(3):339-55","ArticleIdList":{"ArticleId":"7999320"}},{"Citation":"Eur J Neurol. 2014 May;21(5):766-72","ArticleIdList":{"ArticleId":"24612314"}},{"Citation":"Neurology. 2011 Apr 26;76(17):1485-91","ArticleIdList":{"ArticleId":"21490316"}},{"Citation":"Neuroimage. 2007 Feb 15;34(4):1506-18","ArticleIdList":{"ArticleId":"17207638"}},{"Citation":"Neuropsychologia. 2004;42(9):1212-22","ArticleIdList":{"ArticleId":"15178173"}},{"Citation":"Neuroimage. 2013 May 1;71:125-34","ArticleIdList":{"ArticleId":"23313421"}},{"Citation":"J Gerontol B Psychol Sci Soc Sci. 2010 Jul;65(4):405-15","ArticleIdList":{"ArticleId":"20478901"}},{"Citation":"Neuroimage. 2013 Aug 1;76:167-77","ArticleIdList":{"ArticleId":"23518010"}},{"Citation":"Cardiovasc Psychiatry Neurol. 2012;2012:367516","ArticleIdList":{"ArticleId":"23243502"}},{"Citation":"J Alzheimers Dis. 2012;32(1):95-100","ArticleIdList":{"ArticleId":"22766733"}},{"Citation":"J Alzheimers Dis. 2010;19(2):465-80","ArticleIdList":{"ArticleId":"20110594"}},{"Citation":"PLoS One. 2011;6(10):e26377","ArticleIdList":{"ArticleId":"22039475"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25804998","DateCompleted":{"Year":"2016","Month":"08","Day":"26"},"DateRevised":{"Year":"2015","Month":"11","Day":"21"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1552-5279","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"11","Issue":"11","PubDate":{"Year":"2015","Month":"Nov"}},"Title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","ISOAbbreviation":"Alzheimers Dement"},"ArticleTitle":"CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.","Pagination":{"MedlinePgn":"1306-15"},"ELocationID":["10.1016\/j.jalz.2014.12.006","S1552-5260(15)00063-1"],"Abstract":{"AbstractText":["The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (A\u03b21-42), phosphorylated tau, and total tau (tau) to discriminate Alzheimer's disease (AD) dementia from other forms of dementia.","A total of 675 CSF samples collected at eight memory clinics were obtained from healthy controls, AD dementia, subjective memory impairment, mild cognitive impairment, vascular dementia, Lewy body dementia (LBD), fronto-temporal dementia (FTD), depression, or other neurological diseases.","CSF A\u03b21-42 showed the best diagnostic accuracy among the CSF biomarkers. At a sensitivity of 85%, the specificity to differentiate AD dementia against other diagnoses ranged from 42% (for LBD, 95% confidence interval or CI\u00a0=\u00a032-62) to 77% (for FTD, 95% CI\u00a0=\u00a062-90).","CSF A\u03b21-42 discriminates AD dementia from FTD, but shows significant overlap with other non-AD forms of dementia, possibly reflecting the underlying mixed pathologies."],"CopyrightInformation":"Copyright \u00a9 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Ewers","ForeName":"Michael","Initials":"M","AffiliationInfo":{"Affiliation":"Institute for Stroke and Dementia Research, Klinikum der Universit\u00e4t M\u00fcnchen, Ludwig-Maximilian-University, Munich, Bayern, Germany. Electronic address: Michael.ewers@med.uni-muenchen.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mattsson","ForeName":"Niklas","Initials":"N","AffiliationInfo":{"Affiliation":"Department of Radiology, University of California San Francisco, San Francisco, CA, USA; Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Minthon","ForeName":"Lennart","Initials":"L","AffiliationInfo":{"Affiliation":"Clinical Memory Research Unit, Department of Clinical Sciences Malm\u00f6, Lund University, Lund, Sweden; Neuropsychiatric Clinic, Malm\u00f6 University Hospital, Malm\u00f6, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Molinuevo","ForeName":"Jos\u00e9 L","Initials":"JL","AffiliationInfo":{"Affiliation":"Alzheimer's disease and other cognitive disorders unit, Neurology Service, ICN Hospital Clinic i Universitari and Pasqual Maragall Foundation, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Antonell","ForeName":"Anna","Initials":"A","AffiliationInfo":{"Affiliation":"Alzheimer's disease and other cognitive disorders unit, Neurology Service, ICN Hospital Clinic i Universitari and Pasqual Maragall Foundation, Barcelona, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Popp","ForeName":"Julius","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Waadt, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Herukka","ForeName":"Sanna-Kaisa","Initials":"SK","AffiliationInfo":{"Affiliation":"Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Soininen","ForeName":"Hilka","Initials":"H","AffiliationInfo":{"Affiliation":"Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University Hospital, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00fcrger","ForeName":"Katharina","Initials":"K","AffiliationInfo":{"Affiliation":"Institute for Stroke and Dementia Research, Klinikum der Universit\u00e4t M\u00fcnchen, Ludwig-Maximilian-University, Munich, Bayern, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Taniguchi","ForeName":"Miyako","Initials":"M","AffiliationInfo":{"Affiliation":"Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Urakami","ForeName":"Katsuya","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Biological Regulation, School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lista","ForeName":"Simone","Initials":"S","AffiliationInfo":{"Affiliation":"AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Paris 06, Institut de la M\u00e9moire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dubois","ForeName":"Bruno","Initials":"B","AffiliationInfo":{"Affiliation":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Paris 06, Institut de la M\u00e9moire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Blennow","ForeName":"Kaj","Initials":"K","AffiliationInfo":{"Affiliation":"Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hampel","ForeName":"Harald","Initials":"H","AffiliationInfo":{"Affiliation":"AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Paris 06, Institut de la M\u00e9moire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"03","Day":"21"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimers Dement","NlmUniqueID":"101231978","ISSNLinking":"1552-5260"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","diagnosis"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Diagnosis, Differential"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Internationality"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Phosphorylation"},{"DescriptorName":"Sensitivity and Specificity"},{"DescriptorName":"Spinal Puncture"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer's disease","Biomarker","CSF","Cerebrospinal fluid","Classification","Dementia","Differential diagnosis","Fronto-temporal dementia","Lewy body dementia","Vascular dementia"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"06","Day":"11"},{"@attributes":{"PubStatus":"revised"},"Year":"2014","Month":"12","Day":"02"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"12","Day":"05"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"3","Day":"26","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"3","Day":"26","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"8","Day":"27","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25804998","S1552-5260(15)00063-1","10.1016\/j.jalz.2014.12.006"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25520210","DateCompleted":{"Year":"2016","Month":"05","Day":"05"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1435-1463","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"122","Issue":"8","PubDate":{"Year":"2015","Month":"Aug"}},"Title":"Journal of neural transmission (Vienna, Austria : 1996)","ISOAbbreviation":"J Neural Transm (Vienna)"},"ArticleTitle":"The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders.","Pagination":{"MedlinePgn":"1167-74"},"ELocationID":"10.1007\/s00702-014-1351-7","Abstract":{"AbstractText":"Vagus somatosensory evoked potentials (VSEP) have been shown to have higher latencies with aging, which are even more increased in patients with Alzheimer's disease and subjects with mild cognitive impairment compared to age-matched healthy controls. In this study, the association of VSEP with subjective memory impairment (SMI), a potential risk or prodromal marker for Alzheimer's disease, was examined. The association of VSEP latencies and SMI was studied in a healthy risk cohort, including 358 elderly subjects, who are in a longitudinal study of risk factors for neurodegenerative disorders. The results show increased VSEP latencies for peak P2 at Fz-F4 in subjects who report SMI and are worried about it as compared to subjects who report memory impairment, but are not concerned and subjects without complaints. The results support a potential role of VSEP for the detection of very early neurodegenerative processes which may precede Alzheimer's disease. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Hagen","ForeName":"Katja","Initials":"K","AffiliationInfo":{"Affiliation":"German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany, hagen.katja@yahoo.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ehlis","ForeName":"Ann-Christine","Initials":"AC"},{"@attributes":{"ValidYN":"Y"},"LastName":"Haeussinger","ForeName":"Florian B","Initials":"FB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Beeretz","ForeName":"Stefan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kromer","ForeName":"Gina V","Initials":"GV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heinzel","ForeName":"Sebastian","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eschweiler","ForeName":"Gerhard W","Initials":"GW"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fallgatter","ForeName":"Andreas J","Initials":"AJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Metzger","ForeName":"Florian G","Initials":"FG"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"TREND Study Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"12","Day":"18"}},"MedlineJournalInfo":{"Country":"Austria","MedlineTA":"J Neural Transm (Vienna)","NlmUniqueID":"9702341","ISSNLinking":"0300-9564"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":"diagnosis"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":"diagnosis"},{"DescriptorName":"Evoked Potentials, Somatosensory","QualifierName":["drug effects","physiology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Memory Disorders","QualifierName":["drug therapy","physiopathology"]},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":["diagnosis","drug therapy","physiopathology"]},{"DescriptorName":"Perception"},{"DescriptorName":"Prospective Studies"},{"DescriptorName":"Risk"},{"DescriptorName":"Vagus Nerve","QualifierName":["drug effects","physiopathology"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2014","Month":"08","Day":"01"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"12","Day":"06"},{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"12","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"12","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"5","Day":"6","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25520210","10.1007\/s00702-014-1351-7"]},"ReferenceList":{"Reference":[{"Citation":"Neurology. 2006 Sep 12;67(5):834-42","ArticleIdList":{"ArticleId":"16966547"}},{"Citation":"Dement Geriatr Cogn Disord. 2008;26(4):323-9","ArticleIdList":{"ArticleId":"18841017"}},{"Citation":"Psychol Med. 2011 Sep;41(9):1997-2006","ArticleIdList":{"ArticleId":"21284913"}},{"Citation":"Psychol Med. 2001 Apr;31(3):441-9","ArticleIdList":{"ArticleId":"11305852"}},{"Citation":"J Clin Neurophysiol. 2014 Apr;31(2):143-8","ArticleIdList":{"ArticleId":"24691232"}},{"Citation":"J Neuropathol Exp Neurol. 2002 May;61(5):413-26","ArticleIdList":{"ArticleId":"12030260"}},{"Citation":"Dement Geriatr Cogn Disord. 2010;29(1):75-81","ArticleIdList":{"ArticleId":"20110703"}},{"Citation":"J Int Neuropsychol Soc. 2012 Jan;18(1):118-27","ArticleIdList":{"ArticleId":"22115028"}},{"Citation":"Dement Geriatr Cogn Disord. 2012;33(5):289-96","ArticleIdList":{"ArticleId":"22759638"}},{"Citation":"Neuroreport. 2013 Mar 27;24(5):251-3","ArticleIdList":{"ArticleId":"23407276"}},{"Citation":"Arch Gen Psychiatry. 2010 Apr;67(4):414-22","ArticleIdList":{"ArticleId":"20368517"}},{"Citation":"PLoS One. 2011 Feb 18;6(2):e16852","ArticleIdList":{"ArticleId":"21364746"}},{"Citation":"Am J Psychiatry. 1999 Apr;156(4):531-7","ArticleIdList":{"ArticleId":"10200730"}},{"Citation":"Arch Gerontol Geriatr. 2013 Jul-Aug;57(1):110-5","ArticleIdList":{"ArticleId":"23462582"}},{"Citation":"Lancet Neurol. 2010 Jan;9(1):119-28","ArticleIdList":{"ArticleId":"20083042"}},{"Citation":"Int J Psychophysiol. 2005 Apr;56(1):37-43","ArticleIdList":{"ArticleId":"15725488"}},{"Citation":"J Neurol. 2004 Jun;251(6):671-5","ArticleIdList":{"ArticleId":"15311341"}},{"Citation":"J Neurol. 2011 Dec;258(12):2276-7","ArticleIdList":{"ArticleId":"21559938"}},{"Citation":"Int J Geriatr Psychiatry. 2000 Nov;15(11):983-91","ArticleIdList":{"ArticleId":"11113976"}},{"Citation":"J Affect Disord. 2001 Oct;66(2-3):159-64","ArticleIdList":{"ArticleId":"11578668"}},{"Citation":"Neurobiol Aging. 2006 Dec;27(12):1751-6","ArticleIdList":{"ArticleId":"16309795"}},{"Citation":"Arch Gen Psychiatry. 1961 Jun;4:561-71","ArticleIdList":{"ArticleId":"13688369"}},{"Citation":"Psychol Med. 2007 Dec;37(12):1753-62","ArticleIdList":{"ArticleId":"17623488"}},{"Citation":"Eur Arch Psychiatry Clin Neurosci. 2014 Apr;264(3):263-7","ArticleIdList":{"ArticleId":"23736883"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"J Neural Transm (Vienna). 2003 Dec;110(12):1437-43","ArticleIdList":{"ArticleId":"14666414"}},{"Citation":"Int Psychogeriatr. 2008 Feb;20(1):1-16","ArticleIdList":{"ArticleId":"18072981"}},{"Citation":"Neurobiol Aging. 2013 Feb;34(2):439-50","ArticleIdList":{"ArticleId":"22770542"}},{"Citation":"Psychopharmacol Bull. 1988;24(4):641-52","ArticleIdList":{"ArticleId":"3249766"}},{"Citation":"Int J Geriatr Psychiatry. 1999 Oct;14(10):858-65","ArticleIdList":{"ArticleId":"10521885"}},{"Citation":"PLoS One. 2011;6(11):e27831","ArticleIdList":{"ArticleId":"22114705"}},{"Citation":"Neuroepidemiology. 2008;30(1):58-69","ArticleIdList":{"ArticleId":"18259084"}},{"Citation":"Ann Neurol. 2004 Mar;55(3):306-19","ArticleIdList":{"ArticleId":"14991808"}},{"Citation":"Neurology. 2012 Sep 25;79(13):1332-9","ArticleIdList":{"ArticleId":"22914828"}},{"Citation":"J Neural Transm (Vienna). 2007;114(5):613-9","ArticleIdList":{"ArticleId":"17308983"}},{"Citation":"Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):263-70","ArticleIdList":{"ArticleId":"21181110"}},{"Citation":"J Neural Transm (Vienna). 2009 Oct;116(10):1237-42","ArticleIdList":{"ArticleId":"19728032"}},{"Citation":"Ann Neurol. 2001 Jan;49(1):53-66","ArticleIdList":{"ArticleId":"11198297"}},{"Citation":"Arch Gen Psychiatry. 2011 Aug;68(8):845-52","ArticleIdList":{"ArticleId":"21810648"}},{"Citation":"Neurology. 2013 May 7;80(19):1778-83","ArticleIdList":{"ArticleId":"23390181"}},{"Citation":"Mov Disord. 2012 Apr 15;27(5):656-65","ArticleIdList":{"ArticleId":"22508284"}},{"Citation":"Psychol Med. 2004 Nov;34(8):1495-506","ArticleIdList":{"ArticleId":"15724880"}},{"Citation":"J Neural Transm (Vienna). 2009 Apr;116(4):473-7","ArticleIdList":{"ArticleId":"19280116"}},{"Citation":"Eur Psychiatry. 2008 Aug;23(5):321-30","ArticleIdList":{"ArticleId":"18434102"}},{"Citation":"J Neural Transm (Vienna). 2003 May;110(5):517-36","ArticleIdList":{"ArticleId":"12721813"}},{"Citation":"Curr Opin Psychiatry. 2012 Nov;25(6):445-50","ArticleIdList":{"ArticleId":"23037961"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25376537","DateCompleted":{"Year":"2015","Month":"07","Day":"21"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1432-0533","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"128","Issue":"6","PubDate":{"Year":"2014","Month":"Dec"}},"Title":"Acta neuropathologica","ISOAbbreviation":"Acta Neuropathol"},"ArticleTitle":"In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 \u03b1-synuclein antibody.","Pagination":{"MedlinePgn":"893-5"},"ELocationID":"10.1007\/s00401-014-1364-1","AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Hoppe Seyler-Strasse 3, 72076, Tuebingen, Germany, Walter.maetzler@uni-tuebingen.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pilotto","ForeName":"Andrea","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Apel","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kuebart","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heinzel","ForeName":"Sebastian","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt-Scarfone","ForeName":"Inga","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Reusch","ForeName":"Dorothee","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schleicher","ForeName":"Erwin","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rothfuss","ForeName":"Oliver","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schneider","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dodel","ForeName":"Richard","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"11","Day":"07"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Acta Neuropathol","NlmUniqueID":"0412041","ISSNLinking":"0001-6322"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Autoantibodies"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"SNCA protein, human"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Autoantibodies","QualifierName":"blood"},{"DescriptorName":"Biomarkers","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","cerebrospinal fluid","diagnosis"]},{"DescriptorName":"Male"},{"DescriptorName":"Parkinson Disease","QualifierName":["blood","cerebrospinal fluid","diagnosis"]},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Severity of Illness Index"},{"DescriptorName":"alpha-Synuclein","QualifierName":"blood"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2014","Month":"09","Day":"16"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"11","Day":"01"},{"@attributes":{"PubStatus":"revised"},"Year":"2014","Month":"10","Day":"29"},{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"11","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"11","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"7","Day":"22","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25376537","10.1007\/s00401-014-1364-1"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25212850","DateCompleted":{"Year":"2015","Month":"02","Day":"09"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1460-2156","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"137","Issue":"Pt 11","PubDate":{"Year":"2014","Month":"Nov"}},"Title":"Brain : a journal of neurology","ISOAbbreviation":"Brain"},"ArticleTitle":"Highly potent soluble amyloid-\u03b2 seeds in human Alzheimer brain but not cerebrospinal fluid.","Pagination":{"MedlinePgn":"2909-2915"},"ELocationID":"10.1093\/brain\/awu255","Abstract":{"AbstractText":"The soluble fraction of brain samples from patients with Alzheimer's disease contains highly biologically active amyloid-\u03b2 seeds. In this study, we sought to assess the potency of soluble amyloid-\u03b2 seeds derived from the brain and cerebrospinal fluid. Soluble Alzheimer's disease brain extracts were serially diluted and then injected into the hippocampus of young, APP transgenic mice. Eight months later, seeded amyloid-\u03b2 deposition was evident even when the hippocampus received subattomole amounts of brain-derived amyloid-\u03b2. In contrast, cerebrospinal fluid from patients with Alzheimer's disease, which contained more than 10-fold higher levels of amyloid-\u03b2 peptide than the most concentrated soluble brain extracts, did not induce detectable seeding activity in vivo. Similarly, cerebrospinal fluid from aged APP-transgenic donor mice failed to induce cerebral amyloid-\u03b2 deposition. In comparison to the soluble brain fraction, cerebrospinal fluid largely lacked N-terminally truncated amyloid-\u03b2 species and exhibited smaller amyloid-\u03b2-positive particles, features that may contribute to the lack of in vivo seeding by cerebrospinal fluid. Interestingly, the same cerebrospinal fluid showed at least some seeding activity in an in vitro assay. The present results indicate that the biological seeding activity of soluble amyloid-\u03b2 species is orders of magnitude greater in brain extracts than in the cerebrospinal fluid. ","CopyrightInformation":"\u00a9 The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y","EqualContrib":"Y"},"LastName":"Fritschi","ForeName":"Sarah K","Initials":"SK","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Graduate School of Cellular and Molecular Neuroscience, University of T\u00fcbingen, D-72074 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y","EqualContrib":"Y"},"LastName":"Langer","ForeName":"Franziska","Initials":"F","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaeser","ForeName":"Stephan A","Initials":"SA","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Maia","ForeName":"Luis F","Initials":"LF","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Portelius","ForeName":"Erik","Initials":"E","AffiliationInfo":{"Affiliation":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 M\u00f6lndal, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pinotsi","ForeName":"Dorothea","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaminski","ForeName":"Clemens F","Initials":"CF","AffiliationInfo":{"Affiliation":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Winkler","ForeName":"David T","Initials":"DT","AffiliationInfo":{"Affiliation":"Department of Neurology and Institute of Pathology, University Hospital Basel, CH-4003 Basel, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Keyvani","ForeName":"Kathy","Initials":"K","AffiliationInfo":{"Affiliation":"Institute of Neuropathology, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Spitzer","ForeName":"Philipp","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wiltfang","ForeName":"Jens","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University Medical Centre, D-37075 G\u00f6ttingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaminski Schierle","ForeName":"Gabriele S","Initials":"GS","AffiliationInfo":{"Affiliation":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zetterberg","ForeName":"Henrik","Initials":"H","AffiliationInfo":[{"Affiliation":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 M\u00f6lndal, Sweden."},{"Affiliation":"UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Staufenbiel","ForeName":"Matthias","Initials":"M","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Jucker","ForeName":"Mathias","Initials":"M","AffiliationInfo":[{"Affiliation":"German Centre for Neurodegenerative Diseases (DZNE), T\u00fcbingen, D-72076 T\u00fcbingen, Germany."},{"Affiliation":"Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, D-72076 T\u00fcbingen, Germany."}]}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"065807","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"089703","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MC_G1000734","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/K02292X\/1","Agency":"Medical Research Council","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"09","Day":"10"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Brain","NlmUniqueID":"0372537","ISSNLinking":"0006-8950"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Protein Precursor"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"}]},"CitationSubset":["AIM","IM"],"CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"Brain. 2014 Nov;137(Pt 11):2874-5","PMID":"25344080"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","metabolism"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["cerebrospinal fluid","chemistry","metabolism"]},{"DescriptorName":"Amyloid beta-Protein Precursor","QualifierName":"genetics"},{"DescriptorName":"Animals"},{"DescriptorName":"Female"},{"DescriptorName":"Frontal Lobe","QualifierName":["metabolism","pathology"]},{"DescriptorName":"Hippocampus","QualifierName":"metabolism"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Mice"},{"DescriptorName":"Mice, Transgenic"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Peptide Fragments","QualifierName":["cerebrospinal fluid","chemistry"]},{"DescriptorName":"Random Allocation"},{"DescriptorName":"Solubility"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["amyloid","biomarker","dementia","seeding"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"9","Day":"13","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"9","Day":"13","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"2","Day":"11","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25212850","10.1093\/brain\/awu255","PMC5367518","EMS71883"]},"ReferenceList":{"Reference":[{"Citation":"Lancet Neurol. 2013 Apr;12(4):357-67","ArticleIdList":{"ArticleId":"23477989"}},{"Citation":"J Alzheimers Dis. 2010;21(1):81-6","ArticleIdList":{"ArticleId":"20413863"}},{"Citation":"Acta Neuropathol. 2010 Aug;120(2):185-93","ArticleIdList":{"ArticleId":"20419305"}},{"Citation":"Cold Spring Harb Perspect Med. 2012 Apr;2(4):a006213","ArticleIdList":{"ArticleId":"22474610"}},{"Citation":"Science. 2002 Jul 19;297(5580):353-6","ArticleIdList":{"ArticleId":"12130773"}},{"Citation":"J Am Chem Soc. 2011 Aug 24;133(33):12902-5","ArticleIdList":{"ArticleId":"21793568"}},{"Citation":"Nature. 2013 Sep 5;501(7465):45-51","ArticleIdList":{"ArticleId":"24005412"}},{"Citation":"Brain. 2013 May;136(Pt 5):1383-98","ArticleIdList":{"ArticleId":"23576130"}},{"Citation":"Nat Med. 2008 Aug;14(8):837-42","ArticleIdList":{"ArticleId":"18568035"}},{"Citation":"PLoS One. 2013 Jun 14;8(6):e66381","ArticleIdList":{"ArticleId":"23799095"}},{"Citation":"Cell. 2012 Mar 16;148(6):1188-203","ArticleIdList":{"ArticleId":"22424229"}},{"Citation":"Methods Enzymol. 2006;413:20-33","ArticleIdList":{"ArticleId":"17046389"}},{"Citation":"Cell Rep. 2014 Apr 10;7(1):261-8","ArticleIdList":{"ArticleId":"24656814"}},{"Citation":"J Proteome Res. 2007 Nov;6(11):4433-9","ArticleIdList":{"ArticleId":"17927230"}},{"Citation":"Science. 2010 Nov 12;330(6006):980-2","ArticleIdList":{"ArticleId":"20966215"}},{"Citation":"Ann Neurol. 2013 Jan;73(1):104-19","ArticleIdList":{"ArticleId":"23225543"}},{"Citation":"J Neurosci. 2011 Oct 12;31(41):14488-95","ArticleIdList":{"ArticleId":"21994365"}},{"Citation":"Neurobiol Aging. 2009 May;30(5):682-90","ArticleIdList":{"ArticleId":"17889968"}},{"Citation":"Sci Transl Med. 2013 Jul 17;5(194):194re2","ArticleIdList":{"ArticleId":"23863834"}},{"Citation":"J Neurosci. 2002 Jan 15;22(2):515-22","ArticleIdList":{"ArticleId":"11784797"}},{"Citation":"Clin Chem. 2005 Jan;51(1):189-95","ArticleIdList":{"ArticleId":"15539465"}},{"Citation":"Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a006221","ArticleIdList":{"ArticleId":"22951438"}},{"Citation":"Ann Neurol. 1993 Oct;34(4):631-3","ArticleIdList":{"ArticleId":"8215255"}},{"Citation":"Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15818-23","ArticleIdList":{"ArticleId":"17030802"}},{"Citation":"Annu Rev Biochem. 1997;66:385-407","ArticleIdList":{"ArticleId":"9242912"}},{"Citation":"Neurobiol Dis. 2009 Sep;35(3):352-8","ArticleIdList":{"ArticleId":"19523517"}},{"Citation":"Sci Transl Med. 2011 Apr 6;3(77):77sr1","ArticleIdList":{"ArticleId":"21471435"}},{"Citation":"J Biol Chem. 2009 Nov 20;284(47):32895-905","ArticleIdList":{"ArticleId":"19759000"}},{"Citation":"Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338","ArticleIdList":{"ArticleId":"22762015"}},{"Citation":"Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13287-92","ArticleIdList":{"ArticleId":"9371838"}},{"Citation":"Nano Lett. 2014 Jan 8;14(1):339-45","ArticleIdList":{"ArticleId":"24303845"}},{"Citation":"J Neurosci. 2000 May 15;20(10):3606-11","ArticleIdList":{"ArticleId":"10804202"}},{"Citation":"Brain. 2010 May;133(Pt 5):1328-41","ArticleIdList":{"ArticleId":"20403962"}},{"Citation":"Science. 2006 Sep 22;313(5794):1781-4","ArticleIdList":{"ArticleId":"16990547"}},{"Citation":"Alzheimers Dement. 2013 Mar;9(2):99-112","ArticleIdList":{"ArticleId":"23375565"}},{"Citation":"N Engl J Med. 2012 Aug 30;367(9):795-804","ArticleIdList":{"ArticleId":"22784036"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25200336","DateCompleted":{"Year":"2016","Month":"01","Day":"28"},"DateRevised":{"Year":"2015","Month":"05","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1552-5279","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"11","Issue":"5","PubDate":{"Year":"2015","Month":"May"}},"Title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","ISOAbbreviation":"Alzheimers Dement"},"ArticleTitle":"Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease.","Pagination":{"MedlinePgn":"465-74"},"ELocationID":["10.1016\/j.jalz.2014.06.003","S1552-5260(14)02459-5"],"Abstract":{"AbstractText":["Calpain has been associated with the pathophysiology of Alzheimer's disease (AD) and with apoptotic neuronal cell death leading to microparticles (MPs) formation.","A total of 64 patients with AD and 52 age- and gender-matched cognitively healthy elderly controls were included in the study. We measured calpain activity and levels of MPs, amyloid beta (A\u03b21-42), h-tau, and p-tau181.","AD patients showed significantly increased calpain activity and higher levels of MPs in cerebrospinal fluid (CSF) and significantly decreased calpain activity and lower levels of MPs in serum and plasma compared with healthy controls. Combined assessment of calpain activity and A\u03b21-42 levels in CSF improved diagnostic accuracy as compared with singular or combined traditional CSF biomarkers of AD.","This is the first study showing increased calpain activity and microparticle levels in CSF of AD patients. Calpain activity could represent a novel diagnostic and prognostic biomarker and promising treatment target for AD."],"CopyrightInformation":"Copyright \u00a9 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Section for Dementia Research, Hertie-Institute of Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, T\u00fcbingen, Germany; DZNE, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany. Electronic address: christoph.laske@med.uni-tuebingen.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stellos","ForeName":"Konstantinos","Initials":"K","AffiliationInfo":{"Affiliation":"Department of Cardiology, Centre of Internal Medicine III, Goethe University, Frankfurt am Main, Germany; Vascular Inflammation Group, Institute of Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University, Frankfurt am Main, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kempter","ForeName":"Ingrid","Initials":"I","AffiliationInfo":{"Affiliation":"Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E","AffiliationInfo":{"Affiliation":"Section for Dementia Research, Hertie-Institute of Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"DZNE, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany; Department of Neurodegeneration, Center of Neurology, Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fleming","ForeName":"Ingrid","Initials":"I","AffiliationInfo":{"Affiliation":"Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Randriamboavonjy","ForeName":"Voahanginirina","Initials":"V","AffiliationInfo":{"Affiliation":"Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"09","Day":"04"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimers Dement","NlmUniqueID":"101231978","ISSNLinking":"1552-5260"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"EC 3.4.22.-","NameOfSubstance":"Calpain"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Calpain","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Flow Cytometry"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Psychiatric Status Rating Scales"},{"DescriptorName":"Statistics, Nonparametric"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer's disease","CSF","Calpain activity","Dementia","Microparticles","Plasma","Serum"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"11","Day":"21"},{"@attributes":{"PubStatus":"revised"},"Year":"2014","Month":"03","Day":"21"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"06","Day":"11"},{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"9","Day":"10","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"9","Day":"10","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"1","Day":"29","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25200336","S1552-5260(14)02459-5","10.1016\/j.jalz.2014.06.003"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24973356","DateCompleted":{"Year":"2015","Month":"10","Day":"29"},"DateRevised":{"Year":"2019","Month":"10","Day":"08"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1460-2083","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"23","Issue":"23","PubDate":{"Year":"2014","Month":"Dec","Day":"01"}},"Title":"Human molecular genetics","ISOAbbreviation":"Hum Mol Genet"},"ArticleTitle":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.","Pagination":{"MedlinePgn":"6139-46"},"ELocationID":"10.1093\/hmg\/ddu334","Abstract":{"AbstractText":"Clinical and neuropathological similarities between dementia with Lewy bodies (DLB), Parkinson's and Alzheimer's diseases (PD and AD, respectively) suggest that these disorders may share etiology. To test this hypothesis, we have performed an association study of 54 genomic regions, previously implicated in PD or AD, in a large cohort of DLB cases and controls. The cohort comprised 788 DLB cases and 2624 controls. To minimize the issue of potential misdiagnosis, we have also performed the analysis including only neuropathologically proven DLB cases (667 cases). The results show that the APOE is a strong genetic risk factor for DLB, confirming previous findings, and that the SNCA and SCARB2 loci are also associated after a study-wise Bonferroni correction, although these have a different association profile than the associations reported for the same loci in PD. We have previously shown that the p.N370S variant in GBA is associated with DLB, which, together with the findings at the SCARB2 locus, suggests a role for lysosomal dysfunction in this disease. These results indicate that DLB has a unique genetic risk profile when compared with the two most common neurodegenerative diseases and that the lysosome may play an important role in the etiology of this disorder. We make all these data available. ","CopyrightInformation":"\u00a9 The Author 2014. Published by Oxford University Press."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Bras","ForeName":"Jose","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, j.bras@ucl.ac.uk."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Guerreiro","ForeName":"Rita","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Darwent","ForeName":"Lee","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Parkkinen","ForeName":"Laura","Initials":"L","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ansorge","ForeName":"Olaf","Initials":"O","AffiliationInfo":{"Affiliation":"Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Escott-Price","ForeName":"Valentina","Initials":"V","AffiliationInfo":{"Affiliation":"MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hernandez","ForeName":"Dena G","Initials":"DG","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nalls","ForeName":"Michael A","Initials":"MA","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Lorraine N","Initials":"LN","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Department of Pathology and Cell Biology, and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Honig","ForeName":"Lawrence S","Initials":"LS","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Department of Neurology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marder","ForeName":"Karen","Initials":"K","AffiliationInfo":{"Affiliation":"Taub Institute for Alzheimer Disease and the Aging Brain, Department of Neurology, Columbia University, New York, NY, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Der Flier","ForeName":"Wiesje M","Initials":"WM","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lemstra","ForeName":"Afina","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scheltens","ForeName":"Philip","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurology and Alzheimer Center, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rogaeva","ForeName":"Ekaterina","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"St George-Hyslop","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada, Cambridge Institute for Medical Research, and Cambridge National Institute of Health Research Biomedical Research Unit in Dementia, University of Cambridge, Cambridge CB2 0XY, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Londos","ForeName":"Elisabet","Initials":"E","AffiliationInfo":{"Affiliation":"Clinical Memory Research Unit, Institute Clinical Sciences Malm\u00f6, Lund University, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zetterberg","ForeName":"Henrik","Initials":"H","AffiliationInfo":{"Affiliation":"Department of Molecular Neuroscience, Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ortega-Cubero","ForeName":"Sara","Initials":"S","AffiliationInfo":{"Affiliation":"Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain, Department of Neurology, Cl\u00ednica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain, CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pastor","ForeName":"Pau","Initials":"P","AffiliationInfo":{"Affiliation":"Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain, Department of Neurology, Cl\u00ednica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain, CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferman","ForeName":"Tanis J","Initials":"TJ","AffiliationInfo":{"Affiliation":"Department of Psychiatry, Department of Psychology."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff-Radford","ForeName":"Neill R","Initials":"NR","AffiliationInfo":{"Affiliation":"Department of Neurology and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ross","ForeName":"Owen A","Initials":"OA","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Barber","ForeName":"Imelda","Initials":"I","AffiliationInfo":{"Affiliation":"Translation Cell Sciences - Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Braae","ForeName":"Anne","Initials":"A","AffiliationInfo":{"Affiliation":"Translation Cell Sciences - Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brown","ForeName":"Kristelle","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences - Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morgan","ForeName":"Kevin","Initials":"K","AffiliationInfo":{"Affiliation":"Translation Cell Sciences - Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, and DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, and DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Troakes","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"MRC London Neurodegenerative Diseases Brain Bank, Department of Clinical Neuroscience, King's College London, Institute of Psychiatry, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Al-Sarraj","ForeName":"Safa","Initials":"S","AffiliationInfo":{"Affiliation":"MRC London Neurodegenerative Diseases Brain Bank, Department of Clinical Neuroscience, King's College London, Institute of Psychiatry, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lashley","ForeName":"Tammaryn","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Compta","ForeName":"Yaroslau","Initials":"Y","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, and Parkinson's disease and Movement Disorders Unit, Neurology Service, IDIBAPS, CIBERNED, Hospital Cl\u00ednic, Barcelona, Catalonia, Spain."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Revesz","ForeName":"Tamas","Initials":"T","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lees","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Queen Square Brain Bank, Department of Molecular Neuroscience, and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cairns","ForeName":"Nigel","Initials":"N","AffiliationInfo":{"Affiliation":"Knight Alzheimer's Disease Research Center and Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Halliday","ForeName":"Glenda M","Initials":"GM","AffiliationInfo":{"Affiliation":"Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mann","ForeName":"David","Initials":"D","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pickering-Brown","ForeName":"Stuart","Initials":"S","AffiliationInfo":{"Affiliation":"Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK and."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dickson","ForeName":"Dennis W","Initials":"DW","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Singleton","ForeName":"Andrew","Initials":"A","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hardy","ForeName":"John","Initials":"J","AffiliationInfo":{"Affiliation":"Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK."}}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"089701","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"R01 NS078086","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"G-0907","Agency":"Parkinson's UK","Country":"United Kingdom"},{"GrantID":"G0701075","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MC_G1000735","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P50AG008702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"089703","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"AG000951-12","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"089698","Agency":"Wellcome Trust","Country":"United Kingdom"},{"Agency":"Canadian Institutes of Health Research","Country":"Canada"},{"GrantID":"P50 NS072187","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"UL1TR000040","Acronym":"TR","Agency":"NCATS NIH HHS","Country":"United States"},{"GrantID":"MR\/L016397\/1","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L010305\/1","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"100140","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"P50NS038370","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"081864","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L022656\/1","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"K-1204","Agency":"Parkinson's UK","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"06","Day":"27"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Hum Mol Genet","NlmUniqueID":"9208958","ISSNLinking":"0964-6906"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"Lysosome-Associated Membrane Glycoproteins"},{"RegistryNumber":"0","NameOfSubstance":"Receptors, Scavenger"},{"RegistryNumber":"0","NameOfSubstance":"SCARB2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"SNCA protein, human"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["etiology","genetics","pathology"]},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Association Studies"},{"DescriptorName":"Genetic Loci"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["etiology","genetics","pathology"]},{"DescriptorName":"Lysosome-Associated Membrane Glycoproteins","QualifierName":"genetics"},{"DescriptorName":"Lysosomes","QualifierName":"pathology"},{"DescriptorName":"Male"},{"DescriptorName":"Parkinson Disease","QualifierName":["etiology","genetics","pathology"]},{"DescriptorName":"Receptors, Scavenger","QualifierName":"genetics"},{"DescriptorName":"Risk Factors"},{"DescriptorName":"alpha-Synuclein","QualifierName":"genetics"}]},"OtherID":"EMS59506"},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"6","Day":"29","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"6","Day":"29","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"10","Day":"30","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["24973356","ddu334","10.1093\/hmg\/ddu334","PMC4222357","EMS59506"]},"ReferenceList":{"Reference":[{"Citation":"Acta Neuropathol. 2004 Aug;108(2):121-8","ArticleIdList":{"ArticleId":"15235805"}},{"Citation":"Neurology. 2004 Sep 28;63(6):975-82","ArticleIdList":{"ArticleId":"15452286"}},{"Citation":"Lancet. 1994 May 7;343(8906):1155","ArticleIdList":{"ArticleId":"7818636"}},{"Citation":"Neurosci Lett. 1994 Nov 21;182(1):1-2","ArticleIdList":{"ArticleId":"7891871"}},{"Citation":"Neurology. 1996 Nov;47(5):1113-24","ArticleIdList":{"ArticleId":"8909416"}},{"Citation":"J Neural Transm Suppl. 1998;54:107-16","ArticleIdList":{"ArticleId":"9850919"}},{"Citation":"Brain. 2005 Dec;128(Pt 12):2760-2","ArticleIdList":{"ArticleId":"16311269"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"Brain. 2007 Sep;130(Pt 9):2277-91","ArticleIdList":{"ArticleId":"17681982"}},{"Citation":"Neurology. 2007 Mar 13;68(11):812-9","ArticleIdList":{"ArticleId":"17353469"}},{"Citation":"Am J Hum Genet. 2007 Sep;81(3):559-75","ArticleIdList":{"ArticleId":"17701901"}},{"Citation":"Acta Neuropathol. 2008 Apr;115(4):409-15","ArticleIdList":{"ArticleId":"18231798"}},{"Citation":"Arch Neurol. 2009 May;66(5):578-83","ArticleIdList":{"ArticleId":"19433657"}},{"Citation":"Nat Genet. 2009 Oct;41(10):1088-93","ArticleIdList":{"ArticleId":"19734902"}},{"Citation":"Nat Genet. 2009 Oct;41(10):1094-9","ArticleIdList":{"ArticleId":"19734903"}},{"Citation":"N Engl J Med. 2009 Oct 22;361(17):1651-61","ArticleIdList":{"ArticleId":"19846850"}},{"Citation":"Nat Genet. 2009 Dec;41(12):1308-12","ArticleIdList":{"ArticleId":"19915575"}},{"Citation":"Lancet. 2011 Feb 19;377(9766):641-9","ArticleIdList":{"ArticleId":"21292315"}},{"Citation":"Nat Genet. 2011 May;43(5):436-41","ArticleIdList":{"ArticleId":"21460841"}},{"Citation":"PLoS One. 2011;6(4):e18569","ArticleIdList":{"ArticleId":"21552550"}},{"Citation":"JAMA Neurol. 2013 Feb;70(2):223-8","ArticleIdList":{"ArticleId":"23407718"}},{"Citation":"Mov Disord. 2013 Feb;28(2):232-6","ArticleIdList":{"ArticleId":"23225227"}},{"Citation":"JAMA Neurol. 2013 Jun;70(6):727-35","ArticleIdList":{"ArticleId":"23588557"}},{"Citation":"PLoS One. 2013;8(7):e68095","ArticleIdList":{"ArticleId":"23874508"}},{"Citation":"Ann Med. 2013 Dec;45(8):511-21","ArticleIdList":{"ArticleId":"24219755"}},{"Citation":"Nat Genet. 2013 Dec;45(12):1452-8","ArticleIdList":{"ArticleId":"24162737"}},{"Citation":"JAMA Neurol. 2013 Oct;70(10):1268-76","ArticleIdList":{"ArticleId":"23921447"}},{"Citation":"Mov Disord. 2008 Apr 30;23(6):837-44","ArticleIdList":{"ArticleId":"18307261"}},{"Citation":"Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S12-8","ArticleIdList":{"ArticleId":"11748785"}},{"Citation":"Br J Psychiatry. 2002 Feb;180:144-7","ArticleIdList":{"ArticleId":"11823325"}},{"Citation":"Am J Hum Genet. 2004 Jun;74(6):1121-7","ArticleIdList":{"ArticleId":"15122513"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24899140","DateCompleted":{"Year":"2015","Month":"06","Day":"08"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1432-0533","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"128","Issue":"3","PubDate":{"Year":"2014","Month":"Sep"}},"Title":"Acta neuropathologica","ISOAbbreviation":"Acta Neuropathol"},"ArticleTitle":"Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.","Pagination":{"MedlinePgn":"397-410"},"ELocationID":"10.1007\/s00401-014-1298-7","Abstract":{"AbstractText":"Mutations in the gene coding for Sequestosome 1 (SQSTM1) have been genetically associated with amyotrophic lateral sclerosis (ALS) and Paget disease of bone. In the present study, we analyzed the SQSTM1 coding sequence for mutations in an extended cohort of 1,808 patients with frontotemporal lobar degeneration (FTLD), ascertained within the European Early-Onset Dementia consortium. As control dataset, we sequenced 1,625 European control individuals and analyzed whole-exome sequence data of 2,274 German individuals (total n\u00a0=\u00a03,899). Association of rare SQSTM1 mutations was calculated in a meta-analysis of 4,332 FTLD and 10,240 control alleles. We identified 25 coding variants in FTLD patients of which 10 have not been described. Fifteen mutations were absent in the control individuals (carrier frequency <0.00026) whilst the others were rare in both patients and control individuals. When pooling all variants with a minor allele frequency <0.01, an overall frequency of 3.2\u00a0% was calculated in patients. Rare variant association analysis between patients and controls showed no difference over the whole protein, but suggested that rare mutations clustering in the UBA domain of SQSTM1 may influence disease susceptibility by doubling the risk for FTLD (RR\u00a0=\u00a02.18 [95\u00a0% CI 1.24-3.85]; corrected p value\u00a0=\u00a00.042). Detailed histopathology demonstrated that mutations in SQSTM1 associate with widespread neuronal and glial phospho-TDP-43 pathology. With this study, we provide further evidence for a putative role of rare mutations in SQSTM1 in the genetic etiology of FTLD and showed that, comparable to other FTLD\/ALS genes, SQSTM1 mutations are associated with TDP-43 pathology. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Genetics, VIB, Antwerp, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deschamps","ForeName":"William","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mat\u011bj","ForeName":"Radoslav","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sieben","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dermaut","ForeName":"Bart","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Smets","ForeName":"Katrien","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Damme","ForeName":"Philip","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Merlin","ForeName":"C\u00e9line","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Laureys","ForeName":"Annelies","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Den Broeck","ForeName":"Marleen","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mattheijssens","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Peeters","ForeName":"Karin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Archetti","ForeName":"Silvana","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pastor","ForeName":"Pau","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Razquin","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ortega-Cubero","ForeName":"Sara","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hern\u00e1ndez","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Boada","ForeName":"Merc\u00e8","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruiz","ForeName":"Agust\u00edn","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Milt\u00e9nyi","ForeName":"Gabriel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"do Couto","ForeName":"Frederico Sim\u00f5es","Initials":"FS"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chiang","ForeName":"Huei-Hsin","Initials":"HH"},{"@attributes":{"ValidYN":"Y"},"LastName":"Thonberg","ForeName":"H\u00e5kan","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Alexopoulos","ForeName":"Panagiotis","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"vom Hagen","ForeName":"Jennifer M\u00fcller","Initials":"JM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Haack","ForeName":"Tobias B","Initials":"TB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Strom","ForeName":"Tim M","Initials":"TM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Prokisch","ForeName":"Holger","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dols-Icardo","ForeName":"Oriol","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clarim\u00f3n","ForeName":"Jordi","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lle\u00f3","ForeName":"Alberto","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Almeida","ForeName":"Maria Ros\u00e1rio","Initials":"MR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santiago","ForeName":"Beatriz","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Parobkova","ForeName":"Eva","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fabrizi","ForeName":"Gian Maria","Initials":"GM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Str\u00f6bel","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Robberecht","ForeName":"Wim","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Jonghe","ForeName":"Peter","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Martin","ForeName":"Jean-Jacques","Initials":"JJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenberghe","ForeName":"Rik","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter Paul","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2014","Month":"06","Day":"05"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Acta Neuropathol","NlmUniqueID":"0412041","ISSNLinking":"0001-6322"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Adaptor Proteins, Signal Transducing"},{"RegistryNumber":"0","NameOfSubstance":"DNA-Binding Proteins"},{"RegistryNumber":"0","NameOfSubstance":"SQSTM1 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Sequestosome-1 Protein"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adaptor Proteins, Signal Transducing","QualifierName":"genetics"},{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyotrophic Lateral Sclerosis"},{"DescriptorName":"Animals"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"DNA Mutational Analysis"},{"DescriptorName":"DNA-Binding Proteins","QualifierName":"genetics"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["genetics","pathology"]},{"DescriptorName":"Genetic Predisposition to Disease","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"International Cooperation"},{"DescriptorName":"Male"},{"DescriptorName":"Meta-Analysis as Topic"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Polymorphism, Single Nucleotide","QualifierName":"genetics"},{"DescriptorName":"Sequestosome-1 Protein"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2014","Month":"02","Day":"10"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"05","Day":"20"},{"@attributes":{"PubStatus":"revised"},"Year":"2014","Month":"05","Day":"12"},{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"6","Day":"6","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"6","Day":"6","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"6","Day":"9","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["24899140","10.1007\/s00401-014-1298-7","PMC4131163"]},"ReferenceList":{"Reference":[{"Citation":"J Mol Neurosci. 2011 Nov;45(3):522-31","ArticleIdList":{"ArticleId":"21892620"}},{"Citation":"Arch Neurol. 2011 Nov;68(11):1440-6","ArticleIdList":{"ArticleId":"22084127"}},{"Citation":"Acta Neuropathol. 2011 Dec;122(6):691-702","ArticleIdList":{"ArticleId":"22101323"}},{"Citation":"J Neurosci Res. 2012 Oct;90(10):2034-42","ArticleIdList":{"ArticleId":"22674379"}},{"Citation":"Neuropathology. 2012 Oct;32(5):505-14","ArticleIdList":{"ArticleId":"22181065"}},{"Citation":"Neurobiol Aging. 2012 Dec;33(12):2949.e13-7","ArticleIdList":{"ArticleId":"22892309"}},{"Citation":"Neurology. 2012 Oct 9;79(15):1556-62","ArticleIdList":{"ArticleId":"22972638"}},{"Citation":"Ann Med. 2012 Dec;44(8):817-28","ArticleIdList":{"ArticleId":"22420316"}},{"Citation":"Neurology. 2013 Jan 29;80(5):458-63","ArticleIdList":{"ArticleId":"23303844"}},{"Citation":"Science. 2013 Mar 15;339(6125):1335-8","ArticleIdList":{"ArticleId":"23393093"}},{"Citation":"Acta Neuropathol. 2013 Apr;125(4):511-22","ArticleIdList":{"ArticleId":"23417734"}},{"Citation":"Trends Neurosci. 2013 Aug;36(8):450-9","ArticleIdList":{"ArticleId":"23746459"}},{"Citation":"Acta Neuropathol. 2013 Sep;126(3):453-9","ArticleIdList":{"ArticleId":"23812289"}},{"Citation":"Am J Hum Genet. 2013 Aug 8;93(2):211-23","ArticleIdList":{"ArticleId":"23849775"}},{"Citation":"JAMA Neurol. 2013 Nov;70(11):1403-10","ArticleIdList":{"ArticleId":"24042580"}},{"Citation":"Acta Neuropathol. 2013 Dec;126(6):881-93","ArticleIdList":{"ArticleId":"24132570"}},{"Citation":"Neuropathol Appl Neurobiol. 2014 Feb;40(2):225-30","ArticleIdList":{"ArticleId":"23692129"}},{"Citation":"Neurobiol Aging. 2014 May;35(5):1212.e1-5","ArticleIdList":{"ArticleId":"24300238"}},{"Citation":"Hum Mutat. 2013 Feb;34(2):363-73","ArticleIdList":{"ArticleId":"23111906"}},{"Citation":"Neuroreport. 2001 Jul 20;12(10):2085-90","ArticleIdList":{"ArticleId":"11447312"}},{"Citation":"Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9","ArticleIdList":{"ArticleId":"11464847"}},{"Citation":"Am J Hum Genet. 2002 Jun;70(6):1582-8","ArticleIdList":{"ArticleId":"11992264"}},{"Citation":"Neurosci Lett. 2003 May 15;342(1-2):41-4","ArticleIdList":{"ArticleId":"12727313"}},{"Citation":"Nat Genet. 2004 Apr;36(4):377-81","ArticleIdList":{"ArticleId":"15034582"}},{"Citation":"Brain Res. 2004 Jun 25;1012(1-2):42-51","ArticleIdList":{"ArticleId":"15158159"}},{"Citation":"Neurology. 1996 Jul;47(1):1-9","ArticleIdList":{"ArticleId":"8710059"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Genome Res. 2005 Mar;15(3):436-42","ArticleIdList":{"ArticleId":"15741513"}},{"Citation":"J Neurol Sci. 2006 Nov 1;249(1):13-8","ArticleIdList":{"ArticleId":"16820172"}},{"Citation":"J Clin Invest. 2007 Jan;117(1):133-42","ArticleIdList":{"ArticleId":"17187080"}},{"Citation":"J Biol Chem. 2007 Aug 17;282(33):24131-45","ArticleIdList":{"ArticleId":"17580304"}},{"Citation":"Calcif Tissue Int. 2008 Jul;83(1):34-42","ArticleIdList":{"ArticleId":"18543015"}},{"Citation":"Biochim Biophys Acta. 2008 Dec;1782(12):744-8","ArticleIdList":{"ArticleId":"18845250"}},{"Citation":"Neurology. 2009 Aug 25;73(8):626-32","ArticleIdList":{"ArticleId":"19704082"}},{"Citation":"Ann Neurol. 2010 Jun;67(6):739-48","ArticleIdList":{"ArticleId":"20517935"}},{"Citation":"J Bone Miner Res. 2010 Jun;25(6):1375-84","ArticleIdList":{"ArticleId":"20200946"}},{"Citation":"Neuron. 2010 Dec 9;68(5):857-64","ArticleIdList":{"ArticleId":"21145000"}},{"Citation":"Acta Neuropathol. 2011 Jul;122(1):111-3","ArticleIdList":{"ArticleId":"21644037"}},{"Citation":"Am J Hum Genet. 2011 Jul 15;89(1):168-75","ArticleIdList":{"ArticleId":"21763483"}},{"Citation":"Brain. 2011 Sep;134(Pt 9):2456-77","ArticleIdList":{"ArticleId":"21810890"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24349393","DateCompleted":{"Year":"2015","Month":"03","Day":"30"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"8","Issue":"12","PubDate":{"Year":"2013"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia.","Pagination":{"MedlinePgn":"e82902"},"ELocationID":"10.1371\/journal.pone.0082902","Abstract":{"AbstractText":["Dementia in Parkinson's disease (PD) is defined as cognitive decline severe enough to affect activities of daily living function (ADL). The aim of our exploratory study was to compare two groups of PD patients. Both groups had cognitive deficits severe enough to justify diagnosis of dementia, but they differed according to caregivers' rating on ADL dysfunction. Parameters which differed between the two groups were interpreted to affect the caregivers' perception of ADL dysfunction in PD patients with cognitive impairment indicative of Parkinson's disease dementia.","Thirty of 131 Parkinson's disease patients fulfilled the Movement Disorders Society Task Force - recommended, cognitive Level-I-criteria for dementia. According to standardized caregiver ratings, volunteers were grouped into 18 patients with (ADL-) and 12 without instrumental activities of daily living dysfunction (ADL+). Caregiver activities of daily living function ratings closely correlated with self-estimates of patients and those of physician (p<0.001). ADL- patients performed worse on tests assessing visual-construction (p<0.05) and attention (p=0.03) than ADL+ patients. Moreover, the postural instability and gait disorder subtype was more frequent in ADL- patients (p=0.009). ADL- patients tended to have more communication problems (p=0.05), more anxiety (p=0.05) and showed a tendency to be treated more often with neuroleptics (p=0.049) than ADL+.","Results indicate that worse attention, visual-construction abilities, the postural instability and gait disorder subtype, communication problems, medication and presence of anxiety are related to activities of daily living dysfunctions in Parkinson's disease patients with cognitive decline indicative of dementia. Our data suggests that not only cognitive factors but also non-cognitive factors seem to be linked to the diagnosis of Parkinson's disease dementia associated with significant impact on instrumental activities of daily living function. Further studies with larger sample sizes are needed to verify our results."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt-Scarfone","ForeName":"Inga","Initials":"I","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fruhmann Berger","ForeName":"Monika","Initials":"M","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Prakash","ForeName":"Deborah","Initials":"D","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Csoti","ForeName":"Ilona","Initials":"I","AffiliationInfo":{"Affiliation":"Department of Neurology, Gertrudis Hospital, Leun-Biskirchen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gr\u00e4ber","ForeName":"Susanne","Initials":"S","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"German Center of Neurodegenerative Diseases (DZNE), Tuebingen, Germany ; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Clinical Trial","Comparative Study","Journal Article"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"12","Day":"09"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Activities of Daily Living"},{"DescriptorName":"Advisory Committees"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Communication Disorders","QualifierName":["etiology","physiopathology"]},{"DescriptorName":"Dementia","QualifierName":["etiology","physiopathology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parkinson Disease","QualifierName":["complications","physiopathology"]},{"DescriptorName":"Severity of Illness Index"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"06","Day":"26"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"11","Day":"07"},{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"12","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"12","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"3","Day":"31","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["24349393","10.1371\/journal.pone.0082902","PONE-D-13-26420","PMC3857297"]},"ReferenceList":{"Reference":[{"Citation":"Neurology. 1967 May;17(5):427-42","ArticleIdList":{"ArticleId":"6067254"}},{"Citation":"Cortex. 2009 Sep;45(8):930-42","ArticleIdList":{"ArticleId":"19303593"}},{"Citation":"J Neurol Sci. 2012 Jun 15;317(1-2):97-102","ArticleIdList":{"ArticleId":"22503136"}},{"Citation":"Neurology. 2010 Oct 5;75(14):1270-6","ArticleIdList":{"ArticleId":"20921512"}},{"Citation":"Neurology. 2005 Jun 28;64(12):2134-5","ArticleIdList":{"ArticleId":"15985588"}},{"Citation":"Neurology. 2001 Jan 9;56(1):17-24","ArticleIdList":{"ArticleId":"11148230"}},{"Citation":"Int J Geriatr Psychiatry. 2003 Dec;18(12):1115-20","ArticleIdList":{"ArticleId":"14677144"}},{"Citation":"Arch Clin Neuropsychol. 1998 Oct;13(7):575-83","ArticleIdList":{"ArticleId":"14590618"}},{"Citation":"Neurology. 1994 Dec;44(12):2308-14","ArticleIdList":{"ArticleId":"7991117"}},{"Citation":"Neurosci Behav Physiol. 2010 Jan;40(1):61-7","ArticleIdList":{"ArticleId":"20012495"}},{"Citation":"J Neurol. 2010 Jul;257(7):1073-82","ArticleIdList":{"ArticleId":"20140443"}},{"Citation":"Parkinsonism Relat Disord. 2011 Sep;17(8):621-4","ArticleIdList":{"ArticleId":"21684792"}},{"Citation":"Clin Rehabil. 2008 Jan;22(1):14-22","ArticleIdList":{"ArticleId":"18089662"}},{"Citation":"Arch Neurol. 2001 Oct;58(10):1611-5","ArticleIdList":{"ArticleId":"11594919"}},{"Citation":"J Neural Transm (Vienna). 2011 Nov;118(11):1609-12","ArticleIdList":{"ArticleId":"21479865"}},{"Citation":"Mov Disord. 2007 Dec;22(16):2314-24","ArticleIdList":{"ArticleId":"18098298"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52","ArticleIdList":{"ArticleId":"2841426"}},{"Citation":"Mov Disord. 2008 Apr 30;23(6):837-44","ArticleIdList":{"ArticleId":"18307261"}},{"Citation":"Eur J Neurol. 2008 Jul;15(7):737-42","ArticleIdList":{"ArticleId":"18494793"}},{"Citation":"J Neurol Sci. 2011 Nov 15;310(1-2):279-82","ArticleIdList":{"ArticleId":"21851954"}},{"Citation":"Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837","ArticleIdList":{"ArticleId":"17542011"}},{"Citation":"Mov Disord. 2010 Jul 15;25(9):1170-6","ArticleIdList":{"ArticleId":"20310053"}},{"Citation":"Mov Disord. 2012 Aug;27(9):1129-36","ArticleIdList":{"ArticleId":"22778009"}},{"Citation":"Arch Neurol. 2004 Dec;61(12):1906-11","ArticleIdList":{"ArticleId":"15596611"}},{"Citation":"Neurologist. 2001 Nov;7(6):317-26","ArticleIdList":{"ArticleId":"12803662"}},{"Citation":"J Am Geriatr Soc. 2007 Sep;55(9):1415-20","ArticleIdList":{"ArticleId":"17767684"}},{"Citation":"Parkinsonism Relat Disord. 2013 Mar;19(3):371-4","ArticleIdList":{"ArticleId":"23231974"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Parkinsonism Relat Disord. 2008;14(2):93-101","ArticleIdList":{"ArticleId":"17707678"}},{"Citation":"Mov Disord. 2006 Aug;21(8):1123-30","ArticleIdList":{"ArticleId":"16637023"}},{"Citation":"Mov Disord. 2012 Feb;27(2):248-53","ArticleIdList":{"ArticleId":"22162144"}},{"Citation":"Age Ageing. 1997 Sep;26(5):353-7","ArticleIdList":{"ArticleId":"9351479"}},{"Citation":"Brain. 2009 Nov;132(Pt 11):2958-69","ArticleIdList":{"ArticleId":"19812213"}},{"Citation":"Acta Neurol Scand. 2011 Jan;123(1):20-7","ArticleIdList":{"ArticleId":"20199514"}},{"Citation":"Behav Neurol. 1998;11(3):131-137","ArticleIdList":{"ArticleId":"11568413"}},{"Citation":"Mov Disord. 2004 Nov;19(11):1370-4","ArticleIdList":{"ArticleId":"15389984"}},{"Citation":"Neurology. 2004 Jan 27;62(2):201-7","ArticleIdList":{"ArticleId":"14745054"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1136-42","ArticleIdList":{"ArticleId":"16801351"}},{"Citation":"Clin Rehabil. 2001 Jun;15(3):241-6","ArticleIdList":{"ArticleId":"11386393"}},{"Citation":"Mov Disord. 2010 Dec 15;25(16):2769-76","ArticleIdList":{"ArticleId":"20925065"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1992 May;55(5):377-82","ArticleIdList":{"ArticleId":"1602311"}},{"Citation":"Parkinsons Dis. 2011;2011:540843","ArticleIdList":{"ArticleId":"21687757"}},{"Citation":"Neurology. 1990 Oct;40(10):1529-34","ArticleIdList":{"ArticleId":"2215943"}},{"Citation":"Mov Disord. 2008 Sep 15;23(12):1673-80","ArticleIdList":{"ArticleId":"18709684"}},{"Citation":"Nat Rev Neurol. 2012 Jan;8(1):35-47","ArticleIdList":{"ArticleId":"22198405"}},{"Citation":"Neurology. 2005 Nov 8;65(9):1436-41","ArticleIdList":{"ArticleId":"16275832"}},{"Citation":"Mov Disord. 2010 Jan 30;25(2):189-93","ArticleIdList":{"ArticleId":"20063397"}},{"Citation":"Brain. 2007 Jul;130(Pt 7):1847-60","ArticleIdList":{"ArticleId":"17412733"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24058461","DateCompleted":{"Year":"2014","Month":"06","Day":"03"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"8","Issue":"9","PubDate":{"Year":"2013"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.","Pagination":{"MedlinePgn":"e73094"},"ELocationID":"10.1371\/journal.pone.0073094","Abstract":{"AbstractText":["Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a monohexosylceramide) into glucose and ceramide, is the most common genetic risk factor for sporadic Parkinson's disease (PD). GBA mutation carriers are more likely to have an earlier age of onset and to develop cognitive impairment and dementia. We hypothesized that plasma levels of lipids involved in ceramide metabolism would also be altered in PD non-GBA mutation carriers and associated with worse cognition.","Plasma ceramide, monohexosylceramide, and lactosylceramide levels in 26 cognitively normal PD patients, 26 PD patients with cognitive impairment or dementia, and 5 cognitively normal non-PD controls were determined by LC\/ESI\/MS\/MS.","Levels of all lipid species were higher in PD patients versus controls. Among PD patients, levels of ceramide C16:0, C18:0, C20:0, C22:0, and C24:1 and monohexosylceramide C16:0, C20:0 and C24:0 species were higher (all P<0.05) in those with versus without cognitive impairment.","These results suggest that plasma ceramide and monohexosylceramide metabolism is altered in PD non-GBA mutation carriers and that higher levels are associated with worse cognition. Additional studies with larger sample sizes, including cognitively normal controls, are needed to confirm these findings."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Mielke","ForeName":"Michelle M","Initials":"MM","AffiliationInfo":{"Affiliation":"Departments of Health Science Research and Neurology, Mayo Clinic, Rochester, Minnesota, United States of America."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Haughey","ForeName":"Norman J","Initials":"NJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bandaru","ForeName":"Veera V R","Initials":"VV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Savica","ForeName":"Rodolfo","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauser","ForeName":"Ann-Kathrin","Initials":"AK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gr\u00e4ber-Sultan","ForeName":"Susanne","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schleicher","ForeName":"Erwin","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt-Scarfone","ForeName":"Inga","Initials":"I"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"U01 AG037526","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"U01 AG37526","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"09","Day":"18"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Antigens, CD"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Ceramides"},{"RegistryNumber":"0","NameOfSubstance":"Cerebrosides"},{"RegistryNumber":"0","NameOfSubstance":"Lactosylceramides"},{"RegistryNumber":"0","NameOfSubstance":"ceramide monohexoside"},{"RegistryNumber":"4682-48-8","NameOfSubstance":"CDw17 antigen"},{"RegistryNumber":"EC 3.2.1.45","NameOfSubstance":"Glucosylceramidase"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Antigens, CD","QualifierName":"blood"},{"DescriptorName":"Biomarkers","QualifierName":"blood"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Ceramides","QualifierName":"blood"},{"DescriptorName":"Cerebrosides","QualifierName":"blood"},{"DescriptorName":"Cognition"},{"DescriptorName":"Dementia","QualifierName":["blood","genetics","physiopathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Genotype"},{"DescriptorName":"Glucosylceramidase","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"Lactosylceramides","QualifierName":"blood"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Parkinson Disease","QualifierName":["blood","genetics","physiopathology"]},{"DescriptorName":"Severity of Illness Index"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"05","Day":"17"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"07","Day":"17"},{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"9","Day":"24","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"9","Day":"24","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"6","Day":"4","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["24058461","10.1371\/journal.pone.0073094","PONE-D-13-20548","PMC3776817"]},"ReferenceList":{"Reference":[{"Citation":"J Biol Chem. 2000 Aug 4;275(31):24065-9","ArticleIdList":{"ArticleId":"10818098"}},{"Citation":"Neurology. 2012 Nov 6;79(19):1944-50","ArticleIdList":{"ArticleId":"23035075"}},{"Citation":"J Neural Transm (Vienna). 2001;108(5):541-57","ArticleIdList":{"ArticleId":"11459075"}},{"Citation":"Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9110-5","ArticleIdList":{"ArticleId":"11481478"}},{"Citation":"Hum Mol Genet. 2003 Mar 1;12(5):517-26","ArticleIdList":{"ArticleId":"12588799"}},{"Citation":"Ann Neurol. 2004 Feb;55(2):257-67","ArticleIdList":{"ArticleId":"14755730"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52","ArticleIdList":{"ArticleId":"2841426"}},{"Citation":"Science. 1992 May 8;256(5058):794-9","ArticleIdList":{"ArticleId":"1589760"}},{"Citation":"Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7531-6","ArticleIdList":{"ArticleId":"9207126"}},{"Citation":"J Neurochem. 1997 Oct;69(4):1612-21","ArticleIdList":{"ArticleId":"9326290"}},{"Citation":"Exp Neurol. 2004 Dec;190(2):506-14","ArticleIdList":{"ArticleId":"15530889"}},{"Citation":"Neurology. 2007 May 1;68(18):1481-7","ArticleIdList":{"ArticleId":"17470750"}},{"Citation":"Mov Disord. 2007 Dec;22(16):2314-24","ArticleIdList":{"ArticleId":"18098298"}},{"Citation":"FEBS J. 2008 Dec;275(23):5767-73","ArticleIdList":{"ArticleId":"19021754"}},{"Citation":"Brain. 2009 Jul;132(Pt 7):1783-94","ArticleIdList":{"ArticleId":"19286695"}},{"Citation":"N Engl J Med. 2009 Oct 22;361(17):1651-61","ArticleIdList":{"ArticleId":"19846850"}},{"Citation":"Neurobiol Aging. 2010 Jan;31(1):17-24","ArticleIdList":{"ArticleId":"18455839"}},{"Citation":"J Neurol Sci. 2010 Feb 15;289(1-2):18-22","ArticleIdList":{"ArticleId":"19733364"}},{"Citation":"PLoS One. 2011;6(1):e15946","ArticleIdList":{"ArticleId":"21264320"}},{"Citation":"J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):215-8","ArticleIdList":{"ArticleId":"21677254"}},{"Citation":"Cell. 2011 Jul 8;146(1):37-52","ArticleIdList":{"ArticleId":"21700325"}},{"Citation":"Neurology. 2011 Jul 19;77(3):276-80","ArticleIdList":{"ArticleId":"21734182"}},{"Citation":"J Biol Chem. 2011 Aug 12;286(32):28080-8","ArticleIdList":{"ArticleId":"21653695"}},{"Citation":"Neuroepidemiology. 2011;37(3-4):168-76","ArticleIdList":{"ArticleId":"22067139"}},{"Citation":"Mov Disord. 2012 Mar;27(3):349-56","ArticleIdList":{"ArticleId":"22275317"}},{"Citation":"Neurology. 2012 May 1;78(18):1434-40","ArticleIdList":{"ArticleId":"22442429"}},{"Citation":"Neurology. 2012 Aug 14;79(7):633-41","ArticleIdList":{"ArticleId":"22815558"}},{"Citation":"J Biol Chem. 2000 Nov 3;275(44):34328-34","ArticleIdList":{"ArticleId":"10915790"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23978325","DateCompleted":{"Year":"2016","Month":"02","Day":"04"},"DateRevised":{"Year":"2016","Month":"11","Day":"25"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1552-5279","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"10","Issue":"5","PubDate":{"Year":"2014","Month":"Sep"}},"Title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","ISOAbbreviation":"Alzheimers Dement"},"ArticleTitle":"High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.","Pagination":{"MedlinePgn":"530-540.e1"},"ELocationID":["10.1016\/j.jalz.2013.03.010","S1552-5260(13)02463-1"],"Abstract":{"AbstractText":"Apolipoprotein E \u03b54 allele (APOE \u03b54) increases the apolipoprotein E (apoE) protein levels in Alzheimer's disease (AD) cerebrospinal fluid (CSF). Thus, we hypothesized that apoE levels were also associated with the APOE genotype, and amyloid-\u03b2 (A\u03b2)-associated clinical, functional, and imaging parameters in patients with Lewy body-associated disorders (LBD). Indeed, similar to AD, patients with LBD displayed high CSF apoE levels (greatest in patients with dementia with LBD), and this was linked to APOE \u03b54. High CSF apoE protein correlated positively with CSF soluble amyloid precursor protein, total tau, and cortical and striatal Pittsburgh compound B retention; and correlated negatively with CSF A\u03b242, cognitive tests scores, and glucose uptake ratio in the temporal and parietal cortices. APOE \u03b54-triggered accumulation of apoE in CSF is related to A\u03b2-associated clinical and functional imaging parameters in LBD. Accordingly, therapeutic strategies aimed at reducing apoE levels in the brain should be explored not only in AD but also in LBD, particularly when accompanied with dementia. ","CopyrightInformation":"Copyright \u00a9 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Vijayaraghavan","ForeName":"Swetha","Initials":"S","AffiliationInfo":{"Affiliation":"Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Alzheimer Neurobiology Center, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Reimold","ForeName":"Matthias","Initials":"M","AffiliationInfo":{"Affiliation":"Nuclear Medicine and PET Center, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lithner","ForeName":"Christina Unger","Initials":"CU","AffiliationInfo":{"Affiliation":"Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Alzheimer Neurobiology Center, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt-Scarfone","ForeName":"Inga","Initials":"I","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Darreh-Shori","ForeName":"Taher","Initials":"T","AffiliationInfo":{"Affiliation":"Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Alzheimer Neurobiology Center, Stockholm, Sweden. Electronic address: Taher.Darreh-Shori@ki.se."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"08","Day":"24"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimers Dement","NlmUniqueID":"101231978","ISSNLinking":"1552-5260"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole"},{"RegistryNumber":"0","NameOfSubstance":"APP protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Protein Precursor"},{"RegistryNumber":"0","NameOfSubstance":"Aniline Compounds"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Carbon Radioisotopes"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"Radiopharmaceuticals"},{"RegistryNumber":"0","NameOfSubstance":"Thiazoles"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"0Z5B2CJX4D","NameOfSubstance":"Fluorodeoxyglucose F18"},{"RegistryNumber":"IY9XDZ35W2","NameOfSubstance":"Glucose"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Amyloid beta-Protein Precursor","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Aniline Compounds"},{"DescriptorName":"Apolipoproteins E","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Brain","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Carbon Radioisotopes"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Fluorodeoxyglucose F18"},{"DescriptorName":"Glucose","QualifierName":"metabolism"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["cerebrospinal fluid","diagnostic imaging","genetics","psychology"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Positron-Emission Tomography"},{"DescriptorName":"Radiopharmaceuticals"},{"DescriptorName":"Thiazoles"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer\u2019s disease","Amyloid-\u03b2","Apolipoprotein E","Cerebrospinal fluid","Dementia with Lewy bodies","Fluorodeoxyglucose\u2013positron emission tomography","Lewy body-associated disorders","Pittsburgh compound B\u2013positron emission tomography","Positron emission tomography"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"08","Day":"29"},{"@attributes":{"PubStatus":"revised"},"Year":"2013","Month":"02","Day":"25"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"03","Day":"03"},{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"8","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"8","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"2","Day":"5","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23978325","S1552-5260(13)02463-1","10.1016\/j.jalz.2013.03.010"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23741358","DateCompleted":{"Year":"2014","Month":"02","Day":"18"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic-Print"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"8","Issue":"5","PubDate":{"Year":"2013"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"Altered serum IgG levels to \u03b1-synuclein in dementia with Lewy bodies and Alzheimer's disease.","Pagination":{"MedlinePgn":"e64649"},"ELocationID":"10.1371\/journal.pone.0064649","Abstract":{"AbstractText":"Natural self-reactive antibodies in the peripheral blood may play a considerable role in the control of potentially toxic proteins that may otherwise accumulate in the aging brain. The significance of serum antibodies reactive against \u03b1-synuclein is not well known. We explored serum IgG levels to monomeric \u03b1-synuclein in dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) with a novel and validated highly sensitive ELISA assay. Antibody levels revealed stark differences in patients compared to healthy subjects and were dependent on diagnosis, disease duration and age. Anti-\u03b1-synuclein IgG levels were increased in both patient groups, but in early DLB to a much greater extent than in AD. Increased antibody levels were most evident in younger patients, while with advanced age relatively low levels were observed, similar to healthy individuals, exhibiting stable antibody levels independent of age. Our data show the presence of differentially altered IgG levels against \u03b1-synuclein in DLB and AD, which may relate to a disturbed \u03b1-synuclein homeostasis triggered by the disease process. These observations may foster the development of novel, possibly preclinical biomarkers and immunotherapeutic strategies that target \u03b1-synuclein in neurodegenerative disease."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Koehler","ForeName":"Niklas K U","Initials":"NK","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, Eberhard-Karls-University, T\u00fcbingen, Germany. niklaskoehler@yahoo.com"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Shing","ForeName":"Mona","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gaertner","ForeName":"Susanne","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Mirjam","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schreitm\u00fcller","ForeName":"Brigitte","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kahle","ForeName":"Phillipp","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Celej","ForeName":"Maria S","Initials":"MS"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jovin","ForeName":"Thomas M","Initials":"TM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fallgatter","ForeName":"Andreas J","Initials":"AJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Batra","ForeName":"Anil","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Buchkremer","ForeName":"Gerhard","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schott","ForeName":"Klaus","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Richartz-Salzburger","ForeName":"Elke","Initials":"E"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"05","Day":"31"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Autoantibodies"},{"RegistryNumber":"0","NameOfSubstance":"Immunoglobulin G"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age Factors"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","immunology","pathology"]},{"DescriptorName":"Autoantibodies","QualifierName":["blood","immunology"]},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Immunoglobulin G","QualifierName":["blood","immunology"]},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","immunology","pathology"]},{"DescriptorName":"Male"},{"DescriptorName":"Severity of Illness Index"},{"DescriptorName":"alpha-Synuclein","QualifierName":["blood","immunology"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"02","Day":"03"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"04","Day":"16"},{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"6","Day":"7","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"6","Day":"7","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"2","Day":"19","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["23741358","10.1371\/journal.pone.0064649","PONE-D-13-05524","PMC3669378"]},"ReferenceList":{"Reference":[{"Citation":"Nat Med. 2000 Aug;6(8):916-9","ArticleIdList":{"ArticleId":"10932230"}},{"Citation":"Exp Neurol. 2008 Oct;213(2):315-25","ArticleIdList":{"ArticleId":"18625222"}},{"Citation":"Ann Neurol. 2001 Jun;49(6):808-10","ArticleIdList":{"ArticleId":"11409436"}},{"Citation":"Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8850-5","ArticleIdList":{"ArticleId":"11438712"}},{"Citation":"Am J Pathol. 2001 Aug;159(2):439-47","ArticleIdList":{"ArticleId":"11485902"}},{"Citation":"Neurology. 2001 Sep 11;57(5):801-5","ArticleIdList":{"ArticleId":"11552007"}},{"Citation":"J Mol Neurosci. 2001 Oct;17(2):225-32","ArticleIdList":{"ArticleId":"11816795"}},{"Citation":"Neurology. 2002 May 14;58(9):1435-6","ArticleIdList":{"ArticleId":"12011302"}},{"Citation":"Exp Gerontol. 2002 Jul;37(7):943-8","ArticleIdList":{"ArticleId":"12086704"}},{"Citation":"Exp Neurol. 2002 Jul;176(1):98-104","ArticleIdList":{"ArticleId":"12093086"}},{"Citation":"Neuromolecular Med. 2003;3(1):29-39","ArticleIdList":{"ArticleId":"12665674"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Arch Neurol. 1989 Jun;46(6):651-7","ArticleIdList":{"ArticleId":"2730377"}},{"Citation":"J Clin Lab Anal. 1990;4(1):16-21","ArticleIdList":{"ArticleId":"1968967"}},{"Citation":"Mech Ageing Dev. 1997 Mar;94(1-3):213-22","ArticleIdList":{"ArticleId":"9147373"}},{"Citation":"J Immunol Methods. 1998 Jul 1;216(1-2):117-37","ArticleIdList":{"ArticleId":"9760219"}},{"Citation":"J Clin Immunol. 1999 Jan;19(1):26-34","ArticleIdList":{"ArticleId":"10080102"}},{"Citation":"Immunol Today. 1999 Sep;20(9):423-8","ArticleIdList":{"ArticleId":"10462743"}},{"Citation":"Dement Geriatr Cogn Disord. 2005;19(4):184-8","ArticleIdList":{"ArticleId":"15677865"}},{"Citation":"Biol Psychiatry. 2005 Apr 1;57(7):813-6","ArticleIdList":{"ArticleId":"15820240"}},{"Citation":"J Biol Chem. 2005 Apr 29;280(17):17458-63","ArticleIdList":{"ArticleId":"15728175"}},{"Citation":"Neuron. 2005 Jun 16;46(6):857-68","ArticleIdList":{"ArticleId":"15953415"}},{"Citation":"J Psychiatr Res. 2005 Sep;39(5):535-43","ArticleIdList":{"ArticleId":"15992563"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"Brain. 2006 Mar;129(Pt 3):729-35","ArticleIdList":{"ArticleId":"16401618"}},{"Citation":"Ann Neurol. 2006 Mar;59(3):449-58","ArticleIdList":{"ArticleId":"16489609"}},{"Citation":"Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):118-23","ArticleIdList":{"ArticleId":"16772748"}},{"Citation":"Neurodegener Dis. 2005;2(5):261-6","ArticleIdList":{"ArticleId":"16909007"}},{"Citation":"Biochem Biophys Res Commun. 2006 Oct 13;349(1):162-6","ArticleIdList":{"ArticleId":"16930553"}},{"Citation":"J Psychiatr Res. 2007 Jan-Feb;41(1-2):174-8","ArticleIdList":{"ArticleId":"16516234"}},{"Citation":"J Neurochem. 2007 May;101(3):749-56","ArticleIdList":{"ArticleId":"17448146"}},{"Citation":"J Alzheimers Dis. 2007 Jul;11(4):457-63","ArticleIdList":{"ArticleId":"17656824"}},{"Citation":"Int Rev Neurobiol. 2007;82:235-46","ArticleIdList":{"ArticleId":"17678964"}},{"Citation":"Neurodegener Dis. 2008;5(2):55-9","ArticleIdList":{"ArticleId":"18182779"}},{"Citation":"J Biol Chem. 2008 Feb 22;283(8):4714-22","ArticleIdList":{"ArticleId":"18086674"}},{"Citation":"Lancet Neurol. 2009 Dec;8(12):1150-7","ArticleIdList":{"ArticleId":"19909913"}},{"Citation":"J Biol Chem. 2010 Mar 19;285(12):9262-72","ArticleIdList":{"ArticleId":"20071342"}},{"Citation":"Brain. 2010 Mar;133(Pt 3):713-26","ArticleIdList":{"ArticleId":"20157014"}},{"Citation":"Acta Neuropathol. 2010 Jul;120(1):1-12","ArticleIdList":{"ArticleId":"20532896"}},{"Citation":"Acta Neuropathol. 2010 Aug;120(2):131-43","ArticleIdList":{"ArticleId":"20563819"}},{"Citation":"J Neuroimmunol. 2011 Apr;233(1-2):221-7","ArticleIdList":{"ArticleId":"21239064"}},{"Citation":"J Cell Mol Med. 2008 Oct;12(5B):1820-9","ArticleIdList":{"ArticleId":"18671754"}},{"Citation":"J Alzheimers Dis. 2009;16(2):363-9","ArticleIdList":{"ArticleId":"19221426"}},{"Citation":"PLoS One. 2011;6(4):e18513","ArticleIdList":{"ArticleId":"21541339"}},{"Citation":"Ann Neurol. 2011 Oct;70(4):532-40","ArticleIdList":{"ArticleId":"22028219"}},{"Citation":"PLoS One. 2011;6(10):e27230","ArticleIdList":{"ArticleId":"22073131"}},{"Citation":"J Neural Transm (Vienna). 2012 Jul;119(7):861-75","ArticleIdList":{"ArticleId":"22622365"}},{"Citation":"J Neurosci. 2012 Sep 26;32(39):13454-69","ArticleIdList":{"ArticleId":"23015436"}},{"Citation":"Neuroimmunomodulation. 2012;19(6):334-42","ArticleIdList":{"ArticleId":"22986484"}},{"Citation":"PLoS One. 2012;7(12):e52285","ArticleIdList":{"ArticleId":"23284971"}},{"Citation":"Neurology. 2013 Jan 8;80(2):169-75","ArticleIdList":{"ArticleId":"23255825"}},{"Citation":"Neurodegener Dis. 2008;5(3-4):118-21","ArticleIdList":{"ArticleId":"18322367"}},{"Citation":"Mov Disord. 2008 Mar 15;23(4):474-83","ArticleIdList":{"ArticleId":"18044695"}},{"Citation":"Science. 2008 Apr 11;320(5873):167","ArticleIdList":{"ArticleId":"18403684"}},{"Citation":"Nat Med. 2008 May;14(5):504-6","ArticleIdList":{"ArticleId":"18391962"}},{"Citation":"Nat Med. 2008 May;14(5):501-3","ArticleIdList":{"ArticleId":"18391963"}},{"Citation":"Autoimmun Rev. 2008 Jun;7(6):415-20","ArticleIdList":{"ArticleId":"18558354"}},{"Citation":"Brain Res. 2008 Jul 11;1219:169-79","ArticleIdList":{"ArticleId":"18534566"}},{"Citation":"Nat Immunol. 2001 Apr;2(4):279-81","ArticleIdList":{"ArticleId":"11276193"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23588557","DateCompleted":{"Year":"2013","Month":"08","Day":"29"},"DateRevised":{"Year":"2019","Month":"12","Day":"20"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"2168-6157","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"70","Issue":"6","PubDate":{"Year":"2013","Month":"Jun"}},"Title":"JAMA neurology","ISOAbbreviation":"JAMA Neurol"},"ArticleTitle":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.","Pagination":{"MedlinePgn":"727-35"},"ELocationID":"10.1001\/jamaneurol.2013.1925","Abstract":{"AbstractText":["While mutations in glucocerebrosidase (GBA1) are associated with an increased risk for Parkinson disease (PD), it is important to establish whether such mutations are also a common risk factor for other Lewy body disorders.","To establish whether GBA1 mutations are a risk factor for dementia with Lewy bodies (DLB). DESIGN We compared genotype data on patients and controls from 11 centers. Data concerning demographics, age at onset, disease duration, and clinical and pathological features were collected when available. We conducted pooled analyses using logistic regression to investigate GBA1 mutation carrier status as predicting DLB or PD with dementia status, using common control subjects as a reference group. Random-effects meta-analyses were conducted to account for additional heterogeneity.","Eleven centers from sites around the world performing genotyping.","Seven hundred twenty-one cases met diagnostic criteria for DLB and 151 had PD with dementia. We compared these cases with 1962 controls from the same centers matched for age, sex, and ethnicity.","Frequency of GBA1 mutations in cases and controls. RESULTS We found a significant association between GBA1 mutation carrier status and DLB, with an odds ratio of 8.28 (95% CI, 4.78-14.88). The odds ratio for PD with dementia was 6.48 (95% CI, 2.53-15.37). The mean age at diagnosis of DLB was earlier in GBA1 mutation carriers than in noncarriers (63.5 vs 68.9 years; P < .001), with higher disease severity scores.","Mutations in GBA1 are a significant risk factor for DLB. GBA1 mutations likely play an even larger role in the genetic etiology of DLB than in PD, providing insight into the role of glucocerebrosidase in Lewy body disease."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Nalls","ForeName":"Michael A","Initials":"MA","AffiliationInfo":{"Affiliation":"Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Duran","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lopez","ForeName":"Grisel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurzawa-Akanbi","ForeName":"Marzena","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"McKeith","ForeName":"Ian G","Initials":"IG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chinnery","ForeName":"Patrick F","Initials":"PF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Morris","ForeName":"Christopher M","Initials":"CM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Crosiers","ForeName":"David","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter Paul","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mann","ForeName":"David M A","Initials":"DM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Snowden","ForeName":"Julie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pickering-Brown","ForeName":"Stuart","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Halliwell","ForeName":"Nicola","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Davidson","ForeName":"Yvonne","Initials":"Y"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gibbons","ForeName":"Linda","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Harris","ForeName":"Jenny","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sheerin","ForeName":"Una-Marie","Initials":"UM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bras","ForeName":"Jose","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hardy","ForeName":"John","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Lorraine","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Marder","ForeName":"Karen","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Honig","ForeName":"Lawrence S","Initials":"LS"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Novellino","ForeName":"Fabiana","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Quattrone","ForeName":"Aldo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Annesi","ForeName":"Grazia","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Marco","ForeName":"Elvira Valeria","Initials":"EV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rogaeva","ForeName":"Ekaterina","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Masellis","ForeName":"Mario","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Black","ForeName":"Sandra E","Initials":"SE"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bilbao","ForeName":"Juan M","Initials":"JM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Foroud","ForeName":"Tatiana","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghetti","ForeName":"Bernardino","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nichols","ForeName":"William C","Initials":"WC"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pankratz","ForeName":"Nathan","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Halliday","ForeName":"Glenda","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lesage","ForeName":"Suzanne","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Klebe","ForeName":"Stephan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Durr","ForeName":"Alexandra","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Duyckaerts","ForeName":"Charles","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brice","ForeName":"Alexis","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Giasson","ForeName":"Benoit I","Initials":"BI"},{"@attributes":{"ValidYN":"Y"},"LastName":"Trojanowski","ForeName":"John Q","Initials":"JQ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hurtig","ForeName":"Howard I","Initials":"HI"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tayebi","ForeName":"Nahid","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Landazabal","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Knight","ForeName":"Melanie A","Initials":"MA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Margaux","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Singleton","ForeName":"Andrew B","Initials":"AB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfsberg","ForeName":"Tyra G","Initials":"TG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sidransky","ForeName":"Ellen","Initials":"E"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"MR\/L016451\/1","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"M01 RR000645","Acronym":"RR","Agency":"NCRR NIH HHS","Country":"United States"},{"GrantID":"101876","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"R56 NS037167","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"NS053488","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P50AG08702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R56NS036630","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P30 AG010133","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"MC_G0901330","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"G0701075","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/K000608\/1","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"P50 AG008702","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"UL1 RR024156","Acronym":"RR","Agency":"NCRR NIH HHS","Country":"United States"},{"GrantID":"P50 NS053488","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"MC_G1000735","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"2R56NS037167","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"G0900652","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"089698","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"5R01NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"Z99 HG999999","Agency":"Intramural NIH HHS","Country":"United States"},{"GrantID":"G0502157","Agency":"Medical Research Council","Country":"United Kingdom"},{"Agency":"Canadian Institutes of Health Research","Country":"Canada"},{"GrantID":"Z01 AG000949","Agency":"Intramural NIH HHS","Country":"United States"},{"GrantID":"096919","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"R01 NS060113","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"G1100540","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"G0400074","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"G1100479","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"Z01 AG000949-02","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"2P30AG010133","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R56 NS036630","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"G-1107","Agency":"Parkinson's UK","Country":"United Kingdom"},{"GrantID":"MC_PC_09003","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"R01 NS036630","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Meta-Analysis","Multicenter Study","Randomized Controlled Trial","Research Support, N.I.H., Extramural","Research Support, N.I.H., Intramural","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"JAMA Neurol","NlmUniqueID":"101589536","ISSNLinking":"2168-6149"},"ChemicalList":{"Chemical":{"RegistryNumber":"EC 3.2.1.45","NameOfSubstance":"Glucosylceramidase"}},"CitationSubset":["AIM","IM"],"CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"JAMA Neurol. 2013 Jun;70(6):686-8","PMID":"23588619"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Association Studies","QualifierName":"methods"},{"DescriptorName":"Genotype"},{"DescriptorName":"Glucosylceramidase","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["diagnosis","epidemiology","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation","QualifierName":"genetics"},{"DescriptorName":"Risk Factors"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"4","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"4","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"8","Day":"30","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23588557","1678590","10.1001\/jamaneurol.2013.1925","PMC3841974","NIHMS528249"]},"ReferenceList":{"Reference":[{"Citation":"Science. 2004 Aug 27;305(5688):1292-5","ArticleIdList":{"ArticleId":"15333840"}},{"Citation":"Neurology. 2012 Nov 6;79(19):1944-50","ArticleIdList":{"ArticleId":"23035075"}},{"Citation":"Mol Genet Metab. 2004 Jan;81(1):70-3","ArticleIdList":{"ArticleId":"14728994"}},{"Citation":"N Engl J Med. 2004 Nov 4;351(19):1972-7","ArticleIdList":{"ArticleId":"15525722"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"Neurology. 2006 Sep 12;67(5):908-10","ArticleIdList":{"ArticleId":"16790605"}},{"Citation":"Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837","ArticleIdList":{"ArticleId":"17542011"}},{"Citation":"Arch Neurol. 2008 Mar;65(3):379-82","ArticleIdList":{"ArticleId":"18332251"}},{"Citation":"Eur J Hum Genet. 2008 Apr;16(4):471-9","ArticleIdList":{"ArticleId":"18197194"}},{"Citation":"Neurology. 2008 Jun 10;70(24):2277-83","ArticleIdList":{"ArticleId":"18434642"}},{"Citation":"Neurology. 2009 Jan 27;72(4):310-6","ArticleIdList":{"ArticleId":"18987351"}},{"Citation":"Arch Neurol. 2009 May;66(5):571-6","ArticleIdList":{"ArticleId":"19433656"}},{"Citation":"Arch Neurol. 2009 May;66(5):578-83","ArticleIdList":{"ArticleId":"19433657"}},{"Citation":"Parkinsonism Relat Disord. 2009 Jul;15(6):414-6","ArticleIdList":{"ArticleId":"18829375"}},{"Citation":"Neurobiol Aging. 2009 Sep;30(9):1515-7","ArticleIdList":{"ArticleId":"18160183"}},{"Citation":"N Engl J Med. 2009 Oct 22;361(17):1651-61","ArticleIdList":{"ArticleId":"19846850"}},{"Citation":"Neurotoxicology. 2009 Nov;30(6):1127-32","ArticleIdList":{"ArticleId":"19576930"}},{"Citation":"Acta Neuropathol. 2010 Nov;120(5):641-9","ArticleIdList":{"ArticleId":"20838799"}},{"Citation":"Hum Mol Genet. 2011 Jan 1;20(1):202-10","ArticleIdList":{"ArticleId":"20947659"}},{"Citation":"Mol Genet Metab. 2011 Apr;102(4):436-47","ArticleIdList":{"ArticleId":"21257328"}},{"Citation":"J Neuropathol Exp Neurol. 2011 Apr;70(4):264-80","ArticleIdList":{"ArticleId":"21412173"}},{"Citation":"Ann Neurol. 2011 Jun;69(6):940-53","ArticleIdList":{"ArticleId":"21472771"}},{"Citation":"Cell. 2011 Jul 8;146(1):37-52","ArticleIdList":{"ArticleId":"21700325"}},{"Citation":"Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6","ArticleIdList":{"ArticleId":"21730160"}},{"Citation":"Trends Mol Med. 2011 Sep;17(9):485-93","ArticleIdList":{"ArticleId":"21723784"}},{"Citation":"Neurobiol Aging. 2012 Mar;33(3):629.e5-629.e18","ArticleIdList":{"ArticleId":"22118943"}},{"Citation":"Lancet Neurol. 2012 Nov;11(11):986-98","ArticleIdList":{"ArticleId":"23079555"}},{"Citation":"Mol Genet Metab. 2004 Jul;82(3):192-207","ArticleIdList":{"ArticleId":"15234332"}},{"Citation":"Ann Neurol. 2012 Mar;71(3):370-84","ArticleIdList":{"ArticleId":"22451204"}},{"Citation":"Mov Disord. 2012 Mar;27(3):393-9","ArticleIdList":{"ArticleId":"22173904"}},{"Citation":"Brain. 2012 Aug;135(Pt 8):2440-8","ArticleIdList":{"ArticleId":"22843412"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23207486","DateCompleted":{"Year":"2013","Month":"10","Day":"29"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"2","PubDate":{"Year":"2013"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients.","Pagination":{"MedlinePgn":"367-75"},"ELocationID":"10.3233\/JAD-121558","Abstract":{"AbstractText":["Alzheimer's disease (AD) has been linked to a state of cerebral and systemic inflammation. The objective of the present study was to determine whether singular markers or a set of inflammatory biomarkers in peripheral blood allow discrimination between AD patients and healthy controls at the individual level.","Using bead based multiplexed sandwich immunoassays, 25 inflammatory biomarkers were measured in 164 serum samples from individuals with early AD and age-matched cognitively healthy elderly controls. The data set was randomly split into a training set for feature selection and classification training and a test set for class prediction of blinded samples (1 : 1 ratio) to evaluate the chosen predictors and parameters. Multivariate data analysis was performed with use of a support vector machine (SVM).","After selection of sTNF-R1 as most discriminative parameter in the training set, the application of SVM to the independent test dataset resulted in a 90.0% correct classification for individual AD and control subjects.","We identified sTNF-R1 from a marker set consisting of 25 inflammatory biomarkers, which allowed SVM-based discrimination of AD patients from healthy controls on a single-subject classification level comparably well as biomarker panels with a clinically relevant accuracy and validity. Although larger sample populations will be needed to confirm this diagnostic accuracy, our study suggests that sTNF-R1 in serum-either as singular marker or incorporated into a biomarker panel-could be a powerful new biomarker for detection of AD. In addition, selective inhibition of TNF-R1 function may represent a new therapeutic approach in AD."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Section for Dementia Research, Hertie-Institute of Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, Germany. christoph.laske@med.uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schmohl","ForeName":"Michael","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fallgatter","ForeName":"Andreas J","Initials":"AJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Joos","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dietzsch","ForeName":"Janko","Initials":"J"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Inflammation Mediators"},{"RegistryNumber":"0","NameOfSubstance":"Receptors, Tumor Necrosis Factor, Type I"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","classification","metabolism"]},{"DescriptorName":"Biomarkers","QualifierName":"blood"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Inflammation Mediators","QualifierName":["blood","metabolism"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Receptors, Tumor Necrosis Factor, Type I","QualifierName":"blood"},{"DescriptorName":"Registries"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"12","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"12","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"10","Day":"30","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23207486","P7145253K4317421","10.3233\/JAD-121558"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23133543","DateCompleted":{"Year":"2013","Month":"05","Day":"07"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1932-6203","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"7","Issue":"10","PubDate":{"Year":"2012"}},"Title":"PloS one","ISOAbbreviation":"PLoS One"},"ArticleTitle":"Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.","Pagination":{"MedlinePgn":"e48042"},"ELocationID":"10.1371\/journal.pone.0048042","Abstract":{"AbstractText":"Parkinson's disease (PD) without (non-demented, PDND) and with dementia (PDD), and dementia with Lewy bodies (DLB) are subsumed under the umbrella term Lewy body disorders (LBD). The main component of the underlying pathologic substrate, i.e. Lewy bodies and Lewy neurites, is misfolded alpha-synuclein (Asyn), and--in particular in demented LBD patients--co-occurring misfolded amyloid-beta (Abeta). Lowered blood and cerebrospinal fluid (CSF) levels of transthyretin (TTR)--a clearance protein mainly produced in the liver and, autonomously, in the choroid plexus--are associated with Abeta accumulation in Alzheimer's disease. In addition, a recent study suggests that TTR is involved in Asyn clearance. We measured TTR protein levels in serum and cerebrospinal fluid of 131 LBD patients (77 PDND, 26 PDD, and 28 DLB) and 72 controls, and compared TTR levels with demographic and clinical data as well as neurodegenerative markers in the CSF. Five single nucleotide polymorphisms of the TTR gene which are considered to influence the ability of the protein to carry its ligands were also analyzed. CSF TTR levels were significantly higher in LBD patients compared to controls. Post-hoc analysis demonstrated that this effect was driven by PDND patients. In addition, CSF TTR levels correlated negatively with CSF Abeta(1-42), total tau and phospho-tau levels. Serum TTR levels did not significantly differ among the studied groups. There were no relevant associations between TTR levels and genetic, demographic and clinical data, respectively. These results suggest an involvement of the clearance protein TTR in LBD pathophysiology, and should motivate to elucidate TTR-related mechanisms in LBD in more detail."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.d"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tian","ForeName":"Youyong","Initials":"Y"},{"@attributes":{"ValidYN":"Y"},"LastName":"Baur","ForeName":"Stephanie Maria","Initials":"SM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gauger","ForeName":"Tina","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Odoj","ForeName":"Bartholom\u00e4us","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schmid","ForeName":"Benjamin","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Deuschle","ForeName":"Christian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heck","ForeName":"Susanna","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Apel","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2012","Month":"10","Day":"25"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS One","NlmUniqueID":"101285081","ISSNLinking":"1932-6203"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"Ligands"},{"RegistryNumber":"0","NameOfSubstance":"Prealbumin"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Dementia","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Gene Expression Regulation"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Ligands"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":"metabolism"},{"DescriptorName":"Parkinson Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Polymorphism, Genetic"},{"DescriptorName":"Prealbumin","QualifierName":["biosynthesis","cerebrospinal fluid"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"07","Day":"27"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"09","Day":"20"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"11","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"11","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"5","Day":"8","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23133543","10.1371\/journal.pone.0048042","PONE-D-12-23640","PMC3485000"]},"ReferenceList":{"Reference":[{"Citation":"Clin Chem Lab Med. 2007;45(3):419-26","ArticleIdList":{"ArticleId":"17378745"}},{"Citation":"Am J Physiol. 1990 Feb;258(2 Pt 2):R338-45","ArticleIdList":{"ArticleId":"2309926"}},{"Citation":"Muscle Nerve. 2010 Jul;42(1):104-11","ArticleIdList":{"ArticleId":"20583124"}},{"Citation":"Biomarkers. 2009 Nov;14(7):493-501","ArticleIdList":{"ArticleId":"19863188"}},{"Citation":"Mol Neurodegener. 2011;6:79","ArticleIdList":{"ArticleId":"22112803"}},{"Citation":"Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098-102","ArticleIdList":{"ArticleId":"8367470"}},{"Citation":"J Alzheimers Dis. 2012;28(3):553-9","ArticleIdList":{"ArticleId":"22027013"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):506-8","ArticleIdList":{"ArticleId":"9343132"}},{"Citation":"FEBS Lett. 2008 Mar 19;582(6):936-42","ArticleIdList":{"ArticleId":"18295603"}},{"Citation":"Am J Psychiatry. 1993 May;150(5):813-5","ArticleIdList":{"ArticleId":"8480830"}},{"Citation":"Acta Neurol Scand. 1988 Dec;78(6):455-9","ArticleIdList":{"ArticleId":"3223231"}},{"Citation":"Brain. 2011 Aug;134(Pt 8):2358-65","ArticleIdList":{"ArticleId":"21653540"}},{"Citation":"Ann Neurol. 2011 Mar;69(3):570-80","ArticleIdList":{"ArticleId":"21400565"}},{"Citation":"Mov Disord. 2011 Jan;26(1):176-81","ArticleIdList":{"ArticleId":"20842692"}},{"Citation":"J Pathol. 2010 May;221(1):13-25","ArticleIdList":{"ArticleId":"20186922"}},{"Citation":"Neurology. 2009 Apr 21;72(16):1411-6","ArticleIdList":{"ArticleId":"19380700"}},{"Citation":"J Neuroimmunol. 2009 Sep 29;214(1-2):109-12","ArticleIdList":{"ArticleId":"19589605"}},{"Citation":"Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837","ArticleIdList":{"ArticleId":"17542011"}},{"Citation":"J Alzheimers Dis. 2010;22(3):933-8","ArticleIdList":{"ArticleId":"20858953"}},{"Citation":"Acta Neurol Scand. 1986 Sep;74(3):245-50","ArticleIdList":{"ArticleId":"2947417"}},{"Citation":"J Lipid Res. 1990 Mar;31(3):545-8","ArticleIdList":{"ArticleId":"2341813"}},{"Citation":"Neurobiol Aging. 2011 Feb;32(2):249-56","ArticleIdList":{"ArticleId":"19328595"}},{"Citation":"Ann Neurol. 2012 Feb;71(2):258-66","ArticleIdList":{"ArticleId":"22367997"}},{"Citation":"Biochem J. 1993 Jul 1;293 ( Pt 1):27-30","ArticleIdList":{"ArticleId":"8328966"}},{"Citation":"Clin Chim Acta. 2009 Jul;405(1-2):143-7","ArticleIdList":{"ArticleId":"19410571"}},{"Citation":"Am J Pathol. 1982 Apr;107(1):41-50","ArticleIdList":{"ArticleId":"6950666"}},{"Citation":"Neurobiol Dis. 2009 Apr;34(1):107-12","ArticleIdList":{"ArticleId":"19162186"}},{"Citation":"Lancet Neurol. 2006 Mar;5(3):228-34","ArticleIdList":{"ArticleId":"16488378"}},{"Citation":"Amyloid. 2012 Jun;19(2):74-80","ArticleIdList":{"ArticleId":"22591216"}},{"Citation":"Protein Eng Des Sel. 2012 Jul;25(7):337-45","ArticleIdList":{"ArticleId":"22670059"}},{"Citation":"J Am Geriatr Soc. 2008 May;56(5):840-6","ArticleIdList":{"ArticleId":"18410327"}},{"Citation":"Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2681-6","ArticleIdList":{"ArticleId":"18272491"}},{"Citation":"J Neurochem. 2010 Dec;115(6):1434-44","ArticleIdList":{"ArticleId":"21044072"}},{"Citation":"Lancet Neurol. 2011 Mar;10(3):230-40","ArticleIdList":{"ArticleId":"21317042"}},{"Citation":"Neurology. 2005 Apr 26;64(8):1404-10","ArticleIdList":{"ArticleId":"15851731"}},{"Citation":"Ann Neurol. 1995 Oct;38(4):649-52","ArticleIdList":{"ArticleId":"7574462"}},{"Citation":"J Alzheimers Dis. 2010;19(3):937-42","ArticleIdList":{"ArticleId":"20157249"}},{"Citation":"J Alzheimers Dis. 2012;28(2):369-75","ArticleIdList":{"ArticleId":"22002789"}},{"Citation":"J Alzheimers Dis. 2011;27(1):119-26","ArticleIdList":{"ArticleId":"21765209"}},{"Citation":"Int J Alzheimers Dis. 2012;2012:391438","ArticleIdList":{"ArticleId":"23133788"}},{"Citation":"J Clin Lab Anal. 1999;13(6):273-9","ArticleIdList":{"ArticleId":"10633294"}},{"Citation":"Acta Neurol Scand. 2012 Feb;125(2):129-35","ArticleIdList":{"ArticleId":"21434877"}},{"Citation":"J Neurosci. 2011 Aug 31;31(35):12483-90","ArticleIdList":{"ArticleId":"21880910"}},{"Citation":"Science. 2010 Dec 24;330(6012):1774","ArticleIdList":{"ArticleId":"21148344"}},{"Citation":"Mov Disord. 2006 Jan;21(1):45-9","ArticleIdList":{"ArticleId":"16116614"}},{"Citation":"Neurology. 1988 Sep;38(9):1402-6","ArticleIdList":{"ArticleId":"3412587"}},{"Citation":"J Alzheimers Dis. 2011;25(1):77-84","ArticleIdList":{"ArticleId":"21335655"}},{"Citation":"Neurology. 2007 Mar 13;68(11):812-9","ArticleIdList":{"ArticleId":"17353469"}},{"Citation":"Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8368-72","ArticleIdList":{"ArticleId":"8078889"}},{"Citation":"J Alzheimers Dis. 2008 May;14(1):17-25","ArticleIdList":{"ArticleId":"18525124"}},{"Citation":"BMC Med Genet. 2010;11:130","ArticleIdList":{"ArticleId":"20840742"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"J Psychiatr Res. 2007 Oct;41(8):667-72","ArticleIdList":{"ArticleId":"16716350"}},{"Citation":"J Biol Chem. 1985 Oct 5;260(22):12224-7","ArticleIdList":{"ArticleId":"2995367"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23111906","DateCompleted":{"Year":"2013","Month":"07","Day":"26"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1098-1004","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"2","PubDate":{"Year":"2013","Month":"Feb"}},"Title":"Human mutation","ISOAbbreviation":"Hum Mutat"},"ArticleTitle":"A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.","Pagination":{"MedlinePgn":"363-73"},"ELocationID":"10.1002\/humu.22244","Abstract":{"AbstractText":"We assessed the geographical distribution of C9orf72 G(4) C(2) expansions in a pan-European frontotemporal lobar degeneration (FTLD) cohort (n = 1,205), ascertained by the European Early-Onset Dementia (EOD) consortium. Next, we performed a meta-analysis of our data and that of other European studies, together 2,668 patients from 15 Western European countries. The frequency of the C9orf72 expansions in Western Europe was 9.98% in overall FTLD, with 18.52% in familial, and 6.26% in sporadic FTLD patients. Outliers were Finland and Sweden with overall frequencies of respectively 29.33% and 20.73%, but also Spain with 25.49%. In contrast, prevalence in Germany was limited to 4.82%. In addition, we studied the role of intermediate repeats (7-24 repeat units), which are strongly correlated with the risk haplotype, on disease and C9orf72 expression. In vitro reporter gene expression studies demonstrated significantly decreased transcriptional activity of C9orf72 with increasing number of normal repeat units, indicating that intermediate repeats might act as predisposing alleles and in favor of the loss-of-function disease mechanism. Further, we observed a significantly increased frequency of short indels in the GC-rich low complexity sequence adjacent to the G(4) C(2) repeat in C9orf72 expansion carriers (P < 0.001) with the most common indel creating one long contiguous imperfect G(4) C(2) repeat, which is likely more prone to replication slippage and pathological expansion.","CopyrightInformation":"\u00a9 2012 Wiley Periodicals, Inc."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Genetics, VIB, Antwerp, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sieben","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Corsmit","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Archetti","ForeName":"Silvana","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Miltenyi","ForeName":"Gabriel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pereira","ForeName":"S\u00f3nia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pimentel","ForeName":"Jos\u00e9","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chiang","ForeName":"Huei-Hsin","Initials":"HH"},{"@attributes":{"ValidYN":"Y"},"LastName":"Westerlund","ForeName":"Marie","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Almeida","ForeName":"Maria Ros\u00e1rio","Initials":"MR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santiago","ForeName":"Beatriz","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vom Hagen","ForeName":"Jennifer M\u00fcller","Initials":"JM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Matej","ForeName":"Radoslav","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Parobkova","ForeName":"Eva","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Str\u00f6bel","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Danek","ForeName":"Adrian","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Arzberger","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fabrizi","ForeName":"Gian Maria","Initials":"GM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Martin","ForeName":"Jean-Jacques","Initials":"JJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenberghe","ForeName":"Rik","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter Paul","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Corsmit","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter P","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter P","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Archetti","ForeName":"Silvana","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00fcller Vom Hagen","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00fcller Vom Hagen","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurzwelly","ForeName":"Delia","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sachtleben","ForeName":"Carmen","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mairer","ForeName":"Wolfgang","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Miltenyi","ForeName":"Gabriel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pereira","ForeName":"S\u00f3nia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Firmo","ForeName":"Clara","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pimentel","ForeName":"Jos\u00e9","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Antonell","ForeName":"Anna","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Molinuevo","ForeName":"Jose","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chiang","ForeName":"Huei-Hsin","Initials":"HH"},{"@attributes":{"ValidYN":"Y"},"LastName":"Westerlund","ForeName":"Marie","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kinhult St\u00e5hlbom","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Thonberg","ForeName":"H\u00e5kan","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nennesmo","ForeName":"Inger","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00f6rjesson-Hanson","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bessi","ForeName":"Valentina","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Piaceri","ForeName":"Irene","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santiago","ForeName":"Beatriz","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Helena Ribeiro","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ros\u00e1rio Almeida","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Oliveira","ForeName":"Catarina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Massano","ForeName":"Jo\u00e3o","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Garret","ForeName":"Carolina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pires","ForeName":"Paula","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Str\u00f6bel","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurzwelly","ForeName":"Delia","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sachtleben","ForeName":"Carmen","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mairer","ForeName":"Wolfgang","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Matej","ForeName":"Radoslav","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Parobkova","ForeName":"Eva","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Danel","ForeName":"Adrian","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Arzberger","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maria Fabrizi","ForeName":"Gian","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrari","ForeName":"Sergio","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cavallaro","ForeName":"Tiziana","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"European Early-Onset Dementia Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Meta-Analysis","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"01","Day":"04"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Hum Mutat","NlmUniqueID":"9215429","ISSNLinking":"1059-7794"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alleles"},{"DescriptorName":"Alzheimer Disease","QualifierName":"genetics"},{"DescriptorName":"Base Sequence"},{"DescriptorName":"C9orf72 Protein"},{"DescriptorName":"Chromosomes, Human, Pair 9","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"DNA Repeat Expansion"},{"DescriptorName":"Europe","QualifierName":"epidemiology"},{"DescriptorName":"Finland","QualifierName":"epidemiology"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["epidemiology","genetics"]},{"DescriptorName":"Genome-Wide Association Study","QualifierName":"methods"},{"DescriptorName":"Genomic Instability"},{"DescriptorName":"Germany","QualifierName":"epidemiology"},{"DescriptorName":"Haplotypes"},{"DescriptorName":"Humans"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Molecular Sequence Data"},{"DescriptorName":"Prevalence"},{"DescriptorName":"Proteins","QualifierName":"genetics"},{"DescriptorName":"Spain","QualifierName":"epidemiology"},{"DescriptorName":"Sweden","QualifierName":"epidemiology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"06","Day":"29"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"10","Day":"09"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"11","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"11","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"7","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23111906","10.1002\/humu.22244","PMC3638346"]},"ReferenceList":{"Reference":[{"Citation":"Lancet Neurol. 2010 Oct;9(10):978-85","ArticleIdList":{"ArticleId":"20801718"}},{"Citation":"Clin Genet. 2013 Mar;83(3):279-83","ArticleIdList":{"ArticleId":"22650353"}},{"Citation":"J Neurol. 2011 Apr;258(4):647-55","ArticleIdList":{"ArticleId":"21072532"}},{"Citation":"Neuron. 2011 Oct 20;72(2):245-56","ArticleIdList":{"ArticleId":"21944778"}},{"Citation":"Neuron. 2011 Oct 20;72(2):257-68","ArticleIdList":{"ArticleId":"21944779"}},{"Citation":"Neurobiol Aging. 2012 Jan;33(1):209.e3-8","ArticleIdList":{"ArticleId":"21925771"}},{"Citation":"Acta Neuropathol. 2011 Dec;122(6):673-90","ArticleIdList":{"ArticleId":"22083254"}},{"Citation":"Acta Neuropathol. 2011 Dec;122(6):691-702","ArticleIdList":{"ArticleId":"22101323"}},{"Citation":"PLoS One. 2011;6(12):e28260","ArticleIdList":{"ArticleId":"22163004"}},{"Citation":"Methods Mol Biol. 2000;132:365-86","ArticleIdList":{"ArticleId":"10547847"}},{"Citation":"Am J Med Genet. 2000 Jul 17;93(2):99-106","ArticleIdList":{"ArticleId":"10869110"}},{"Citation":"Cell. 1994 Jun 17;77(6):853-61","ArticleIdList":{"ArticleId":"7911740"}},{"Citation":"Hum Mol Genet. 1998 Nov;7(12):1935-46","ArticleIdList":{"ArticleId":"9811938"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Hum Mol Genet. 1999 Jun;8(6):1061-7","ArticleIdList":{"ArticleId":"10332038"}},{"Citation":"Genome Res. 2005 Mar;15(3):436-42","ArticleIdList":{"ArticleId":"15741513"}},{"Citation":"Brain. 2006 Apr;129(Pt 4):868-76","ArticleIdList":{"ArticleId":"16495328"}},{"Citation":"Neurology. 2006 Mar 28;66(6):839-44","ArticleIdList":{"ArticleId":"16421333"}},{"Citation":"Eur J Hum Genet. 2008 Feb;16(2):140-2","ArticleIdList":{"ArticleId":"18043718"}},{"Citation":"PLoS Genet. 2008;4(9):e1000193","ArticleIdList":{"ArticleId":"18802454"}},{"Citation":"BMC Neurol. 2008;8:32","ArticleIdList":{"ArticleId":"18755042"}},{"Citation":"Neurology. 2009 May 12;72(19):1669-76","ArticleIdList":{"ArticleId":"19433740"}},{"Citation":"Nat Genet. 2009 Oct;41(10):1083-7","ArticleIdList":{"ArticleId":"19734901"}},{"Citation":"Neurology. 2009 Oct 20;73(16):1280-5","ArticleIdList":{"ArticleId":"19776381"}},{"Citation":"Acta Neuropathol. 2010 Jan;119(1):1-4","ArticleIdList":{"ArticleId":"19924424"}},{"Citation":"Nat Genet. 2010 Mar;42(3):234-9","ArticleIdList":{"ArticleId":"20154673"}},{"Citation":"Arch Neurol. 2010 May;67(5):606-16","ArticleIdList":{"ArticleId":"20457961"}},{"Citation":"BMC Genomics. 2010;11:298","ArticleIdList":{"ArticleId":"20459859"}},{"Citation":"Lancet Neurol. 2010 Oct;9(10):986-94","ArticleIdList":{"ArticleId":"20801717"}},{"Citation":"Lancet Neurol. 2012 Jan;11(1):54-65","ArticleIdList":{"ArticleId":"22154785"}},{"Citation":"Acta Neuropathol. 2012 Mar;123(3):409-17","ArticleIdList":{"ArticleId":"22228244"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):693-708","ArticleIdList":{"ArticleId":"22300873"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):723-35","ArticleIdList":{"ArticleId":"22300876"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):709-22","ArticleIdList":{"ArticleId":"22344582"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):736-50","ArticleIdList":{"ArticleId":"22366791"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):765-83","ArticleIdList":{"ArticleId":"22366793"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):784-93","ArticleIdList":{"ArticleId":"22366794"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):794-806","ArticleIdList":{"ArticleId":"22366795"}},{"Citation":"Lancet Neurol. 2012 Apr;11(4):323-30","ArticleIdList":{"ArticleId":"22406228"}},{"Citation":"Nat Rev Neurol. 2012 May;8(5):249-50","ArticleIdList":{"ArticleId":"22487746"}},{"Citation":"Neuroreport. 2012 Jun 20;23(9):556-9","ArticleIdList":{"ArticleId":"22564974"}},{"Citation":"Neurobiol Aging. 2012 Aug;33(8):1850.e1-11","ArticleIdList":{"ArticleId":"22459598"}},{"Citation":"J Alzheimers Dis. 2012;31(2):447-52","ArticleIdList":{"ArticleId":"22571983"}},{"Citation":"Neuropathology. 2012 Oct;32(5):505-14","ArticleIdList":{"ArticleId":"22181065"}},{"Citation":"Ann Med. 2012 Dec;44(8):817-28","ArticleIdList":{"ArticleId":"22420316"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203","ArticleIdList":{"ArticleId":"20562461"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"22892309","DateCompleted":{"Year":"2013","Month":"03","Day":"12"},"DateRevised":{"Year":"2012","Month":"10","Day":"01"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1558-1497","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"33","Issue":"12","PubDate":{"Year":"2012","Month":"Dec"}},"Title":"Neurobiology of aging","ISOAbbreviation":"Neurobiol Aging"},"ArticleTitle":"Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.","Pagination":{"MedlinePgn":"2949.e13-7"},"ELocationID":["10.1016\/j.neurobiolaging.2012.07.002","S0197-4580(12)00377-6"],"Abstract":{"AbstractText":"Mutations in UBQLN2 have recently been shown to cause dominant X-linked amyotrophic lateral sclerosis (ALS) and ALS plus frontotemporal dementia (FTD). Information on their frequency in different populations is still rare, and a pure FTD phenotype has not yet been reported. Moreover, the mutational spectrum of known UBQLN2 mutations is still limited to its PXX repeat region. Based on a screening of 206 ALS and FTD patients, we here report 3 novel UBQLN2 mutations, accounting for 1.2% (2\/161) ALS and 2.2% (1\/45) FTD patients, including a patient with pure FTD. All mutations were located in highly conserved domains outside the PXX repeat region and not observed in 1450 ethnically matched control X-chromosomes. All affected patients presented with apparently sporadic disease. UBQLN2 mutations are rare in Central European ALS and FTD patients, but contribute significantly to patients with seemingly sporadic disease. UBQLN2 is able to cause any disease on the ALS-FTD continuum, including pure FTD. Because the pathogenic mechanism of UBQLN2 mutations is not limited to its PXX region, UBQLN2 screening in neurodegenerative patients should not be limited to this region.","CopyrightInformation":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany. matthis.synofzik@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Grehl","ForeName":"Torsten","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Prudlo","ForeName":"Johannes","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vom Hagen","ForeName":"Jennifer M\u00fcller","Initials":"JM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Haack","ForeName":"Tobias","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rebassoo","ForeName":"Piret","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Munz","ForeName":"Marita","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Biskup","ForeName":"Saskia","Initials":"S"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2012","Month":"08","Day":"11"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Aging","NlmUniqueID":"8100437","ISSNLinking":"0197-4580"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Cell Cycle Proteins"},{"RegistryNumber":"0","NameOfSubstance":"UBQLN2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Ubiquitins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyotrophic Lateral Sclerosis","QualifierName":["diagnosis","genetics"]},{"DescriptorName":"Animals"},{"DescriptorName":"Cell Cycle Proteins","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["diagnosis","genetics"]},{"DescriptorName":"Genetic Predisposition to Disease"},{"DescriptorName":"Genetic Testing"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation","QualifierName":"genetics"},{"DescriptorName":"Phenotype"},{"DescriptorName":"Repetitive Sequences, Amino Acid","QualifierName":"genetics"},{"DescriptorName":"Ubiquitins","QualifierName":"genetics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"04","Day":"05"},{"@attributes":{"PubStatus":"revised"},"Year":"2012","Month":"06","Day":"03"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"07","Day":"01"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"8","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"8","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"3","Day":"13","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["22892309","S0197-4580(12)00377-6","10.1016\/j.neurobiolaging.2012.07.002"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21765209","DateCompleted":{"Year":"2012","Month":"02","Day":"27"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"27","Issue":"1","PubDate":{"Year":"2011"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-\u03b2 pathway.","Pagination":{"MedlinePgn":"119-26"},"ELocationID":"10.3233\/JAD-2011-110587","Abstract":{"AbstractText":"Recent studies have provided evidence that uric acid (UA), a natural antioxidant, may play a role in the development and progression of Parkinson's disease (PD) and of dementia. In this clinical study we were therefore interested in the role of UA in Lewy body disorders (LBD), which includes Parkinson's disease (PD) and a common form of neurodegenerative dementias, dementia with Lewy bodies (DLB). Ninety-five LBD patients (55 non-demented PD patients, PDND; 20 PD patients with dementia, PDD; and 20 DLB patients) and 76 controls underwent clinical and biochemical analyses including, from a subcohort, cerebrospinal fluid (CSF) analyses, and analysis of three single nucleotide polymorphisms (SNPs) known to be associated with altered serum UA levels. We confirmed previous findings of lowered serum UA levels in LBD patients compared to controls. In CSF, UA levels were significantly higher in PDND patients (median 0.7 mg\/dl) compared only to demented LBD patients (0.4 mg\/dl; p = 0.03), but not to controls (0.5 mg\/dl; p = 0.12). CSF UA levels correlated positively with CSF A\u03b242 levels. This correlation was highest in controls (\u03c1 = 0.67), intermediate in PDND (\u03c1 = 0.49), but not observable in demented LBD patients (\u03c1 = 0.10). These findings suggest an involvement of serum UA in LBD occurrence, and an involvement of CSF UA in cognitive decline in LBD, possibly through the A\u03b2 pathway. SNP rs1165205 (SLC17A3) was weakly associated with altered CSF UA levels. Taken together, our results provide first evidence for disease-relevant but potentially distinct roles of UA in the blood and CSF compartment, respectively, in LBD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stapf","ForeName":"Anne Kathrin","Initials":"AK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauser","ForeName":"Ann-Kathrin","Initials":"AK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lerche","ForeName":"Stefanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wurster","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schleicher","ForeName":"Erwin","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"ABCG2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"ATP Binding Cassette Transporter, Subfamily G, Member 2"},{"RegistryNumber":"0","NameOfSubstance":"ATP-Binding Cassette Transporters"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Glucose Transport Proteins, Facilitative"},{"RegistryNumber":"0","NameOfSubstance":"Neoplasm Proteins"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"Receptors, Drug"},{"RegistryNumber":"0","NameOfSubstance":"SLC12A3 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"SLC2A9 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Solute Carrier Family 12, Member 3"},{"RegistryNumber":"0","NameOfSubstance":"Symporters"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"268B43MJ25","NameOfSubstance":"Uric Acid"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"ATP Binding Cassette Transporter, Subfamily G, Member 2"},{"DescriptorName":"ATP-Binding Cassette Transporters","QualifierName":"genetics"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"genetics"},{"DescriptorName":"Cognition Disorders","QualifierName":"etiology"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Female"},{"DescriptorName":"Glucose Transport Proteins, Facilitative","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","cerebrospinal fluid","complications","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Mental Status Schedule"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neoplasm Proteins","QualifierName":"genetics"},{"DescriptorName":"Peptide Fragments","QualifierName":"genetics"},{"DescriptorName":"Polymorphism, Single Nucleotide"},{"DescriptorName":"Receptors, Drug","QualifierName":"genetics"},{"DescriptorName":"Solute Carrier Family 12, Member 3"},{"DescriptorName":"Symporters","QualifierName":"genetics"},{"DescriptorName":"Uric Acid","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"tau Proteins","QualifierName":"genetics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2011","Month":"7","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2011","Month":"7","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"3","Day":"1","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21765209","TXG367K04008TK87","10.3233\/JAD-2011-110587"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21757905","DateCompleted":{"Year":"2011","Month":"12","Day":"06"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1421-9824","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"31","Issue":"6","PubDate":{"Year":"2011"}},"Title":"Dementia and geriatric cognitive disorders","ISOAbbreviation":"Dement Geriatr Cogn Disord"},"ArticleTitle":"Decreased \u03b1-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects.","Pagination":{"MedlinePgn":"413-6"},"ELocationID":"10.1159\/000329763","Abstract":{"AbstractText":["Detection and differentiation of neurodegenerative dementias, such as dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), with blood-based biomarkers would facilitate diagnosis and treatment.","By use of a commercially available ELISA kit, we measured \u03b1-synuclein levels in the serum of 40 DLB patients and controls, and of 80 AD patients.","We found significantly reduced \u03b1-synuclein serum levels in DLB compared to both AD (p = 0.006) and control subjects (p = 0.001), reaching an area under the curve of >0.70.","Although these results do not justify a definition of serum \u03b1-synuclein as a potential single biomarker, results may contribute to a multimarker strategy in DLB diagnosis."],"CopyrightInformation":"Copyright \u00a9 2011 S. Karger AG, Basel."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, Osianderstrasse 24, T\u00fcbingen, Germany. christoph.laske@med.uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fallgatter","ForeName":"Andreas J","Initials":"AJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hagen","ForeName":"Katja","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2011","Month":"07","Day":"13"}},"MedlineJournalInfo":{"Country":"Switzerland","MedlineTA":"Dement Geriatr Cogn Disord","NlmUniqueID":"9705200","ISSNLinking":"1420-8008"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"blood"},{"DescriptorName":"Area Under Curve"},{"DescriptorName":"Biomarkers","QualifierName":"blood"},{"DescriptorName":"Data Interpretation, Statistical"},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"blood"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"ROC Curve"},{"DescriptorName":"Reproducibility of Results"},{"DescriptorName":"alpha-Synuclein","QualifierName":"blood"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"accepted"},"Year":"2011","Month":"05","Day":"27"},{"@attributes":{"PubStatus":"entrez"},"Year":"2011","Month":"7","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2011","Month":"7","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"12","Day":"13","Hour":"0","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21757905","000329763","10.1159\/000329763"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21593566","DateCompleted":{"Year":"2012","Month":"01","Day":"10"},"DateRevised":{"Year":"2013","Month":"11","Day":"21"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"26","Issue":"1","PubDate":{"Year":"2011"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.","Pagination":{"MedlinePgn":"171-9"},"ELocationID":"10.3233\/JAD-2011-110221","Abstract":{"AbstractText":"There is increasing evidence that in Lewy body-associated dementias (encompassing Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB)), the adaptive immune system is altered and the degenerative process includes glial cells in addition to neuronal structures. We therefore aimed to determine levels of autoantibodies against amyloid and glial-derived structures in these dementia types. Using a newly developed Enzyme-linked immunosorbent assay (ELISA), we measured levels of IgG autoantibodies against neuronal and glial structures in serum and cerebrospinal fluid of a total of 91 subjects (13 PDD, 14 DLB, 11 Alzheimer's disease (AD), 11 frontotemporal dementia (FTD), 11 vascular dementia patients (VaD), and 31 healthy controls). Autoantibody levels against \u03b1-synuclein, amyloid-\u03b2\u2084\u2082 (A\u03b2\u2084\u2082), myelin oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and S100B were determined. In all groups, autoantibody levels were about three magnitudes higher in serum than in CSF. Serum autoantibody levels against \u03b1-synuclein, A\u03b2\u2084\u2082, MOG, MBP, and S100B were higher in PDD\/DLB compared to tau-associated dementias (AD, FTD), VaD, and controls, respectively, with most of them reaching highly significant p-values. In cerebrospinal fluid (CSF), levels of antibodies against oligodendrocyte-derived antigens (MOG, MBP) were significantly increased in PDD\/DLB. Increased levels of autoantibodies against both neuronal- and glial-derived antigens in serum and CSF of Lewy body-associated dementias indicate an altered activity of the adaptive immune system in these dementia types. The potential of neural-derived IgG autoantibodies as part of a biomarker panel for the diagnosis of Lewy body-associated dementias should be further evaluated."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Godau","ForeName":"Jana","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"H\u00f6rnig","ForeName":"Stephanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Langkamp","ForeName":"Markus","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Autoantibodies"},{"RegistryNumber":"0","NameOfSubstance":"MOG protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Myelin Basic Protein"},{"RegistryNumber":"0","NameOfSubstance":"Myelin Proteins"},{"RegistryNumber":"0","NameOfSubstance":"Myelin-Oligodendrocyte Glycoprotein"},{"RegistryNumber":"0","NameOfSubstance":"Nerve Growth Factors"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"S100 Calcium Binding Protein beta Subunit"},{"RegistryNumber":"0","NameOfSubstance":"S100 Proteins"},{"RegistryNumber":"0","NameOfSubstance":"S100B protein, human"},{"RegistryNumber":"0","NameOfSubstance":"alpha-Synuclein"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"immunology"},{"DescriptorName":"Autoantibodies","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Male"},{"DescriptorName":"Myelin Basic Protein","QualifierName":"immunology"},{"DescriptorName":"Myelin Proteins","QualifierName":"immunology"},{"DescriptorName":"Myelin-Oligodendrocyte Glycoprotein"},{"DescriptorName":"Nerve Growth Factors","QualifierName":"immunology"},{"DescriptorName":"Peptide Fragments","QualifierName":"immunology"},{"DescriptorName":"S100 Calcium Binding Protein beta Subunit"},{"DescriptorName":"S100 Proteins","QualifierName":"immunology"},{"DescriptorName":"alpha-Synuclein","QualifierName":"immunology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2011","Month":"5","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2011","Month":"5","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"1","Day":"11","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21593566","RK0K828204J83477","10.3233\/JAD-2011-110221"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20858953","DateCompleted":{"Year":"2011","Month":"06","Day":"09"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"22","Issue":"3","PubDate":{"Year":"2010"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-\u03b242 levels in Lewy body disease.","Pagination":{"MedlinePgn":"933-8"},"ELocationID":"10.3233\/JAD-2010-101197","Abstract":{"AbstractText":"Lewy body disease, defined by the occurrence of \u03b1-synuclein aggregates as fibrils in Lewy bodies and Lewy neurites, is associated with increased probabilities for both co-occurrence of dementia, and co-occurrence of Alzheimer's disease (AD)-like pathology, in particular amyloid-\u03b2 (A\u03b2) plaques and lowered cerebrospinal fluid (CSF) A\u03b242 levels. Not surprisingly, in patients with Lewy body disease patients, there is a strong association between dementia and A\u03b2 pathology. Neprilysin (NEP) is an A\u03b2-degrading protein found at presynaptic terminals and in body fluids. Reduced CSF NEP activity levels have been shown to occur in early AD, suggesting that altered CSF NEP activity levels may also be associated with dementia and lowered CSF A\u03b242 levels in Lewy body disease. Hypothesizing a relation between CSF NEP activity and dementia in Lewy body disease, we determined CSF and serum NEP activity, and A\u03b242 levels of 41 demented Lewy body disease patients, 38 non-demented Lewy body disease patients, and of 23 elderly controls. Demented Lewy body disease patients had lowered CSF NEP activity levels (0.3 pmol\/min*ml, 0.2-81.5), compared to both non-demented Lewy body disease subjects (8.5 pmol\/min*ml, 0.2-87.2; p=0.004) and controls (21.5 pmol\/ml*min, 0.15-413.4; p=0.02). In addition, CSF NEP activity levels correlated positively with CSF A\u03b242 levels (Rho=0.28, p=0.008) which was not explained by the presence or absence of ApoE4. Serum NEP activity levels were not significantly different between the groups. We conclude that, in Lewy body disease, CSF NEP activity levels are associated with dementia, probably via the A\u03b2 pathway."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stoycheva","ForeName":"Velichka","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schmid","ForeName":"Benjamin","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hauser","ForeName":"Ann-Kathrin","Initials":"AK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"EC 3.4.24.11","NameOfSubstance":"Neprilysin"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["cerebrospinal fluid","physiology"]},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Dementia","QualifierName":["cerebrospinal fluid","enzymology","psychology"]},{"DescriptorName":"Enzyme Activation","QualifierName":"physiology"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["cerebrospinal fluid","enzymology","psychology"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neprilysin","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Peptide Fragments","QualifierName":["cerebrospinal fluid","physiology"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"9","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"9","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"6","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20858953","T401674827265652","10.3233\/JAD-2010-101197"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20842692","DateCompleted":{"Year":"2011","Month":"06","Day":"06"},"DateRevised":{"Year":"2013","Month":"11","Day":"21"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1531-8257","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"26","Issue":"1","PubDate":{"Year":"2011","Month":"Jan"}},"Title":"Movement disorders : official journal of the Movement Disorder Society","ISOAbbreviation":"Mov Disord"},"ArticleTitle":"Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases.","Pagination":{"MedlinePgn":"176-81"},"ELocationID":"10.1002\/mds.23358","Abstract":{"AbstractText":"Reduced (GSH(R)) but not oxidized glutathione (GSSG) has been shown to be dramatically altered in the substantia nigra (SN) of Lewy body disease (LBD) patients post mortem; but up to now, there is no convincing evidence that these changes can be monitored in vivo. We investigated GSH(R) and GSSG in rapidly processed cerebrospinal fluid (CSF) and plasma samples of 80 LBD and 35 control subjects and detected reduced CSF GSH(R) levels in LBD subjects. The reduction was negatively associated with age but not with disease-associated parameters. Plasma GSH(R), CSF GSSG, and plasma GSSG levels did not significantly differ between the groups. Our findings confirm the results from neuropathologic studies, which demonstrated an alteration of the glutathione system in LBD. We hypothesize that alterations of the glutathione system occur in a very early stage of the disease or may even represent a risk marker for LBD.","CopyrightInformation":"Copyright \u00a9 2010 Movement Disorder Society."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schmid","ForeName":"Stefan P","Initials":"SP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wurster","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt","ForeName":"Inga","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gaenslen","ForeName":"Alexandra","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2010","Month":"09","Day":"14"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Mov Disord","NlmUniqueID":"8610688","ISSNLinking":"0885-3185"},"ChemicalList":{"Chemical":[{"RegistryNumber":"GAN16C9B8O","NameOfSubstance":"Glutathione"},{"RegistryNumber":"ULW86O013H","NameOfSubstance":"Glutathione Disulfide"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Dementia","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Female"},{"DescriptorName":"Glutathione","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Glutathione Disulfide","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parkinson Disease","QualifierName":["blood","cerebrospinal fluid"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2010","Month":"05","Day":"03"},{"@attributes":{"PubStatus":"accepted"},"Year":"2010","Month":"06","Day":"28"},{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"9","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"9","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"6","Day":"7","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20842692","10.1002\/mds.23358"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20157249","DateCompleted":{"Year":"2010","Month":"05","Day":"05"},"DateRevised":{"Year":"2010","Month":"11","Day":"18"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"19","Issue":"3","PubDate":{"Year":"2010"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.","Pagination":{"MedlinePgn":"937-42"},"ELocationID":"10.3233\/JAD-2010-1289","Abstract":{"AbstractText":"A large proportion of demented Lewy body disease patients have Alzheimer's disease (AD)- like pathology, in particular amyloid-beta (Abeta) plaques. Cystatin C (CysC) is a carrier of soluble Abeta (42) in the cerebrospinal fluid (CSF) and reduces Abeta plaque formation. The CST3 BB genotype leads to a reduced secretion of the protein in vitro and increases the risk for AD, suggesting that variability in the CST3 gene and CysC protein concentration may be associated with dementia in Lewy body disease. We therefore determined the CST3 genotype in 51 demented and 71 nondemented Lewy body disease patients, and in 52 controls, as well as CSF CysC and Abeta (42) levels from 132 of these subjects. The CST3 BB genotype was associated with lowered CSF CysC levels and with dementia. Demented Lewy body disease patients had decreased CSF CysC levels. The correlation between CSF CysC and Abeta (42) levels was high in non-demented subjects, but poor in demented patients. We conclude that, in Lewy body disease, the CST3 BB genotype and low CSF CysC levels are associated with dementia, possibly through a disturbed elimination of soluble Abeta(42)."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegeneration, University of Tuebingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schmid","ForeName":"Benjamin","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Riester","ForeName":"Karin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Huber","ForeName":"Heiko","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brockmann","ForeName":"Kathrin","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"CST3 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Cystatin C"},{"RegistryNumber":"0","NameOfSubstance":"Immunoglobulin G"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"metabolism"},{"DescriptorName":"Amyloidosis","QualifierName":["genetics","metabolism","pathology"]},{"DescriptorName":"Cystatin C","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Female"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Immunoglobulin G","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Lewy Body Disease","QualifierName":["cerebrospinal fluid","diagnosis","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Parkinson Disease","QualifierName":["genetics","metabolism","pathology"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"2","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"2","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2010","Month":"5","Day":"6","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20157249","G931160775412444","10.3233\/JAD-2010-1289"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19909914","DateCompleted":{"Year":"2009","Month":"12","Day":"07"},"DateRevised":{"Year":"2016","Month":"11","Day":"25"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1474-4465","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"8","Issue":"12","PubDate":{"Year":"2009","Month":"Dec"}},"Title":"The Lancet. Neurology","ISOAbbreviation":"Lancet Neurol"},"ArticleTitle":"Progression of Parkinson's disease in the clinical phase: potential markers.","Pagination":{"MedlinePgn":"1158-71"},"ELocationID":"10.1016\/S1474-4422(09)70291-1","Abstract":{"AbstractText":"Neuromodulatory or even neuroprotective therapy could soon be available for Parkinson's disease (PD), raising the question of how we should define and measure disease progression. Reported evidence suggests that several symptoms worsen with disease duration. Bradykinesia, rigidity, and activities of daily living deteriorate faster at the beginning of the disease, and this deterioration is paralleled by a decline in functional presynaptic dopaminergic activity, as shown by imaging techniques. Cognitive, speech, sleep, and gait difficulties might progress linearly in proportion to disease duration. Reduced variability in heart rate, orthostatic dysfunction, and visual hallucinations start to develop at mid-stage disease and are more common in late stages than earlier stages. In this Review, we summarise our current understanding of the progression of PD-associated symptoms and markers and conclude that an effective measurement of progression of PD must adapt to the different stages of the disease. In addition to routine clinical rating scales, new quantitative assessments of motor and non-motor symptoms, which should be more broadly available, reasonably priced, and easy-to-use, are needed."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt","ForeName":"Inga","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't","Review"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Lancet Neurol","NlmUniqueID":"101139309","ISSNLinking":"1474-4422"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Autonomic Nervous System","QualifierName":"physiology"},{"DescriptorName":"Biomarkers"},{"DescriptorName":"Dementia","QualifierName":"etiology"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Executive Function"},{"DescriptorName":"Humans"},{"DescriptorName":"Mental Disorders","QualifierName":["etiology","psychology"]},{"DescriptorName":"Nutritional Physiological Phenomena"},{"DescriptorName":"Parkinson Disease","QualifierName":["diagnostic imaging","pathology","psychology"]},{"DescriptorName":"Quality of Life"},{"DescriptorName":"Radiography"},{"DescriptorName":"Radionuclide Imaging"},{"DescriptorName":"Sensation Disorders","QualifierName":"etiology"},{"DescriptorName":"Sleep Wake Disorders","QualifierName":"etiology"}]},"NumberOfReferences":"148"},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"11","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"11","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"12","Day":"16","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19909914","S1474-4422(09)70291-1","10.1016\/S1474-4422(09)70291-1"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19584438","DateCompleted":{"Year":"2009","Month":"12","Day":"17"},"DateRevised":{"Year":"2010","Month":"11","Day":"18"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"18","Issue":"2","PubDate":{"Year":"2009"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls.","Pagination":{"MedlinePgn":"331-7"},"ELocationID":"10.3233\/JAD-2009-1146","Abstract":{"AbstractText":"As neurotrophic factors play an important role in development and maintenance of global central nervous system (CNS) function, we supposed that glial cell-line derived neurotrophic factor (GDNF), which has been extensively studied for its survival promoting effects especially concerning catecholaminergic neurons, also plays a significant role in neurodegenerative disease characterized mainly by damage of cholinergic CNS neurons like AD. Here we compared GDNF concentrations in serum and cerebrospinal fluid (CSF) of patients with probable Alzheimer's disease (AD) and normal controls (NC). While GDNF concentrations in CSF were significantly increased in patients with AD (291.7 +\/- 85.8 pg\/ml) compared with NC subjects (218.7 +\/- 93.3 pg\/ml, p = 0.012), GDNF concentration of AD patients (486.5 +\/- 72.3 pg\/ml) in serum were significantly decreased compared with the NC group (711.5 +\/- 186.5 pg\/ml, p < 0.001). Increased GDNF in CSF of AD might be due to an upregulated expression in CNS as an adaptive process of the impaired brain to enhance neurotrophic support at least in early stages of disease and\/or impairment of CSF turnover. Decreased serum concentration of GDNF might be related to altered function of the blood brain barrier thus disturbing clearance or facilitating passover of potentially harmful metabolites."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Straten","ForeName":"Guido","Initials":"G","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of T\u00fcbingen, T\u00fcbingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Eschweiler","ForeName":"Gerhard W","Initials":"GW"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Glial Cell Line-Derived Neurotrophic Factor"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Chi-Square Distribution"},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay","QualifierName":"methods"},{"DescriptorName":"Female"},{"DescriptorName":"Glial Cell Line-Derived Neurotrophic Factor","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Mental Status Schedule"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Peptide Fragments","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"tau Proteins","QualifierName":["blood","cerebrospinal fluid"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"7","Day":"9","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"7","Day":"9","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"12","Day":"18","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19584438","6446004642066105","10.3233\/JAD-2009-1146"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19481150","DateCompleted":{"Year":"2009","Month":"09","Day":"21"},"DateRevised":{"Year":"2017","Month":"11","Day":"16"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1095-953X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"35","Issue":"2","PubDate":{"Year":"2009","Month":"Aug"}},"Title":"Neurobiology of disease","ISOAbbreviation":"Neurobiol Dis"},"ArticleTitle":"No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.","Pagination":{"MedlinePgn":"296-301"},"ELocationID":"10.1016\/j.nbd.2009.05.014","Abstract":{"AbstractText":"Butyrylcholinesterase (BChE) genotypes and protein (BuChE) activity, especially in combination with Apolipoprotein E4 (ApoE4), have been investigated as risk factors for developing Alzheimer disease (AD) and may be associated with the rate of progression of cognitive decline. Despite similar pathologic (e.g. amyloid deposition) and neurochemical (e.g. cholinergic deficits) aspects between AD and Lewy body diseases (LBD), scarce data is obtainable about BChE genotypes and BuChE activity in LBD. We measured BuChE activity levels in serum and cerebrospinal fluid (CSF) of 114 LBD subjects (59 of them were demented) and 31 elderly controls. We found higher CSF BuChE activity in males compared to females, and a negative correlation of serum BuChE activity with age and cognitive function. Demented LBD patients, non-demented LBD patients and controls did not differ significantly with regard to serum and CSF BuChE activity. Furthermore, BChE K variant and ApoE4 allele frequencies were determined. The BChE K variant was significantly associated with lower serum activity; the same trend was observable in CSF. The subgroups did not differ significantly with regard to BChE K\/ApoE4 occurrence. These data confirm and extend previous results on the relationship between BChE gene and BuChE activity, and argue rather against a major impact of BuChE on LBD-associated pathologies."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Otfried-M\u00fcller-Strasse 27, Tuebingen D-72076, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Stefanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelis","ForeName":"Joan","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Koehler","ForeName":"Niklas","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Becker","ForeName":"Clemens","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2009","Month":"05","Day":"27"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Dis","NlmUniqueID":"9500169","ISSNLinking":"0969-9961"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoprotein E4"},{"RegistryNumber":"0","NameOfSubstance":"Enzymes"},{"RegistryNumber":"EC 3.1.1.8","NameOfSubstance":"Butyrylcholinesterase"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Aging"},{"DescriptorName":"Apolipoprotein E4","QualifierName":"genetics"},{"DescriptorName":"Butyrylcholinesterase","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Cognition","QualifierName":"physiology"},{"DescriptorName":"Cognition Disorders","QualifierName":["enzymology","genetics"]},{"DescriptorName":"Enzymes","QualifierName":["blood","cerebrospinal fluid","genetics"]},{"DescriptorName":"Female"},{"DescriptorName":"Gene Frequency"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["enzymology","genetics"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Sequence Analysis, DNA"},{"DescriptorName":"Sex Characteristics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"12","Day":"29"},{"@attributes":{"PubStatus":"revised"},"Year":"2009","Month":"04","Day":"09"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"05","Day":"17"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"6","Day":"2","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"6","Day":"2","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"9","Day":"22","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19481150","S0969-9961(09)00111-9","10.1016\/j.nbd.2009.05.014"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19340392","DateCompleted":{"Year":"2009","Month":"08","Day":"14"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1435-1463","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"116","Issue":"5","PubDate":{"Year":"2009","Month":"May"}},"Title":"Journal of neural transmission (Vienna, Austria : 1996)","ISOAbbreviation":"J Neural Transm (Vienna)"},"ArticleTitle":"A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.","Pagination":{"MedlinePgn":"599-605"},"ELocationID":"10.1007\/s00702-009-0209-x","Abstract":{"AbstractText":"In Lewy body disease, inflammation is discussed to be involved in the pathophysiological cascade. Osteopontin (OPN) is a multifunctional molecule, which is increased in inflammatory states. Here, we analyzed the allele frequency of two SNPs of the OPN gene, serum, and CSF OPN levels in Lewy body disease patients and controls. In accordance with our previous findings, we detected increased serum (P = 0.006) and CSF OPN levels (P = 0.0003) in the Lewy body disease cohort, compared to non-Lewy body disease subjects. The genotypic variation of SNP-66 was associated with the occurrence of Lewy body disease (odds ratio: 2.64, 95% CI 1.07-6.54, unadjusted P = 0.036). SNP+1239 was not related to Lewy body disease prevalence (odds ratio 1.61, 95% CI 0.66-3.91, P = 0.29). Genotype prevalence and OPN levels were not significantly related. These findings suggest that OPN is associated with the occurrence of Lewy body disease and SNP-66 may be a susceptibility factor."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tuebingen, T\u00fcbingen, Germany. walter.maetzler@uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelis","ForeName":"Joan","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tomiuk","ForeName":"Juergen","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Becker","ForeName":"Clemens","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2009","Month":"04","Day":"02"}},"MedlineJournalInfo":{"Country":"Austria","MedlineTA":"J Neural Transm (Vienna)","NlmUniqueID":"9702341","ISSNLinking":"0300-9564"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Genetic Markers"},{"RegistryNumber":"106441-73-0","NameOfSubstance":"Osteopontin"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"DNA Mutational Analysis"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Frequency","QualifierName":"genetics"},{"DescriptorName":"Genetic Markers","QualifierName":"genetics"},{"DescriptorName":"Genetic Predisposition to Disease","QualifierName":"genetics"},{"DescriptorName":"Genetic Testing"},{"DescriptorName":"Genetic Variation","QualifierName":"genetics"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["epidemiology","genetics","metabolism"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Osteopontin","QualifierName":["blood","cerebrospinal fluid","genetics"]},{"DescriptorName":"Polymorphism, Single Nucleotide","QualifierName":"genetics"},{"DescriptorName":"Prevalence"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"09","Day":"21"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"03","Day":"17"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"4","Day":"3","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"4","Day":"3","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"8","Day":"15","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19340392","10.1007\/s00702-009-0209-x"]},"ReferenceList":{"Reference":[{"Citation":"J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4","ArticleIdList":{"ArticleId":"1564476"}},{"Citation":"Matrix Biol. 2000 Dec;19(7):615-22","ArticleIdList":{"ArticleId":"11102750"}},{"Citation":"J Cell Physiol. 2000 Jul;184(1):118-30","ArticleIdList":{"ArticleId":"10825241"}},{"Citation":"J Leukoc Biol. 2007 Nov;82(5):1083-94","ArticleIdList":{"ArticleId":"17675560"}},{"Citation":"Acta Neuropathol. 1988;76(3):217-221","ArticleIdList":{"ArticleId":"2850698"}},{"Citation":"Eur J Neurosci. 2005 Apr;21(7):1911-20","ArticleIdList":{"ArticleId":"15869484"}},{"Citation":"J Leukoc Biol. 2007 Jun;81(6):1504-11","ArticleIdList":{"ArticleId":"17369493"}},{"Citation":"Blood. 2004 Feb 15;103(4):1376-82","ArticleIdList":{"ArticleId":"14592838"}},{"Citation":"Hepatol Res. 2003 Jun;26(2):87-90","ArticleIdList":{"ArticleId":"12809934"}},{"Citation":"Neurology. 2002 Jun 25;58(12):1809-15","ArticleIdList":{"ArticleId":"12084881"}},{"Citation":"J Neuroimmunol. 2005 Jun;163(1-2):172-8","ArticleIdList":{"ArticleId":"15885319"}},{"Citation":"J Clin Invest. 1993 Oct;92(4):1686-96","ArticleIdList":{"ArticleId":"8408622"}},{"Citation":"J Neuroimmunol. 2007 Aug;188(1-2):117-27","ArticleIdList":{"ArticleId":"17582512"}},{"Citation":"Stroke. 2006 Jul;37(7):1691-6","ArticleIdList":{"ArticleId":"16741188"}},{"Citation":"Mol Immunol. 2006 Mar;43(7):980-6","ArticleIdList":{"ArticleId":"16009426"}},{"Citation":"J Neuroimmunol. 2003 Mar;136(1-2):125-9","ArticleIdList":{"ArticleId":"12620651"}},{"Citation":"PLoS One. 2008 Mar 12;3(3):e0001757","ArticleIdList":{"ArticleId":"18335026"}},{"Citation":"J Neural Transm Suppl. 1995;46:33-57","ArticleIdList":{"ArticleId":"8821040"}},{"Citation":"Neurobiol Dis. 2007 Mar;25(3):473-82","ArticleIdList":{"ArticleId":"17188882"}},{"Citation":"Arthritis Rheum. 2005 Feb;52(2):539-47","ArticleIdList":{"ArticleId":"15692970"}},{"Citation":"Front Biosci. 2008 Jan 01;13:709-17","ArticleIdList":{"ArticleId":"17981581"}},{"Citation":"Crit Rev Oral Biol Med. 2000;11(3):279-303","ArticleIdList":{"ArticleId":"11021631"}},{"Citation":"Clin Immunol. 2009 Apr;131(1):84-91","ArticleIdList":{"ArticleId":"19138884"}},{"Citation":"Int J Exp Pathol. 2000 Dec;81(6):373-90","ArticleIdList":{"ArticleId":"11298186"}},{"Citation":"Exp Brain Res. 2004 Feb;154(3):275-80","ArticleIdList":{"ArticleId":"14557908"}},{"Citation":"J Biol Chem. 1994 Jan 7;269(1):711-5","ArticleIdList":{"ArticleId":"7506262"}},{"Citation":"FASEB J. 2005 Apr;19(6):533-42","ArticleIdList":{"ArticleId":"15791003"}},{"Citation":"Hum Mutat. 2002 Apr;19(4):459","ArticleIdList":{"ArticleId":"11933203"}},{"Citation":"Nat Immunol. 2007 Jan;8(1):74-83","ArticleIdList":{"ArticleId":"17143274"}},{"Citation":"Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9435-40","ArticleIdList":{"ArticleId":"15197276"}},{"Citation":"Cancer Metastasis Rev. 2008 Mar;27(1):103-18","ArticleIdList":{"ArticleId":"18049863"}},{"Citation":"J Immunol. 2001 Jan 15;166(2):1079-86","ArticleIdList":{"ArticleId":"11145688"}},{"Citation":"Brain Res. 2006 Nov 6;1118(1):239-50","ArticleIdList":{"ArticleId":"16962083"}},{"Citation":"Neurology. 2007 Mar 13;68(11):812-9","ArticleIdList":{"ArticleId":"17353469"}},{"Citation":"Lab Invest. 1993 Sep;69(3):355-63","ArticleIdList":{"ArticleId":"8377476"}},{"Citation":"Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2302-9","ArticleIdList":{"ArticleId":"17717292"}},{"Citation":"J Leukoc Biol. 1996 Sep;60(3):397-404","ArticleIdList":{"ArticleId":"8830797"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19162186","DateCompleted":{"Year":"2009","Month":"05","Day":"05"},"DateRevised":{"Year":"2016","Month":"11","Day":"25"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1095-953X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"1","PubDate":{"Year":"2009","Month":"Apr"}},"Title":"Neurobiology of disease","ISOAbbreviation":"Neurobiol Dis"},"ArticleTitle":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.","Pagination":{"MedlinePgn":"107-12"},"ELocationID":"10.1016\/j.nbd.2008.12.008","Abstract":{"AbstractText":"About one fourth of Lewy body disease (LBD) patients show cortical beta-amyloid load, basically a hallmark of Alzheimer disease (AD). Using [11C]PIB-PET, we tested whether LBD patients with beta-amyloid burden differ from those without with respect to demographic, clinical, biochemical and genetic parameters. Thirty-five LBD subjects (9 patients with Lewy body dementia, DLB; 12 demented Parkinson patients, PDD; 14 non-demented PD, PDND) underwent [11C]PIB-PET, and were classified as either PIB(+) or PIB(-) according to cortical PIB uptake. PIB+ and PIB(-) patients were then compared according to demographic, clinical, biochemical and genetic parameters. None of the PDND, but four PDD and four DLB subjects were PIB+. In PIB+ subjects, ApoE4 prevalence was higher, CSF Abeta42 levels were lower and, among demented patients, PIB-binding was associated with a lower MMSE score. Motor symptoms were not associated with PIB binding. Thus, LBD patients with cortical beta-amyloid show characteristics usually observed in AD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt","ForeName":"Inga","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Reimold","ForeName":"Matthias","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Reischl","ForeName":"Gerald","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Solbach","ForeName":"Christoph","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Becker","ForeName":"Clemens","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schulte","ForeName":"Claudia","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Keller","ForeName":"Stefanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Melms","ForeName":"Arthur","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2008","Month":"12","Day":"31"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Dis","NlmUniqueID":"9500169","ISSNLinking":"0969-9961"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Aniline Compounds"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoprotein E4"},{"RegistryNumber":"0","NameOfSubstance":"Carbon Radioisotopes"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"Thiazoles"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["cerebrospinal fluid","metabolism"]},{"DescriptorName":"Aniline Compounds","QualifierName":"metabolism"},{"DescriptorName":"Apolipoprotein E4","QualifierName":"metabolism"},{"DescriptorName":"Brain","QualifierName":"metabolism"},{"DescriptorName":"Carbon Radioisotopes"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["diagnostic imaging","metabolism"]},{"DescriptorName":"Likelihood Functions"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Parkinson Disease","QualifierName":["diagnostic imaging","metabolism"]},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Positron-Emission Tomography"},{"DescriptorName":"Regression Analysis"},{"DescriptorName":"Sequence Analysis, DNA"},{"DescriptorName":"Thiazoles","QualifierName":"metabolism"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"11","Day":"02"},{"@attributes":{"PubStatus":"revised"},"Year":"2008","Month":"12","Day":"15"},{"@attributes":{"PubStatus":"accepted"},"Year":"2008","Month":"12","Day":"20"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"1","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"1","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"5","Day":"6","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19162186","S0969-9961(08)00319-7","10.1016\/j.nbd.2008.12.008"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18035558","DateCompleted":{"Year":"2008","Month":"03","Day":"25"},"DateRevised":{"Year":"2016","Month":"11","Day":"24"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1053-8119","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"39","Issue":"3","PubDate":{"Year":"2008","Month":"Feb","Day":"01"}},"Title":"NeuroImage","ISOAbbreviation":"Neuroimage"},"ArticleTitle":"[11C]PIB binding in Parkinson's disease dementia.","Pagination":{"MedlinePgn":"1027-33"},"Abstract":{"AbstractText":"[(11)C]PIB ((11)C-6-OH benzothiazole) reflects the regional distribution of amyloid (beta-sheeted proteins) in patients with Alzheimer's disease (AD). Proteinaceous inclusions in Parkinson's disease with dementia (PDD), so-called Lewy bodies, also consist of fibrillar, misfolded proteins, chiefly alpha-synuclein. To test whether PDD subjects show specific amyloid binding in vivo and whether this could reflect fibrillar alpha-synuclein accumulation, we investigated 10 PDD subjects with [(11)C]PIB-PET. Radioligand binding was compared to that in 11 control and 6 AD subjects. Furthermore, postmortem sections of 4 patients with Parkinson's disease (PD), therefrom 2 with dementia (PDD), and of 6 controls were stained with PIB to evaluate the histological distribution of the fluorescent ligand in the brainstem. In PET, only 2 PDD patients displayed increased PIB binding to cortical amyloid comparable to AD patients. The other 8 patients showed control-like cortical findings but elevated PIB binding in the pons and mesencephalon. Fluorescence microscopy showed PIB binding to Lewy bodies and neuromelanin in the substantia nigra of PD and PDD brainstem sections, but not in controls. These data suggest that PIB-PET can be used to further differentiate PDD with respect to cortical amyloid. Furthermore, we provide evidence that--in addition to nonspecific binding--PIB uptake in the brainstem may also reflect PDD related amyloid."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Reimold","ForeName":"Matthias","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt","ForeName":"Inga","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Solbach","ForeName":"Christoph","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schweitzer","ForeName":"Katherine","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eschweiler","ForeName":"Gerhard W","Initials":"GW"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mittelbronn","ForeName":"Michel","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gaenslen","ForeName":"Alexandra","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Uebele","ForeName":"Michael","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Reischl","ForeName":"Gerald","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Machulla","ForeName":"Hans-J\u00fcrgen","Initials":"HJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bares","ForeName":"Roland","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2007","Month":"10","Day":"22"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neuroimage","NlmUniqueID":"9215515","ISSNLinking":"1053-8119"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole"},{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Aniline Compounds"},{"RegistryNumber":"0","NameOfSubstance":"Melanins"},{"RegistryNumber":"0","NameOfSubstance":"Radiopharmaceuticals"},{"RegistryNumber":"0","NameOfSubstance":"Thiazoles"},{"RegistryNumber":"0","NameOfSubstance":"neuromelanin"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"pathology"},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"metabolism"},{"DescriptorName":"Aniline Compounds"},{"DescriptorName":"Brain","QualifierName":["diagnostic imaging","pathology"]},{"DescriptorName":"Dementia","QualifierName":["diagnostic imaging","etiology"]},{"DescriptorName":"Diagnosis, Differential"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"diagnostic imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Melanins","QualifierName":"metabolism"},{"DescriptorName":"Microscopy, Fluorescence"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Parkinson Disease","QualifierName":["complications","diagnostic imaging"]},{"DescriptorName":"Protein Structure, Secondary"},{"DescriptorName":"Radionuclide Imaging"},{"DescriptorName":"Radiopharmaceuticals"},{"DescriptorName":"Thiazoles"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2007","Month":"04","Day":"04"},{"@attributes":{"PubStatus":"revised"},"Year":"2007","Month":"09","Day":"24"},{"@attributes":{"PubStatus":"accepted"},"Year":"2007","Month":"09","Day":"29"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2007","Month":"11","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"3","Day":"26","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2007","Month":"11","Day":"24","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18035558","S1053-8119(07)00902-0","10.1016\/j.neuroimage.2007.09.072"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"17389795","DateCompleted":{"Year":"2007","Month":"07","Day":"24"},"DateRevised":{"Year":"2008","Month":"03","Day":"24"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1420-8008","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"23","Issue":"6","PubDate":{"Year":"2007"}},"Title":"Dementia and geriatric cognitive disorders","ISOAbbreviation":"Dement Geriatr Cogn Disord"},"ArticleTitle":"Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.","Pagination":{"MedlinePgn":"351-67"},"Abstract":{"AbstractText":"In Parkinsonian syndromes behavioural symptoms and dementia can be even more debilitating than motor symptoms and are an important predictor for nursing home placement and mortality. Neuropathologically, dementia seems to be primarily related to cortical changes rather than to subcortical alterations. Concerning neurotransmitter systems, the cholinergic system has been proposed to play a key role in cognitive disturbances. Based on studies with patients with Alzheimer disease, the application of cholinesterase inhibitors is vividly discussed also for dementia associated with parkinsonian syndromes. This review focuses on the specific symptoms of dementia in different parkinsonian syndromes and critically questions the effect of cholinergic treatment on cognitive functions in patients with extrapyramidal syndromes and dementia. There is evidence that medication with some cholinesterase inhibitors can enhance cognition as well as activities of daily living in dementia with Parkinson's disease and seems to reduce behavioural disturbances in both dementia with Parkinson's disease and dementia with Lewy bodies. The effect of treatment with cholinesterase inhibitors in progressive supranuclear palsy and corticobasal degeneration warrants carefully designed studies including a sufficient number of patients and symptom-adopted dementia scales."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Liepelt","ForeName":"Inga","Initials":"I","AffiliationInfo":{"Affiliation":"Hertie Institute for Clinical Brain Research, University of Tubingen, Tubingen, Germany. info-hih@med.uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Blaicher","ForeName":"Hans-Peter","Initials":"HP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasser","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Berg","ForeName":"Daniela","Initials":"D"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't","Review"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2007","Month":"03","Day":"26"}},"MedlineJournalInfo":{"Country":"Switzerland","MedlineTA":"Dement Geriatr Cogn Disord","NlmUniqueID":"9705200","ISSNLinking":"1420-8008"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Basal Ganglia Diseases","QualifierName":["complications","drug therapy","psychology"]},{"DescriptorName":"Behavioral Symptoms","QualifierName":["complications","drug therapy"]},{"DescriptorName":"Cholinesterase Inhibitors","QualifierName":"therapeutic use"},{"DescriptorName":"Dementia","QualifierName":["diagnosis","drug therapy","etiology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":["complications","drug therapy","psychology"]},{"DescriptorName":"Male"},{"DescriptorName":"Parkinsonian Disorders","QualifierName":["complications","drug therapy","psychology"]},{"DescriptorName":"Supranuclear Palsy, Progressive","QualifierName":["complications","drug therapy","psychology"]}]},"NumberOfReferences":"176"},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"accepted"},"Year":"2006","Month":"11","Day":"25"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2007","Month":"3","Day":"29","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2007","Month":"7","Day":"25","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2007","Month":"3","Day":"29","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["17389795","000101337","10.1159\/000101337"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16554070","DateCompleted":{"Year":"2007","Month":"04","Day":"10"},"DateRevised":{"Year":"2007","Month":"02","Day":"07"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"0022-3956","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"41","Issue":"5","PubDate":{"Year":"2007","Month":"Aug"}},"Title":"Journal of psychiatric research","ISOAbbreviation":"J Psychiatr Res"},"ArticleTitle":"BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.","Pagination":{"MedlinePgn":"387-94"},"Abstract":{"AbstractText":"Alzheimer's disease (AD) and normal pressure hydrocephalus (NPH) are common forms of dementia in the elderly. Recent findings have suggested an involvement of brain-derived neurotrophic factor (BDNF) in the pathogenesis of AD. BDNF is an endogenous protein involved in the maintenance of neuronal function, synaptic plasticity and structural integrity in the adult brain. BDNF serum and cerebrospinal fluid (CSF) concentrations were assessed by a sensitive ELISA in 27 AD patients in comparison to 9 NPH patients and 28 age-matched healthy controls (10 CSF samples). We found a significant decrease of BDNF serum concentration in AD (18.6ng\/ml) and NPH patients (18.1ng\/ml) as compared to healthy controls (21.3ng\/ml; p=0.041\/p=0.017). BDNF serum concentrations did not correlate with CSF levels, age or MMSE scores both in AD and NPH patients. In unconcentrated CSF samples, BDNF could be detected in AD patients in 8\/27 cases (29.6%; mean of 4.6pg\/ml), in NPH patients in 1\/9 cases (11.1%; mean of 6.4pg\/ml) and in the control subjects in 5\/10 cases (50%; mean of 1.6pg\/ml) with no significant differences as regards mean concentration and frequency of detectable BDNF in CSF. The decrease of BDNF serum levels in AD and NPH may reflect a lack of trophic support and thus contribute to progressive degeneration in both diseases. In contrast to serum, CSF seems to be no useful source to determine BDNF in AD or NPH because of too low concentrations. Further examinations have to follow to elucidate the potential sources and the meaning of reduced BDNF levels in the blood in AD and NPH."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Laske","ForeName":"Christoph","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Osianderstr. 24, D-72076 Tuebingen, Germany. christoph.laske@med.uni-tuebingen.de"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stransky","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leyhe","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eschweiler","ForeName":"Gerhard W","Initials":"GW"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wittorf","ForeName":"Andreas","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Soekadar","ForeName":"Surjo","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Richartz","ForeName":"Elke","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Koehler","ForeName":"Niklas","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartels","ForeName":"Mathias","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Buchkremer","ForeName":"Gerhard","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schott","ForeName":"Klaus","Initials":"K"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2006","Month":"03","Day":"22"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"J Psychiatr Res","NlmUniqueID":"0376331","ISSNLinking":"0022-3956"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Brain-Derived Neurotrophic Factor"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Brain-Derived Neurotrophic Factor","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Enzyme-Linked Immunosorbent Assay"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Hydrocephalus, Normal Pressure","QualifierName":["blood","cerebrospinal fluid"]},{"DescriptorName":"Male"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2005","Month":"12","Day":"05"},{"@attributes":{"PubStatus":"revised"},"Year":"2006","Month":"01","Day":"10"},{"@attributes":{"PubStatus":"accepted"},"Year":"2006","Month":"01","Day":"16"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"3","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2007","Month":"4","Day":"11","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"3","Day":"24","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16554070","S0022-3956(06)00021-5","10.1016\/j.jpsychires.2006.01.014"]}}}]}